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The aim of this work was to improve the utility of hollow fibre bioreactors (HFB) for the growth of 
clinically applicable cell populations by improving initial rates of cell attachment using a novel dynamic 
seeding methods, and to investigate their use as a novel cell encapsulation device for the delivery of 
cell therapies to infarcted heart tissue.  
Cardiac cell therapies starting are traditionally administered by direct injection or intravenous infusion 
to a target area in the heart. Mesenchymal stem cells (MSCs) have shown promise as a cell therapy and 
can be isolated from a patient’s adipose tissue surrounding the heart, allowing 812,800 ± 318,400 cells 
to be harvested; however this population requires expansion to a minimum of 50 million cells to be an 
effective traditionally administered dose in humans. Hollow fibre bioreactors have shown to offer the 
highest rates of MSC growth compared to other bioreactor designs, owing to their large surface area to 
volume ratio and their ability to provide the cells with a low shear environment that can emulate in vivo 
conditions. However, a concern with using HFBs is the relatively low rates of initial cell attachment, 
with authors observing rates around 20%. At this rate of attachment and with an initial population of 
812,800 ± 318,400 cells, it would take 12.6 ± 5.2 days to grow 50 million MSCs in a HFB. For use as 
a medical intervention the MSCs must be grown as soon as possible, and to ensure this the efficiency 
of cell seeding on the external hollow fibre surface must be as high as possible. In an attempt to improve 
rates of initial cell attachment Chapter 4 illustrated how dynamic seeding can allow additional 
opportunities for a given cell to make contact with hollow fibres contained in a bioreactor. MG63 human 
osteosarcoma cells were used as an alternative cell type due to their lower cost and increased resilience 
over a greater number of passages. Static horizontal seeding of MG63 cells on single fibre bioreactors 
provided 18% ± 16% cell attachment confirming values found in literature, however dynamic 
attachment on horizontally orientated multi fibre bioreactors rotating at 6 RPM offered improved 
attachment of 39% ± 12%, double the rate of static attachment. At this improved rate of cell attachment, 
it would now take 11.2 ± 4.7 days to grow 50 million cells, 1.4 days quicker than before. This novel 
approach to HFB seeding will lead to quicker administration of medical treatments for patients.   
While traditional delivery methods have shown to improve heart function, the active dose retained at 
the wound site is around 2%, much lower than that actually administered. Cells can be ejected from the 
insertion site due to heart contractions, and doses contained in the bloodstream become highly diluted. 
Engineered alternatives include cellular sheets, cell-loaded sutures, and cell encapsulation within 
hydrogels. However, each of these have their own inherent limitations, with cellular sheets 
demonstrating poor rates of migration into infarct site, cells on suture surfaces shearing away when 
sown into a wound site, and cells in hydrogels suffering from poor initial rates of engraftment. 
Hollow fibres made from poly(lactic-co-glycolic acid) (PLGA) were further investigated for use as an 
engineered cell delivery vector, with cells seeded within the hollow fibre lumen, allowing cells to be 
protected during implantation, biodegrade, and provide a concentrated cell dose at a wound site. Hollow 
fibre scaffolds have been used as a delivery device for encapsulation of pharmaceuticals, but never for 
encapsulation of cells in this manner. Chapter 5 investigates the development of a hollow fibre with 
internal and external surface porosity, which allowed passive permeation of liquid through its structure 
from one side to the other. Manufacturing a hollow fibre using NaCl porogen at 60% the weight of 
PLGA resulted in pores 4 – 6 µm in diameter, which provided the desired liquid permeation 
characteristics and a flux of 6.6 m3m-2h-1bar-1 (± 77%). Chapter 6 sought to encapsulate a population of 
MG63 cells within the lumen of the hollow fibre, fed by permeation of media flowing in the 
extracapillary space (ECS), and investigate the viability of cells over a 6 day time course. Studies 
revealed that the cells became non-viable after 24 hours as a result of poor rates of dissolved oxygen 
permeation. Subsequent modelling of the system showed that an increased ECS flow rate of a 
1.49 mL/min should provide sufficient dissolved oxygen to sustain a population of 100,000 cells in this 
system.  This work demonstrates a vital first step in exploring a potential evolution in cell delivery, with 
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1. CHAPTER ONE: INTRODUCTION 
1.1 THE NEED FOR HEART TISSUE ENGINEERING 
All organs have potential for infection or injury, and the heart is no exception, however the 
impact of heart disorders on patients and the associated costs are comparatively greater than 
any other organ disease. The National Health Service (NHS) in the United Kingdom spent 
approximately £6.8 billion on treating cardiovascular disease with in the tax year 2012/2013 
(BHF, 2014) making up 7.2% of the total NHS budget that year (NHS-England, 2013), with 
costs set to rise greatly before the end of the decade (Cebr, 2014). This is second only to mental 
health spending, but greater than the funds allocated to treat the respiratory system, 
gastrointestinal system, musculoskeletal system and sensory organs. Including private 
institutions, the direct healthcare cost of cardiovascular disease in the UK is approximately 
£8.7 billion, with an additional economic bill of over £10.3 billion for loss of patient 
productivity and the costs of informal care by spouses, family members, friends etc. This is 
displayed in Table 1.1 (Nichols, 2012). 
Table 1.1 – Total Costs of Cardiovascular Disease in the UK in 2009 (Nichols, 2012). 
Healthcare Parameter Cost (£1,000's) % of Total 
Primary care  1,123,675 5.9% 
Outpatient care  1,027,352 5.4% 
A&E 154,784 0.8% 
Inpatient care 4,363,721 23.0% 
Medications 2,011,360 10.6% 
Productivity loss due to mortality 4,023,834 21.2% 
Productivity loss due to morbidity 2,446,575 12.9% 
Informal care costs 3,797,564 20.0% 
Total 18,948,865 100.0% 
Cardiovascular disease, an umbrella term for any disease that affects the cardiovascular 
system, is the second largest cause of death in the UK (second only to dementia), causing 27% 
of all deaths in 2014 (BHF, 2015). The number of deaths has been in decline since the 1960’s, 
due to a combination of improved treatment and mitigation of risk factors. An increased 
survival rate from heart attacks is the main reason, which can be characterised by an upward 
trend in the number of prescriptions being written to prevent and treat cardiovascular disease 
and an increase in the number of heart surgeries. In 2014 approximately 313 million 
prescriptions were written, with 92,000 instances of percutaneous coronary interventions and 
180 whole heart transplant surgeries performed (BHF, 2015). Reduction in behavioural risk 
factors such as an overall decline in smoking and the consumption of fats have also helped to 




mitigate heart disease, but a decrease in the prevalence for individuals to perform physical 
activity and an increase in childhood obesity is countering this effect (BHF, 2015). 
Given the remarkably high cost of treating cardiovascular disease and the general 
unavailability of replacement hearts from donors, the field of tissue engineering has been 
investigating how to treat heart problems using cell therapies. In this report the work is 
continued.  
1.2 AIM OF THE RESEARCH 
The research contained in this report aims to assist the field of heart tissue engineering by 
applying the principles of engineering, biology and material science to address the current 
limitations of heart tissue engineering. Specifically, this report aims to improve the initial rate 
of cell attachment on poly (lactic-co-glycolic) acid (PLGA) hollow fibre membranes within 
hollow fibre bioreactors (HFB), to facilitate an acceleration in the acquisition of a clinically 
applicable number of cells for use as a cell therapy for the heart. In parallel with this, hollow 
fibres made from PLGA will be modified with sodium chloride (NaCl) in order to impart a 
surface porosity to its external structure, which will allow the prolonged culture of cells within 
a perfused flow HFB system. PLGA hollow fibres will also be investigated for use as a device 
to encapsulate cells, which could be used to deliver cell therapies into the heart, while 
overcoming the limitations of current methods.   
1.3 OUTLINE OF THESIS 
This report is presented in six chapters. Chapter One is an introduction to the report which 
shows a basic financial assessment and the moral costs of heart disease in the UK, and the 
important trends and statistics in heart health. The research to be conducted in this report is 
presented.  
Chapter Two reviews the available literature on the subject of heart tissue engineering. 
Initially tissue engineering is defined, including a brief history of major historical events in 
the field. Next, major breakthroughs in heart surgery are discussed, including the introduction 
of cell therapies as treatment option, and the fundamentals of heart anatomy and histology are 
explored. Cell types with clinical applications in heart tissue engineering are investigated, as 
well as the technologies used to grow these cells. Methods of cell delivery into the heart are 
reviewed, and their limitations discussed; followed by outlining the available methods used to 
manufacture hollow fibres, and the ways surface porosity can be imparted onto this scaffold. 
It concludes with outlining the aims and objectives of Chapter Four, Chapter Five and Chapter 
Six. 




Chapter Three describes the various materials and methods used in the experiments shown in 
Chapter Four, Chapter Five and Chapter Six. Materials used for this work are subcategorised 
into those used for cell culture, cell analysis, membrane production and bioreactor 
construction; including a list of lab consumables and equipment. Experimental procedures for 
manufacture of flat sheet and hollow fibre membranes are described, as well as cell attachment 
on or within these scaffolds, including production of the NaCl porogen. Analytical methods 
used to investigate scaffold properties such as porosity and permeability are shown; including 
assays investigating cell viability and media composition. Chapter Three concludes with a 
statistical methods section, documenting the statistical analyses undertaken in this report. 
Chapter Four analyses cell attachment onto flat sheets of PLGA to determine the time needed 
for different levels of cell attachment. Following this, both static and dynamic seeding 
experiments are conducted on single module hollow fibre bioreactors, and then subsequently 
on larger bundles of hollow fibres using static and dynamic seeding methods. Cell attachment 
efficiency is determined through a combination of mass balances and picogreen assay. This 
chapter includes discussion of the feasibility of the hollow fibre bioreactor system in light of 
the conclusions drawn from the experiments within Chapter Four and a thorough error analysis 
of the available data. 
Chapter Five investigates how the surface porosity of PLGA hollow fibres can be changed by 
supplementing the polymer dope with different quantities of NaCl porogen. Four different 
proportions of NaCl will be added, with the resulting scaffolds imaged and analysed to 
determine the resulting degree of porosity and if any trends emerge. The porous scaffolds will 
then be tested for their gas and liquid permeability to determine the optimum degree of 
porosity to allow sufficient media flow when used in a hollow fibre bioreactor.    
Chapter Six studies the feasibility of using a porous hollow fibre to maintain an internally 
seeded cell population, specifically investigating if cells are affected by media flow rate in a 
continuously recycling hollow fibre bioreactor system. Cell viability is analysed by picogreen 
assay, and concentrations of D-glucose and L-lactic acid in the media are monitored over a 
six day time course. This is a vital first step to determine the feasibility for hollow fibres to be 
used as devices for cell encapsulation. 
Chapter Seven concludes the studies undertaken in this report and proposes avenues for future 
work in the areas of dynamic cell attachment, porous hollow fibre manufacture and internally 
encapsulated cell viability.  
 































2. CHAPTER TWO: IDENTIFYING THE 
LIMITATIONS OF CELL THERAPIES FOR 
HEART TISSUE REPAIR  
2.1 INTRODUCTION 
Tissue engineering is a branch of engineering which pools knowledge from cell biology, 
material science and engineering methodology to improve or replace biological functions in 
the human body (Culme-Seymour, 2012). It encompasses areas of medicine such as surgical 
implants, organ transplants and targeted drug delivery. Typically cells are seeded onto a three 
dimensional (3D) biological scaffold specially manufactured to ensure good biocompatibility 
with the attached cells and host’s extracellular matrix (ECM) within the target tissue. 
A branch of tissue engineering is regenerative medicine, which investigates how the human 
body’s own cells can be applied as ‘cell therapies’ to treat diseases and injuries. Cells can be 
removed from a patient, grown or modified in the laboratory, and reintroduced to a wound 
area within that patient. This method is used to aid in the healing of damaged organs without 
the risk of rejection by the host tissue (Mason and Dunnill, 2007). These cells may be one of 
many differentiated cell types in the body known as somatic cells, or undifferentiated adult or 
embryo derived stem cells.  
The advancement of medical science and development of new technologies in the last century 
has led to improved outcomes for patients suffering from heart conditions.   The design of the 
heart-lung machine to maintain oxygenated blood flow around the body led to the first 
successful heart operation in 1953 (Cohn, 2003). This technology is still used today for 
operations such as valve replacement and coronary bypass surgeries. The first tissue grafts to 
treat damaged regions of the heart were utilised in a surgical procedure called cardiomyoplasty 
in 1985, which sourced an autograft of skeletal muscle from the patient that was sewn into the 
wound site of the heart and activated by electrical stimulation to aid heart contraction 
(Carpentier and Chachques, 1985). 
It wasn’t until the 1990’s that cell therapies were investigated as a method for regenerating 
scarred heart tissue. A successful study on transplanting functional skeletal myoblasts onto 
diseased myocardium was published in 1993 (Koh et al., 1993), quickly followed by 
transplanting foetal cardiomyocytes (Soonpaa et al., 1994). Later studies on rat models 
investigated injecting skeletal myoblasts suspended in culture media and phosphate buffered 
saline into heart tissue, however this study also showed limited retention and survival of the 
transplanted cells (Reinecke and Murry, 2000). From this a number of different cell sources 




began to be utilised including skeletal myoblasts and cardiomyocytes derived from 
mesenchymal stem cells (MSCs), embryonic stem cells (ESCs) and hematopoietic stem cells 
(HSCs). Today cell therapies are still being investigated for their efficacy in treating heart 
conditions, incorporating patient derived cells with engineered scaffolds to improve the 
targeting of wound sites.  
This chapter will provide a brief overview of the heart and its histology, and an in-depth look 
at cells that can provide therapeutic benefits to heart, the bioreactors used to expand them, the 
methods used to deliver them, and identify limitations in current technologies and potential 
solutions.  
2.2 THE HEART 
The heart is a vital organ present in any organism which uses a circulatory system for the 
transfer of oxygen, carbon dioxide, nutrients and waste materials around its body. The heart 
is the core organ of the circulatory system, which acts as a peristaltic pump rhythmically 
pulsating to facilitate blood flow to other organs and to the extremities of the body.  
All cells within the human body require oxygen for aerobic respiration (Jafri et al., 2001), so 
the performance of the heart directly effects the operation of every organ, tissue and cell in 
the human body. A highly distributed circulatory system facilitates this, comprising of larger 
arteries (diameter ~30 mm) (Litalien et al., 1979) to narrow capillaries (diameter < 10 µm) 
(Wiedeman, 1963) where the majority of mass transfer to and from cells takes place. 
The circulatory system can be said to be analogous to a chemical engineering processes. A 
peristaltic pump forcing liquid into a pipe which flows into a series of smaller pipes and 
undergoes mass transfer exchanges and separation processes through semi-permeable walls, 
before being recycled back to the pump. However this comparison is complicated by 
additional human factors such as health, diet, mood and sex; all of which could lead to 
variations in heart flow rate, pressure drop through blood vessels, and mass transfer of 
dissolved gases, chemicals and hormones.   
The following section will provide a general overview of the anatomy, physiology, histology 
and pathology of the heart. It will aid in improving the understanding of how the heart 
functions on a cellular level, and what intrinsic and extrinsic factors affect its performance.   
 




2.2.1 Heart Structure and Anatomy 
The structure of the heart is comprised of several layers as shown in Figure 2.1. The outer 
layer is a fibrous membrane named the pericardium, and the inner layer is the heart wall. A 
narrow layer of pericardial fluid resides in the pericardial cavity in between these two layers 
that provides lubrication for the heart as it pumps (Carola et al., 1992). 
 
Figure 2.1 – Layers of the heart wall (Carola et al., 1992). 
The thick inner wall of the heart is the myocardium which is mostly comprised of cardiac 
muscle cells known as cardiomyocytes (NCBI, 2009). The myocardium contracts and 
provides the necessary pressure to pump blood from the heart. It is lined with a thin layer of 
squamous endothelial cells called the endocardium, which regulates myocardium contraction 
(Hsieh et al., 2006). Blood that is pumped through the heart does not exchange material 
through the walls of the heart to the myocardial cells, instead blood is supplied through 
coronary arteries in the epicardium which branch off from the aorta (Iskandrian and Segal, 
1979). Approximately 5% of the blood pumped by the heart is used for its own muscle tissue 
(Carola et al., 1992).  
2.2.2 Heart Histology 
 Cardiac Skeleton 
At its core the heart is comprised of fibrous connective tissue providing sites of attachment 
for the valves and cardiac muscles, and gives overall structure to the heart (Zhu, 2015). A 
decellularised rat heart is shown in Figure 2.2 (Tandon and Joachim, 2014). The connected 
muscle tissue is arranged such that a wringing motion is induced when the ventricles contract, 
allowing a more efficient expulsion of blood (Seeley et al., 2000). 





Figure 2.2 – Decellularised human heart (Tandon and Joachim, 2014). 
 The Myocardium 
The myocardium (cardiac muscle) comprises of cardiomyocytes, smooth muscle cells, 
fibroblasts and cardiac pacemaker cells (Xin et al., 2013). It is responsible for the synchronised 
beating of the heart that facilitates blood flow. Cardiac, skeletal and smooth muscle cells are 
the three main type of muscle in the human body (NCBI, 2011). The myocardium is comprised 
of basic muscle units (sarcomeres) which contain thick myosin and thin actin filaments, and 
are joined end to end by intercalated discs with adjacent gap junctions (Widmaier et al., 2006). 
Intercalated discs allow the connected cells to function as one tissue, allowing the 
synchronised contraction of the myocardium (Hill, 2016). The myosin and actin filaments are 
contractile proteins organised into an array which enables muscle contraction (Leger et al., 
1975). Gap junctions provide a connection between the cytoplasm of two adjacent cells, and 
allow the efficient transfer of signalling between cells for muscle contraction (Kanno and 
Saffitz, 2001). 





Cardiomyocytes (also known as myocardiocytes or cardiac muscle cells) comprise the 
majority (56%) of the heart myocardium (Banerjee et al., 2007), and are built from several 
muscle fibres (myofibrils) joined by a network of sarcoplasmic reticulum, encompassed in a 
plasma membrane (sarcolemma) (Tomanek and Runyan, 2012) and contain high quantities of 
mitochondria, as shown Figure 2.3 (Blausen, 2014).  
 
Figure 2.3 – The structure of a cardiomyocyte (Blausen, 2014). 
The sarcolemma controls diffusion between the ECM and the cell, and contains proteins to 
aid electrical signalling between cells (Walker and Spinale, 1999). The sarcoplasmic reticulum 
is used as a storage area for calcium ions and pumps these ions around the cell to facilitate 
electrical signalling (Diaz et al., 2005). Mitochondria are organelles that participate in the 
chemical production of energy by making adenosine triphosphate (ATP) molecules via 
cellular respiration (Lemieux and Hoppel, 2009). Mitochondria comprise 36% of 
cardiomyocyte volume due to the increased energy demand required for muscle contraction, 
compared to 2% in skeletal muscle cells (Carola et al., 1992). 
2.2.3 Quantifying Heart Disease 
Heart disease usually results from lifestyle choices such as poor diet, smoking or lack of 
exercise; with subsequent angina or heart attack a result of insufficient oxygen reaching the 
cardiomyocytes in the heart. Data collected by physicians can provide insight into the 
performance of the heart, and indicate if enough oxygen is being provided to heart tissue 
(Libonati et al., 1999).  
Blood pressure is typically expressed as systolic pressure (ventricles contracting) over 
diastolic pressure (ventricles filling), for example 180 over 110, each with units of mmHg. An 
individual with these blood pressure readings is categorised as having a ‘hypertensive crisis’ 
and is in need of immediate medical attention (AHA, 2016). Other negative factors are a high 
pulse and high left ventricular end-diastolic pressure (LVEDP), which can lead to undesirably 




low diastolic time (Salem et al., 2006). The pressure of blood entering the coronary arteries is 
calculated as the difference between diastolic pressure and LVEDP.  
Utilising these parameters, a value called the endocardial viability ratio (EVR) can be 
calculated, the value of which illustrates if the heart tissue is receiving enough oxygen as a 
result of the blood flow through the coronary arteries, which is dependent on overall heart 
health. It is the ratio of the diastolic pressure time index (the product of coronary pressure and 
diastolic time), and the tension time index (the product of systolic pressure and systolic time).  
A value of 1 or more characterises a ‘normal’ healthy value, and a value less than 0.8 
associated with subendocardial ischemia (Ramanathan and Skinner, 2005).  Typical values for 
a healthy and unhealthy individuals are shown in Table 2.1. 







Systolic Pressure (mmHg) 180 105 
Diastolic Pressure (mmHg) 110 70 
Heart Rate (beats per min) 120 80 
Left Ventricular End Diastolic Pressure (mmHg) 15 8 
Coronary Perfusion Pressure (mmHg) 95 62 
Heart Beat Duration (s) 0.50 0.75 
Systolic Time (s) 0.20 0.20 
Diastolic Time (s) 0.30 0.55 
Diastolic Pressure Time Index (mmHg.s) 28.5 34.1 
Tension time index (mmHg.s) 36.0 21.0 
Endocardial Viability Ratio (-) 0.79 1.62 
These values are useful to clinicians for characterising a patient’s condition, but do not provide 
quantifiable values for a required blood oxygen content for normal heart function. However, 
by knowing the quantity of oxygen in blood, as well as blood flow rate through the coronary 
arteries, the quantity of oxygen the heart requires can be calculated.  
An average healthy heart beats at 80 bpm, pumping 95 mL of blood per beat for a total of 
7.6 L per minute (Maceira et al., 2006). Approximately 5% of this is required by the heart 
itself to maintain its functionality (Carola et al., 1992), therefore a healthy heart will utilise 
380 mL/min of blood. In patients with a partial blockage of the coronary arteries this is reduced 
to 290 ± 60 mL/min, and in those with a significant blockage blood flow rate can be further 
inhibited to 165 ± 30 mL/min (Zafar et al., 2014). At these flow rates the amount of oxygen 
provided can be calculated by taking into account the density of the blood, the amount of 
haemoglobin in the blood and the number of oxygen molecules bound to the haemoglobin. As 




the left ventricle is fed newly oxygenated blood directly from the lungs, and the coronary 
arteries are served first after expulsion into the aorta, the oxygen content of blood passing 
through coronary arteries is assumed to be fully oxygenated at 20.4% (AnaesthesiaUK, 2005) 
or 9.87 µmol/mL assuming a total of 4.7 L of blood in an average human body.  The rate of 
oxygen consumption has been identified as 5.3 µmol/min.gheart in some studies (Beard, 2006) 
and total oxygen consumption is dependent on the mass of the heart, which is 300 g on average 
(Shier et al., 1996). A mass balance on oxygen in heart tissue is shown in Table 2.2 












Coronary arteries flow rate (mL/min) 380 290 165 Calculated 
Density of Blood (g/mL) 1.06 Cutnell et al. (1995) 
Coronary arteries flow rate (g/min) 403 307 175 Calculated 
Haemoglobin proportion in blood (%) 15% Klabunde (2014) 
Haemoglobin molecular mass (g/mol) 64,450 
Van Beekvelt et al. 
(2001) 
Haemoglobin flow rate (mol/min) 9.37E-04 7.15E-04 4.07E-04 Calculated 
Number of O2 per Haemoglobin (-) 4 Costanzo (2007) 
O2 flow rate (mol/min) 3.75E-03 2.86E-03 1.63E-03 Calculated 
O2 flow rate (µmol/min) 3,750 2,862 1,628 Calculated 
Entering O2 content in blood (%) 20.4% AnaesthesiaUK (2005) 
O2 
Used 
Consumption rate (µmol/min.gheart) 5.3 Beard (2006) 
Average mass of human heart (g) 300 300 300 Shier et al. (1996) 
Consumption rate (µmol/min) 1,590 1,590 1,590 Calculated 
O2 
Out 
O2 flow rate (µmol/min) 2,160 1,272 38 Calculated 
Extraction rate (%) 42% 56% 98% Calculated 
Exiting O2 content in blood (%) 12% 9% 1% Calculated 
From Table 2.2 it can be seen that a normal heart with no blockages will extract 42% of the 
available oxygen for normal resting function. This is larger in hearts with blockages in their 
coronary arteries as the available flow rate of oxygenated blood coming in has been reduced. 
Table 2.2 is a simplification of oxygen consumption. In reality diseased hearts will compensate 
by developing new heart muscle to increase the stroke volume, but this increases the heart’s 
mass and thus again increases its oxygen requirements, which is not sustainable (Pai, 2016).  
However, this analysis has shown the required rate of oxygen required for normal heart 
operation (3,751 µmol/min), which is important when emulating in vivo conditions ex vivo. 




2.3 HEART TISSUE ENGINEERING 
2.3.1 Cells with Clinical Applications 
One of the main symptoms of heart disease is a heart attack, which occurs when blood flow is 
limited to the heart tissue, which in turn limits the amount of oxygen available to 
cardiomyocytes, which subsequently die. This is a myocardial infarction, which damages the 
tissue in the left ventricle, reducing its ability to pump blood. The size of the infarct is 
dependent on the duration of low oxygen (ischemic) conditions and is typically quantified as 
a percentage of the available left ventricle area, increasing from 21% ± 13% at less than 
3 hours of ischemic conditions to 77% ± 10% at greater than 9 hours (Hasche et al., 1995). 
Clinicians typically quantify the severity of the infarction by stating the percentage of 
available surface that has been damaged. Presumably this is because of the heart’s contractive 
nature causing the actual value of internal surface area to change as the heart beats.  
The health of the left ventricle is primarily characterised by its ejection fraction (LVEF), which 
is 67% ± 5% in a healthy human heart (Maceira et al., 2006). Studies have shown that patients 
who have suffered acute myocardial infarction have a lower LVEF ranging from 31% ± 6% 
(Sjoblom et al., 2014), 48% ± 7% (Nijland et al., 2002) or 52% ± 12% (Ndrepepa et al., 2007)) 
depending on the severity.  
Native cardiomyocytes have a remarkably low rate of turnover, with an annual renewal of 
only 1% in a healthy 20 year old human, decreasing with age to 0.3% at age 75 (Bergmann et 
al., 2009). Cell therapies seek to facilitate accelerated tissue renewal by introducing a new 
population of cells to repair the infarcted tissue and improve heart LVEF. Human clinical trials 
traditionally administer somatic muscle cells, angiogenic cells and stem cell derived myocytes 
at doses ranging between 50-800 million cells (Sanganalmath and Bolli, 2013). These studies 
do not quantify cell dose for a specific ‘infarct area’, with many focusing on the improvement 
of heart functionality such as stroke volume and LVEF, and not directly characterising the 
reduction in the infarct area (Sanganalmath and Bolli, 2013).  
The introduction of cell therapies to infarcted regions of the heart promotes myocardial repair 
by releasing signals to the surrounding tissue, which then initiate a number of mechanisms 
that regenerate the damaged areas. These include activation and proliferation of endogenous 
cardiac stem cells (Tang et al., 2010), the formation of microvascular networks to enable blood 
flow (Jujo et al., 2008), the inhibition of native cardiomyocyte apoptosis (Bonaros et al., 
2006), the inhibition of heart hypertrophy (Farahmand et al., 2008) and the remodelling of the 
ECM (Rota et al., 2008). Essentially, the administration and engraftment of living cells can 
kick-start a chain of events that can lead to improved heart function, with higher cell doses 
showing improved effectiveness (Menasché et al., 2008), (Schuleri et al., 2009). 




 Somatic Muscle Cells 
Somatic cells are a classification for cells that make up the internal organs, muscle, bone and 
skin in the body. Somatic muscle cells are a subcategory which focuses on the cells that make 
up muscles and connective tissue in the body (Chen et al., 2008).  
 Foetal Cardiomyocytes   
Foetal cardiomyocytes share similar properties with adult cardiomyocytes whilst maintaining 
a greater degree of proliferation and in vivo survival. Studies in rat models show foetal and 
adult cardiomyocytes grafted into normal and damaged myocardium behave differently, with 
adult cells not surviving the grafting procedure and foetal cells proliferating in the host tissue 
(Reinecke et al., 1999). Foetal cells formed gap junctions and intercalated disks to the host 
myocardium, and grew in volume over an 8 week period (Reinecke et al., 1999). Other studies 
suggest that nearly half of the implanted foetal cells die off one hour after implantation, with 
15% remaining after 12 weeks. These cells were shown to be 25% smaller than the host 
myocardium, which is indicative of arrested development (Muller-Ehmsen et al., 2002). In 
another study, less than 2% of the initial inoculum of neonatal cardiomyocytes survived past 
30 minutes in the host tissue, with authors citing that cells died from irreversible ischemic 
injury and apoptosis (Zhang et al., 2001). While the concept of foetal cardiomyocyte 
replacement cell therapy was initially promising, an insufficient quantity of viable 
replacement tissue is formed to heal a sufficient area of infarcted heart tissue; and as the cells 
were from a donor, an immunosuppressant was also required (Chen et al., 2008). 
 Skeletal Myoblasts  
Skeletal myoblasts are progenitor cells that give rise to skeletal muscle fibres (Seeley et al., 
2000) and originate from myosatellite cells found in healthy, mature muscle tissue. 
Myosatellite cells activate when muscle damage is detected, triggering their differentiation 
into myoblasts. These can then attach to the damaged muscle fibres or form new fibres (Kadi 
et al., 2004). Skeletal myoblasts possess many of the same properties as cardiomyocytes and 
can be harvested from the patient to allow an autologous transplant of cells. This eliminates 
the problem of tissue rejection from the patient’s immune response. They are also able to 
withstand ischemic conditions better than other types of cells, and pose no risk of 
tumorigenicity when expanded in high concentrations (Menasche, 2005). Unfortunately in 
most cases skeletal myoblasts do not change into a cardiomyocyte phenotype when placed 
into heart tissue. Gap junctions do not form in myoblasts, thus electromechanical connections 
cannot be formed between the host tissue and the implanted cells (Rubart et al., 2004). Despite 
this, in animal models the pumping efficiency of the left ventricle was improved after 
treatment of infarcted host tissue with skeletal myoblasts (Scorsin et al., 2000), and soon after 
the method was accepted for phase I clinical trials. A four year follow up study on one of these 




trials heralded it as a success (Dib et al., 2005), however fundamental flaws with the 
experimental method of the trial such as not being randomised, inconsistent cell 
transplantation methodology, and the procedure occurring alongside a standard coronary 
bypass surgery cast doubt onto the effectiveness of this cell therapy alone (Caspi and Gepstein, 
2006). Another trial also displayed a high incidence of patients displaying arrhythmia after 
treatment (Menasche et al., 2003).  
 Angiogenic Cells 
Angiogenic cells contribute to the formation of new blood vessels from pre-existing vessels 
(angiogenesis). Angiogenesis is dependent on the presence of vascular endothelial growth 
factor A (VEGF-A) released from tissues in hypoxic conditions and the metabolic activity of 
the patient (Adair, 2010). Angiogenesis usually occurs at the proliferative phase of the wound 
healing process where ‘sprouts’ of endothelial cells grow towards tissue expressing VEGF-A. 
In the context of tissue engineering, it is important that after a cell therapy has been 
administered to a patient the new graft has an adequate blood supply so that the implanted 
cells can successfully assimilate into the existing heart structure. 
 Fibroblasts  
Fibroblasts are a vital component of the ECM, helping to form collagens, glycoproteins and 
elastins. They are used in the wound healing process to make new connective tissue 
(granulation tissue). Fibroblasts enter the wound site during the proliferative phase of wound 
healing at the same time as angiogenesis is initiated in the wound area  (Falanga, 2005). Whole 
3D scaffolds with fibroblast culture have shown to stimulate angiogenesis and improve heart 
wall blood flow in an infarct region of the heart in animal models (Kellar et al., 2001). 
However, subsequent studies have shown that this does not improve left ventricle pump 
ejection efficiency or help in left ventricle remodelling (Lancaster et al., 2010). Remodelling 
has been seen to reverse in one case (Thai et al., 2009)  
 Endothelial Progenitor Cells 
Endothelial Progenitor Cells (EPCs) are precursor cells that can differentiate into endothelial 
cells. They aid vascular regeneration by forming the lining of blood vessels and by secreting 
other angiogenic factors (Kawamoto et al., 2011). They are sourced from bone marrow and 
peripheral blood (Urbich and Dimmeler, 2004), and make up less than 1% and 0.01% of these 
sources respectively (Smadja et al., 2007). EPCs in peripheral blood are in such low 
abundance in the blood stream that over 10 L is required to produce a sufficient quantity of 
EPCs to achieve angiogenesis in one patient (Iwaguro and Asahara, 2005). EPCs are identified 
by their expression of a combination of CD133, CD34 and KDR markers, however there is 
some dispute over this (Smadja et al., 2007). Studies have indicated that the inoculation of 




EPCs into the bloodstream improve myocardial performance in animal models suffering from 
induced infarcted heart tissue (Werner et al., 2005).  EPCs have been attached to a collagen 
matrix and were shown to improve cardiac function when used to treat myocardial infarction 
in rodent hearts (Ahmadi et al., 2010); however there is concern that sufficient numbers of 
cells cannot be cultured for human treatments, and that long term culture may cause 
modifications to the cell’s phenotype (Eggermann et al., 2003).  
 Stem Cell Derived Myocytes 
Stem cells have the ability to differentiate into many different types of cell, including 
cardiomyocytes. This process can be controlled, allowing a stem cell to selectively 
differentiate into whatever cell type is desired simply by modifying the conditions the stem 
cell is subjected to (Thomson et al., 1998). They can be sourced from several different places, 
including the patient’s own tissue. All cells have surface molecules which can act as ligands 
that allow attachment, or can play a role in cell signalling. Cell populations can be defined by 
determining if they possess or lack these markers using a ‘+’ or ‘-’ symbol respectively. Stem 
cells can be quantified from other cells in this way by looking for these characteristic protein 
molecules on their surfaces. For example the researchers at Bristol Royal Infirmary consider 
MSCs to be positive for CD90, CD73, and CD105 and negative for CD45, CD34, CD14 or 
CD11b, CD79α or CD19 and HLA-DR surface markers; however in many published articles 
there is not a consensus as to what combinations of markers guarantee a certain cell type.  
Stem cells are classified by the differentiation potential of the stem cell in question (potency), 
of which there are five subcategories shown in Table 2.3 (Ilic and Polak, 2011); or by their 
origin - divided into embryonic, foetal, perinatal and adult stem cells, shown in Table 2.4. 
Ethical and religious arguments are unavoidable when discussing the sourcing of embryonic 
and foetal stem cells, and have affected scientific policy in some countries (Mazzaschi, 2015). 
However, the recovery and storage of perinatal stem cells after pregnancy as an insurance for 
the future health of a child is increasing in popularity (Searcey, 2014). 
 
 
Table 2.3 – Classification of stem cells based on their differentiation potential. 
Potency Differentiation Potential Cell Example 
Totipotent Embryonic and extra-embryonic tissue  Fertilised ovum 
Pluripotent All tissues and organs Embryonic stem cell 
Multipotent Restricted to the associated cell family Mesenchymal stem cell 
Oligopotent Restricted to a few cell families Hematopoietic stem cell 
Unipotent Restricted to one cell type Muscle stem cell 




Table 2.4 – Classification of stem cells based on their origin. 
Stem Cell Type Source Potency 
Embryonic Blastocyst stage of embryo (5-6 days) Pluripotent 
Foetal Terminated pregnancies Pluripotent 
Perinatal Amniotic fluid, placenta and umbilical cord Multipotent 
Adult Bone Marrow, peripheral blood and adipose  Oligopotent or Unipotent 
Adult stem cells are present in all organs of the body and are used for tissue regeneration and 
cell renewal in normal bodily operations. They can be isolated from some areas of the body 
such as the bone marrow, blood and adipose (fat) tissue; however it is much more difficult and 
intrusive to obtain cells from an internal organ. Because of this, research is being undertaken 
to see how to encourage adult stem cells sourced from one tissue to be used in repairing a 
different tissue (Ilic and Polak, 2011). Some of the stem cells mentioned in this section will 
be expanded upon in regards to their use in cardiac tissue engineering. 
 Hematopoietic Stem Cells 
Hematopoietic stem cells are progenitor cells that give rise to all blood cells, and are sourced 
from bone marrow, umbilical cord blood and peripheral blood. They are also part of the 
revascularisation process in wound healing. In conjunction with EPCs they have been shown 
to improve heart function in ischemic heart disease patients (Caspi and Gepstein, 2006), 
however HSCs cannot directly differentiate into cardiomyocytes (Murry et al., 2004).  
 Native Cardiac Progenitor Cells 
As previously stated, cardiomyocytes have a small degree of self-renewal in vivo (Bergmann 
et al., 2009) but this occurs at too low a rate to be useful in regenerating badly damaged heart 
tissue. Recent clinical studies in humans have shown improvements in cardiac regeneration 
using autologous cardiac progenitor cells isolated from heart biopsies, expanded in vitro, then 
injected into the target tissue during surgery (Chugh et al., 2012). Cells sourced in a similar 
way, but suspended on spherical beads, showed reduction in cardiac scarring after 
administration in human heart tissue (Makkar et al., 2012). However there is some debate as 
to whether or not these cells were actually cardiomyocytes, despite the author’s claims 
(Mummery and Lee, 2013).  
 Bone Marrow Derived Mesenchymal Stem Cells 
Mesenchymal stem cells are multipotent, and as such are restricted to differentiating within 
specific cell families. In this case MSCs differentiate into connective tissue such as bone, 
cartilage and adipose. MSCs from bone marrow has been observed differentiating into 
cardiomyocytes both in vitro and in vivo, with human MSCs transplanted into infarcted mouse 
and pig heart tissue showing spontaneous improvement in heart function (Behfar et al., 2010; 




Williams et al., 2013). Their ability to not stimulate an immune response indicates a potential 
for the cells to be autotransplanted or allotransplanted in patients. Some experiments have 
shown that their presence delays immune responses by inhibiting the formation of 
T-lymphocytes, indicating that MSCs possess an intrinsic immunosuppressive property (Le 
Blanc, 2003). A meta-analysis of bone marrow stem cell transplants in 999 patients over 18 
studies concluded with 95% confidence that only an average increase of 3.66% in left 
ventricular ejection fraction (LVEF) was established (Abdel-Latif et al., 2007). 
 Adipose Derived Mesenchymal Stem Cells 
MSCs can also be found within human adipose tissue. They are contained within the stromal 
vascular fraction of adipose tissue, and can be isolated using various separation processes. 
Depending on its location in the body, adipose tissue can be removed via liposuction, a low 
cost and low risk procedure. It has been proposed that adipose MSCs are superior to bone 
marrow MSCs in regards to their angiogenic ability when responding to ischemia in mouse 
leg muscle (Kim et al., 2007). There are mixed results from studies using these cells, with 
MSCs derived from rat epididymis adipose tissue aiding treatment of cardiomyopathy (Lin et 
al., 2010) and those derived from rat skin promoting angiogenesis in heart tissue (Schenke-
Layland et al., 2009); but in other instances have shown no disposition to take to the host heart 
tissue (van der Bogt et al., 2009). Some data suggests that adipose tissue can spontaneously 
differentiate into functional cardiomyocyte cells without the need for chemical intervention 
(Choi et al., 2010). A majority of studies derive adipose derived MSCs from rat groin tissue 
(Lin et al., 2010; Diaz-Herraez et al., 2013), rat subcutaneous skin tissue (Schenke-Layland 
et al., 2009), or human abdomen fat (Kim et al., 2013; Yang et al., 2013a) for use in animal 
heart models.  
Studies into isolation of adipose derived MSCs from around the heart itself is a new avenue 
of investigation which has not yet been fully explored, primarily because of the invasive 
methods of obtaining the tissue and the requirement for cell expansion to clinically applicable 
quantities. No studies have investigated a human autographed transplant; however an allograft 
transplant is currently being set up for human clinical trials (Bayes-Genis et al., 2013). Stem 
cells derived from adipose tissue provide higher yields compared with those derived from 
bone marrow and amniotic fluid (Kim and Heo, 2014). It is believed that stem cells isolated 
from adipose tissue surrounding the heart will be more likely to differentiate into 
cardiomyocytes (Ascione, 2013) making this cell type unique out of those described in this 
section, and suitable for further investigation.  
MSCs extracted from abdomen adipose tissue yield around 2,000,000 cells per 250 mL of 
lipoaspirate using a standard isolation technique (Francis et al., 2010), however the volume of 




epicardial adipose tissue around the heart is only 101.6 ± 39.8 mL in patients suffering from 
heart disease (Wu et al., 2016). This equates to a total extraction of approximately 812,800 ± 
318,400 cells from a patient. As doses of traditional cell therapies into the human heart 
myocardium typically start at 50 million cells (Sanganalmath and Bolli, 2013), it is clear that 
the quantity of cells extracted from a patient’s heart must be expanded in order to be used as 
a cell therapy. 
2.3.2 Cell Expansion 
Once a suitable cell type has been identified to be therapeutically relevant it must be expanded 
to a clinically applicable quantity for use as a successful cell therapy. As mentioned in the 
previous section a starting population of 812,800 ± 318,400 MSCs must be expanded to a dose 
of 50 million cells. This represents 5.9 ± 0.5 population doublings or an increase in initial cell 
number by 61 ± 17 times. There are many different technologies that can be used to culture 
cells, from simple flat flasks to engineered perfused bioreactors. The advantages and 
drawbacks of these devices are described in this section.  
 Traditional Bioreactors for Cell Culture 
Microbiologists would rarely describe their cell culture flasks as bioreactors, but from a 
chemical engineering perspective T-flasks and tissue culture well plates would be static 
semi-batch bioreactor systems. Examples of such flasks are shown in Figure 2.4. This is 
defined as a system that operates with either batch or continuous inputs of reactants and/or 
outputs of undesired products. Taking the T-flask as an example, it is initially seeded with a 
batch of cells in a solution of cell media, and as the cells grow they utilise oxygen as a reactant 
and provide carbon dioxide as a waste product, which can be defined as a continuous input 
and output respectively. The cells consume the nutrients in the media over time, after which 
the cells must be moved into a new T-flask as a batch and given fresh media.  
 
Figure 2.4 – A typical T-75 flask and a stackable T-75 flask manufactured by Corning.  




The available specific area for cells that can be cultured on a traditional T-75 tissue culture 
flask is approximately 300 cm2/L. This can be improved with multi-layered flasks which 
increases the overall surface area by a factor of ten, for the same available flask volume. One 
model shown in Figure 2.4 has a specific area of 3,000 cm2/L, however these stacked designs 
still have the same limitations as single flask models. These flasks only encourage 2D 
monolayer cell growth, whereas 3D cell culture offered by alternative bioreactors allow 
improved cell-cell interactions that lead to cells which resemble in vivo architecture 
(Edmondson et al., 2014). Flat flasks do have a use in the initial expansion of cells to sufficient 
quantities before their passage into other systems that encourage 3D cell culture.  
 Stirred Tank Bioreactors 
This bioreactor type can be operated as batch, semi batch or continuous configuration, and is 
usually characterised by the dynamic mixing from a mechanical force. This includes using a 
rotating impeller or magnetic stirrer to mix the bioreactor contents from within; or placing the 
reactor onto rollers to provide an external source for the mixing. The dynamic agitation of the 
bioreactor contents mitigates the presence of concentration gradients, allowing a well-mixed 
homogeneous system. Any mechanical force applied to the bioreactor must be strong enough 
so that the contents become well mixed, however excessive forces could cause cells to detach 
from their solid support. For this reason impellers are not generally used for cell culture as 
their edges could contact the cells. External forces typically provide a more uniform flow.  
 Spinning Flask 
A spinning flask bioreactor is a static flask with an internal stirring metal bar and ports on its 
lid for the addition and removal of cells, media and gases. An image of this bioreactor design 
is shown in Figure 2.5 (Techne, 2012). MSCs can be seeded onto micro-carriers that remain 
in suspension within the media. Spinning flasks have been used for MSC growth and 
differentiation in several studies showing improved rates of cell growth and increases in final 
cell number over monolayer culturing in T-flasks (Wang et al., 2009; Boo et al., 2011; 
Elseberg et al., 2012; Rafiq et al., 2013). Metabolism of porcine bone marrow (BM) derived 
MSCs has been shown to be unaffected when grown in a spinning flask, showing comparable 
energy usage to BM-MSCs grown in T-flasks, but with a 40% increase in growth rate (Ferrari 
et al., 2014). Initial rates of cell attachment onto micro-carriers can be as high at 63% with 
improved rates occurring at a high stirring speed delivered intermittently (100 rotations per 
minute (RPM) for 3 minutes, 0 RPM for 27 mins) for shorter durations (4 hours) and lower 
bovine serum concentrations (0%) (Yuan et al., 2014).  Spinning flask bioreactors are more 
complex than monolayer cultures because of the added factor of micro-carrier properties. 
Micro-carriers with a greater surface area per gram (Ferrari et al., 2014) and larger pore sizes 
(Mygind et al., 2007) yield larger growth rates and increased cell number after 14 days. 





Figure 2.5 – Spinning flask culture system, 125 mL – 5 L, manufactured by Techne. 
One of the drawbacks of the spinning flask bioreactor is cell aggregation which can lead to 
sub-populations of MSCs with unwanted heterogeneity. This can be reduced by adding 
additional carriers free of cells to the bioreactor for the excess cells to migrate to (Ferrari et 
al., 2012). In one study variation of stirring rates in the bioreactor (25 RPM and 75 RPM ) had 
no effect on growth kinetics of porcine BM-MSCs over 14 days, showing the same growth 
curve trends and identical growth rates (Ferrari et al., 2012). 
 Rotating Wall Bioreactor 
A rotating-wall bioreactor, shown in Figure 2.6 (Synthecon, 2015), also known as a slow 
turning lateral vessel (STLV), is a cylindrical flask that rotates about its central radial point at 
a radial velocity that keeps the cells or cell carriers suspended in a state of free fall within the 
bioreactor. The bioreactor is completely filled with media, with no gas–liquid surface interface 
available; however in some designs oxygen can be applied to the system via the rotating 
central cylinder. The radial velocity of the bioreactor can be set to provide a radial velocity to 
the cell media that is equal and opposite to the sedimentation rate of the cells/cell carriers, 
essentially fixing them in the same space. This flow regime around the particles reduces the 
thickness of the boundary layer surrounding the micro-carriers leading to a shorter diffusion 
distance for gas or nutrients to travel (Godara et al., 2008). Some studies have shown that 
rotating wall bioreactors have improved MSC growth rates over static culture (Chen et al., 
2006; Song et al., 2011), but others show worse performance in comparison to spinner flasks 
(Sikavitsas et al., 2002; Wang et al., 2009). These studies also show that spinner flasks are 
better for encouraging osteogenic and chondrogenic differentiation due to the mechanically 
active environment. One study has shown no appreciable difference in turnover rate between 












Figure 2.6 – Rotating wall bioreactors, 110 mL, 250 mL and 1 L, manufactured by Synthecon. 
Differentiation of human ESCs into the cardiac phenotype using a STLV and a spinning flask 
has been achieved by applying hypoxic conditions as evidenced by expression of a number of 
cardiac genes (Niebruegge et al., 2009). A STLV has been optimised to culture high levels of 
embryoid bodies, the intermediate between ESCs and specialised cell types, which then 
spontaneously differentiated into cardiomyocytes (Rungarunlert et al., 2011). 
Whilst the gentle shear conditions have led to the cultivation and differentiation of various 
cell types, rotating wall bioreactors are not well suited for culture within scaffolds as the low 
shear environment inhibits sufficient nutrient transport to cells seeded internally (Rauh et al., 
2011). This can be addressed by not operating the bioreactor as a STLV and simply rotating 
the bioreactor at a faster rate, however this can lead to collisions between scaffolds, causing 
damage and disruption of cell functions. Other disadvantages include poor scalability to larger 
volumes, and an increased complexity compared to other configurations (Schaffer et al., 
2012). 
 Wave Bioreactor 
A sterile disposable bag is inoculated with cells and media and inflated with air. The bag is 
placed on a moving platform that induces waves at the gas-liquid interface, as shown in Figure 
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(Godara et al., 2008), is easily scalable up to 500 L  (Schaffer et al., 2012), and is compliable 
with good manufacturing practice (GMP) guidelines due to its low likelihood of contamination 
(Somerville et al., 2012); however the bags are expensive, only have a single use, and 
monitoring and sampling the cells within the bag is difficult (Rodrigues et al., 2011). Only a 
single instance of MSC expansion using a wave bioreactor was found, but did not offer 
empirical comparisons to other bioreactor types (Timmins et al., 2012), however studies on 
HSCs show improvements in cell yield using this system (Hami et al., 2004; Timmins et al., 
2009).  
 
Figure 2.7 – A wave bioreactor manufactured by GE Healthcare. 
Stirred tank bioreactor configurations have proven to be useful when attempting to grow a 
large quantity of cells in solution, but the final cell number when harvesting is still not enough 
for a one step cell expansion system for to reach a clinically applicable number of cells (Rafiq 
et al., 2013). These bioreactors are sufficient for mixing bulk media in a system, however they 
have additional disadvantages such as the inability to regulate shear stress or manage oxygen, 
carbon dioxide and nutrient concentrations within the structure of the scaffolds, creating non 
homogeneous regions (Yeatts et al., 2013).  
 Perfusion Bioreactors 
These bioreactors are typically characterised by a recirculating media over cells attached to a 
firm surface. This flow ensures a continuous concentration gradient that encourages nutrient 
and waste exchange between the cells and bulk media. It also more closely emulates blood 
flow in an in vivo environment, leading to improved rates of cell growth compared to static 
systems.  
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 Packed Bed Bioreactor 
A packed bed (also known as fixed bed) reactor is a tubular shape, orientated vertically, and 
filled with macro-structured, reactive packing material, as shown in Figure 2.8 (Medorex, 
2014). Packed beds facilitate excellent contact between a fluid and solid, typically catalysing 
reactions or removing impurities from fluid streams depending on the packing material and 
application. Packing is fixed in position with supporting plates so the bed does not move with 
the fluid flow. For use as a bioreactor, immobilised cells or enzymes are attached to the 
packing material, which can be made from glass, ceramic, plastic (Meuwly et al., 2007), all 
of which vary in porosity and available internal surface area. Cultured cells are seeded within 
the packing material, to provide protection from the shear forces of the flowing liquid.  
 
Figure 2.8 – A packed bed bioreactor manufactured by Medorex. 
MSCs have been successfully grown in packed bed bioreactors, with a Fibra-Cel disks 
(Eppendorf) (Mizukami et al., 2013; Tsai et al., 2016), polystyrene pellets (Osiecki et al., 
2015) and glass beads (Weber et al., 2010), as packing material. Single-use packed bed 
bioreactors are increasingly being used in lab scale mammalian cell production including for 
culturing MSCs (Kaiser et al., 2015).  
Problems inherent with packed bed bioreactors typically arise due to poor homogeneity of the 
bioreactor contents, with localised concentration gradients of nutrients and dissolved oxygen, 
however this issue is limited at bench-scales. They are also difficult to scale up due to the 
increasing pressure drop, require proper liquid distribution to avoid channelling, and direct 










 Fluidised Bed Bioreactor 
Advantages of a fluidised bed are similar to those found in a packed bed. Good mixing ensures 
good mass transfer of nutrients and waste, and seeding within particles protects them from the 
shear forces that arise from the mixing. A fluidised bed has several improvements over a 
packed bed. Fluidisation removes the risk of channelling between particles, provides a lower 
risk of particle abrasion and subsequent cell damage, and the low gravity environment 
encourages proliferation as opposed to differentiation (Ellis et al., 2005).  Fluidised beds also 
require complex computational fluid dynamics modelling to determine optimum conditions 
for cell expansion (Benzeval et al., 2012).  
Comparisons with static controls show fluidised beds to be superior, with greater cell 
proliferation and distribution of murine MSCs on coral scaffolds for use as bone constructs 
(David et al., 2011). Placental-derived human MSCs co-cultured with hepatoma-derived C3A 
cells seeded onto alginate microspheres have been grown in a fluidised bed system and showed 
increased urea secretion compared to a static control (Yang et al., 2013b). However, in a direct 
comparison with a packed bed bioreactor, a fluidised bed performed worse at cultivating a co-
culture of peripheral blood derived human hematopoietic stem cells and bone marrow derived 
stromal cells over a 2 week time course (Meissner et al., 1999), with the author determining 
that the weak adherence between the two cell types causes detachment of the hematopoietic 
stem cells in the fluidised conditions.  
 Hollow Fibre Bioreactor 
A hollow fibre bioreactor (HFB) consists of a bundle of hollow fibres enclosed in a cylindrical 
housing with openings at either end for tube side media flow and side ports for shell side media 
flow (Figure 2.9). Cells are typically attached to the external fibre surface, or within a hydrogel 
in the extra-capillary space between the fibres and the reactor housing. The fibres themselves 
are porous, allowing the bioreactor to act as a membrane for size exclusion of certain 
molecules or cellular products. Like all membranes HFBs can foul, but this is mitigated 
through good flow control and occasional back-flushing. HFBs allow for a much increased 
surface area to volume ratio over stirred bioreactors and other perfusion bioreactors, allowing 
for a greater number of cells to be cultured per unit reactor capacity. Good shear and mixing 
conditions are provided in a HFB, with convection through the fibres and diffusion within the 
porous matrix of the fibres available to provide good rates of oxygenation and nutrient uptake 
in seeded cells.  





Figure 2.9 – A hollow fibre bioreactor system from Fibercell Systems. 
HFBs have been utilised in commercial products for renal dialysis treatments as membranes 
to filter out proteins from blood. Other commercial products have been developed for the 
specific task of cell expansion (Spectrum-Labs, 2012; Terumo-BCT, 2012; FiberCell, 2014), 
with researchers using these systems yielding cells in greater number than other reactor types.  
In one study using the Quantum cell expansion system from Terumo, 5 million MSCs were 
seeded and expanded 20 fold over 13 days to 98 million MSCs (Nold et al. 2013). In a different 
study using the same HFB (2100 cm2 surface area) but comparing it to equivalent static 
seeding in a T-flask (25 cm2 surface area), data suggests that at identical seeding densities of 
MSCs (775 ± 251 cells/cm2) after 6 days 122 million ± 49 million MSCs were harvested from 
the HFB and 748,000 ± 419,000 MSCs from a T-25 flask (Rojewski et al., 2013). Whilst this 
is expected due to the increased available surface area, the harvesting density was 
5,800 ± 2,300 MSCs/cm2 in the HFB and 29,900 ± 16,700 MSCs/cm2 in the flask, which, may 
indicate that an increase in culture time in the HFB may allow for further population doublings 
due to the additional availability of surface area within the HFB. The material the hollow 
fibres are made from is not indicated in this product.  
A phenomenon known as Starling flow is also present in HFB. Higher upstream pressure can 
force media flowing within the fibre lumen out of the upstream section of the fibre into the 
ECS and then back through the fibre into the lumen downstream where the pressure is lower. 
This drives cells to the end of the hollow fibre and causes an inhomogeneous cell density on 
the hollow fibres (Godara et al., 2008). Investigations on a bundle of 46 polypropylene hollow 
fibres of 330 μm inner diameter, 150 μm wall thickness and 0.1 μm maximal pore size with 
sheep BM-MSCs seeded in Matrigel in the ECS showed lower Starling flows in HFBs 
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(0.3 mL/min intraluminal flow) led to increased cell viability and improve rates of sheep BM-
MSC attachment throughout the hollow fibre surface, but do not provide favourable conditions 
for MSC proliferation or differentiation; whereas high Starling flows (11 mL/min intraluminal 
flow) promote MSC proliferation, accelerate differentiation but yield dense 3D cell aggregates 
in the downstream section of the fibre (De Napoli et al., 2011).  However this effect is not as 
apparent in hollow fibres with lower permeability (Godara et al., 2008). 
Hollow fibres provide a great deal of flexibility for cell proliferation, with adjustable fibre 
permeability and bioreactor flow rates. Cells are most commonly attached to the external 
surface to take advantage of the increased surface area to volume ratio, low shear environment, 
and simple operation. While direct sampling of cells during operation is not achievable, and 
uniform seeding is often difficult, hollow fibre bioreactors provide the highest quantity of cells 
of all bioreactor types, which is imperative in order to produce a highly concentrated cell dose 
for cell therapies.  
One major drawback of HFBs is the poor initial rates of cell attachment (Wung et al., 2014). 
Seeding efficiencies of around 15% (Storm et al., 2016), and 20% (Morgan et al., 2007) have 
been reported, with authors requiring higher initial seeding densities compared to flat tissue 
culture plastic in order to obtain equivalent cell densities (Storm et al., 2016). This is likely 
due to the curvature of hollow fibres providing a sub-optimal geometry for cells to easily 
attach to, instead rolling off the fibre or potentially ‘missing’ it entirely. This can also lead to 
poor distribution of the initial dose across the length of the hollow fibre (Ellis and Chaudhuri, 
2007). No authors have sought to improve initial cell attachment rates of hollow fibres, despite 
the potential time saving benefits when growing a dose of cells for clinical purposes. A 
dynamic seeding regime which would offer cells several opportunities to attach, might offer 
improved rates of cell attachment, and should be investigated.  
 Comparing Bioreactors 
A collection of data showing the growth of MSCs over 7 days in each bioreactor type is shown 
in Table 2.5, with average values for cell doubling, fold increase, growth rate and doubling 
time for each bioreactor type summarised in Table 2.6. These tables show that MSCs grown 
in hollow fibre bioreactors offer the quickest rate of growth, the shortest doubling times, and 
the greatest increase in cell number over 7 days. Hollow fibre bioreactors are typically seeded 
at much higher concentrations in part due to their increased available surface area for cell 
attachment, resulting in larger batches of MSCs compared to other systems. As speed of 
treatment may be critical in a medical environment, the hollow fibre bioreactor was chosen as 
the cell expansion device for this work. 










Cell Expansion Properties 
Source 










MSC Human 500,000 1,500,000 1.6 2.0 0.2 4.4 (Wang et al., 2009) 
MSC Human 20,000 380,000 4.2 18.0 0.4 1.6 (Elseberg et al., 2012) 
MSC Human 19,375 748,000 5.3 37.6 0.5 1.3 (Nold et al., 2013) 
Spinner Flask 
MSC Human 500,000 3,200,000 2.7 5.4 0.3 2.6 (Wang et al., 2009) 
MSC Lapine 121,000 221,000 0.9 0.8 0.1 8.1 (Boo et al., 2011) 
MSC Human 20,000 620,000 5.0 30.0 0.5 1.4 (Elseberg et al., 2012) 
Rotating Wall 
MSC Human 160,000 192,000 0.3 0.2 0.0 26.6 (Zhang et al., 2010) 
MSC Human 500,000 4,400,000 3.1 7.8 0.3 2.2 (Wang et al., 2009) 
Packed Bed 
MSC Human 160,000 1,600,000 3.3 9.0 0.3 2.1 (Osiecki et al., 2015) 
MSC Human 10,000,000 54,000,000 2.4 4.4 0.2 2.9 (Tsai et al., 2016) 
Fluidised Bed C3H/10T1/2 Murine 300,000 1,100,000 1.9 2.7 0.2 3.7 (David et al., 2011) 
Hollow Fibre 
Bioreactor 
PDC Human 20,000,000 440,000,000 4.5 21.0 0.4 1.6 (Lambrechts et al., 2016) 
MSC Lapine 500,000 8,500,000 4.1 16.0 0.4 1.7 (Li et al., 2016) 
MSC Human 2,000,000 18,700,000 3.2 8.4 0.3 2.2 (Nold et al., 2013) 
MSC Human 1,627,500 122,000,000 6.2 74.0 0.6 1.1 (Rojewski et al., 2013) 
MSC Human 200,000 16,000,000 6.3 79.0 0.6 1.1 (Morgan et al., 2007) 




Table 2.6 - Average MSC expansion data for each bioreactor type. 
Bioreactor Type 
Cell Expansion Properties 





Av. SD Av. SD Av. SD Av. SD 
Monolayer 3.7 1.9 19.2 17.8 0.4 0.2 2.5 1.7 
Spinner Flask 2.8 2.0 12.1 15.7 0.3 0.2 4.0 3.5 
Rotating Wall 1.7 2.0 4.0 5.4 0.2 0.2 14.4 17.2 
Packed Bed 2.9 0.6 6.7 3.3 0.3 0.1 2.5 0.5 
Fluidised Bed 1.9 0.0 2.7 0.0 0.2 0.0 3.7 0.0 
Hollow Fibre Bioreactor 5.0 1.6 44.3 37.3 0.5 0.2 1.5 0.5 
Taking into account the maximum number of MSCs that can be extracted from around the 
human heart (812,800 ± 318,400), the expected rate of cell attachment within HFBs (20%) the 
quantity typically required for a therapeutic dose in a damaged human heart (50 million), and 
the average doubling time of MSCs in hollow fibre bioreactors from literature (1.5 ± 0.5 days); 
a hollow fibre bioreactor could grow the necessary number of cells in 12.6 ± 5.2 days. If 100% 
cell attachment can be obtained, this is reduced to 9.1 ± 4.0 days. Clearly, if rates of cell 
attachment on hollow fibres can be improved, this would reduce the amount of time taken to 
acquire the necessary cell dose, and would accelerate a patients treatment timetable.  
2.3.3 Cell Delivery 
Many of the research trials mentioned in Section 2.3.1 were utilising isolated cell suspensions 
which were directly injected into the damaged areas of the heart. This method of delivery has 
an advantage because it avoids an intrusive open heart surgery; however it can be difficult to 
be accurate when administering this treatment and a large number of the injected cells are 
often not retained at the wound site. To combat these issues, alternative delivery vectors have 
been investigated such as using a scaffold seeded with cells for grafting onto a specific area 
of damaged tissue. This section outlines traditional and engineered methods of cell delivery.  
 Traditional Cell Delivery Vectors 
Traditional delivery vectors administer cells to a wound site using a syringe, a catheter or 
intravenously. It is a common theory among authors that MSCs will migrate to either their 
organ of origin, or to a site of damage in a tissue (Lee et al., 2016). Traditional cell delivery 
methods take advantage of this homing behaviour by administering free floating cells into the 
patient. Studies utilising stem cells have consistently shown low rates of cell retention in the 
target tissue, independent of cell type, cell dose, and method of delivery. Typically over 90% 
of injected cells disappear from the wound site in the first few days, with less than 2% retained 
after 4 weeks, with high doses of cells required (starting from 50 million) in order to facilitate 
improvements in heart function (Sanganalmath and Bolli, 2013). 




 Intravenous Infusion 
Intravenous (IV) infusion takes advantage of cell homing mechanisms to treat myocardial 
infarction. The cells are directly injected into a vein and are transported to the heart as shown 
in Figure 2.10. It is a simple and non-invasive procedure. A Phase I study (NCT00114452) 
dosing patients (n=53) with 0.5 – 5.0 million MSCs/kg within 10 days after a myocardial 
infarction showed improvement in pulmonary function, LVEF and reduced instances of 
tachycardia (Hare et al., 2009). 
 
Figure 2.10 – Intravenous infusion of cells to treat myocardial infarction (Shim et al., 2013). 
This method is heavily hindered by the first pass effect, with the cell dose becoming greatly 
diluted by the time it reaches the target area. In one study, MSCs administered to treat 
myocardial infarction initially became highly localised in the lungs with slower accumulations 
in the liver, spleen and bone marrow (Chin et al., 2003). There is also evidence that MSCs 
administered intravenously are also eliminated by monocytes and macrophages by the 
immune system (Barbash et al., 2003). Other studies with smaller patient cohorts report no 
clinical effectiveness (Chin et al., 2003; Hofmann et al., 2005; Nogueira et al., 2009), and a 
Phase II trial (NCT00877903), evaluating the efficacy of this treatment using MSCs to 
improve left ventricular end-systolic volume, is currently ongoing (n=220). 




 Intra-coronary infusion 
Cells are administered directly to the infarct site using a catheter fed through the coronary 
artery as shown in Figure 2.11. A balloon catheter inflates to block the blood vessel preventing 
the backflow of cells and increasing exposure times to the affected area. This method is cost 
effective and non-invasive (Shim et al., 2013) and is the standard cell therapy for patients 
suffering from a myocardial infarction (Mozid et al., 2011; Wu et al., 2012).   
 
Figure 2.11 – Intra-coronary infusion of cells to treat myocardial infarction (Shim et al., 2013). 
The main disadvantage of this method is navigating the tortuous circulatory network of the 
heart to get to the damaged tissue. This network also varies between patients, making the 
procedure highly challenging, however it is possible to reach the distant areas of cardiac tissue 
located in the apex of the heart using this method (Siminiak et al., 2005). Cells administered 
in this way have similar drawbacks to IV infusion in that the first pass effect is still present, 
and cells usually escape into the circulatory system and reappear in other organs. Studies have 
shown a retention rate less than 10% within the damaged myocardium after 2 hours, 
decreasing to 2-3% by 24 hours (Schots et al., 2007), indicating that a large cell dose would 
be required to facilitate myocardial repair.  Despite this, several controlled trials using bone 
marrow cells have shown improvements in patient left ventricle function, fitness and infarct 
size (Akar et al., 2009; Miettinen et al., 2010; Bolli et al., 2011; Quyyumi et al., 2011; Roncalli 
et al., 2011), and at least five Phase III trials are currently ongoing (Wu et al., 2012).  




 Trans-Epicardial Route 
This method is much more invasive, but is normally used in situations where surgical 
intervention needs to be undertaken already. Cells are directly injected into the infarct region 
as shown in Figure 2.12. This eliminates the first pass effect found using IV infusion, 
improving dosage accuracy, and removing the additional complications of cell mobilisation 
and homing (Sheng et al., 2013). From studies that utilise direct injection of bone marrow 
mononuclear cells (14), bone marrow stem cells (7), granulocyte colony-stimulating factor 
activated CD34+ cells (3), myoblasts (2) and  MSCs (1), 20 showed improved LVEF (Wu et 
al., 2012; Shim et al., 2013). 
 
Figure 2.12 – Direct external injection of cells to treat myocardial infarction (Shim et al., 2013). 
Direct injection results in longer recovery times due to the required surgery, as well as 
potential complications resulting from accidental perforation of the ventricular wall, 
embolisation of coronary blood vessels, and cardiac arrhythmias (Hagege et al., 2006). The 
main drawback of this method is the low retention of the cell dose due to leakage from the site 
of injection. An ischemic swine model injected with peripheral blood mononuclear cells had 
a maximum retention of 11% ± 3%, with 26% ± 3% of those cells found within the lungs (Hou 
et al., 2005). Another swine model using MSCs observed only 5.8% of the initial cell dose in 
the heart after 10 days (Gyongyosi et al., 2008). A Phase III clinical trial (NCT00950274) 
involving the injection of CD133+ bone marrow stem cells into infarcted heart tissue during 
routine coronary artery bypass graft surgery is in progress (n=142). 




 Trans-endocardial route  
This method is features a catheter fitted with a needle that pierces the myocardial wall when 
expanded allowing a targeted release of cells into the inside of the ventricle as shown in Figure 
2.13. Cells are administered in this way when the arteries in the infarct region have become 
blocked (Wu et al., 2012). Electromechanical mapping techniques are employed to facilitate 
this avenue of treatment, allowing a contrast between viable, infarcted and scarred heart tissue 
(Kornowski et al., 1998). 
 
Figure 2.13 - Direct internal injection of cells to treat myocardial infarction (Shim et al., 2013). 
It has similar risks to the trans-epicardial route but with lower likelihoods of wall perforation 
or arrhythmia occurring (Sheng et al., 2013). Very few trials have reported on the efficacy of 
this method (Shim et al., 2013), but those that have been positive showing improvements in 
myocardial perfusion and LV function (Wu et al., 2012). Current research is focussing on 
optimal catheter design to improve the efficiency of this treatment (Sheng et al., 2013). No 
studies at present give details on cell retention after injection. 




 Engineered Cell Delivery Vectors 
Engineered delivery vectors involve direct application of the cells to the damaged area through 
the use of an artificial scaffold to provide a targeted treatment that can also provide additional 
structural support to the infarct region. A scaffold (also referred to as a substrate or matrix) is 
a construct that the desired cells are seeded onto or within in order to form a 2D or 3D tissue. 
Typically these scaffolds are biodegradable, and their degradation products biocompatible 
with the host, and can be constructed from natural ECM materials such as collagen, fibrin or 
chitosan, or synthetic polymers such as poly (lactic-co-glycolic acid) (PLGA), 
poly (glycerol sebacate) (PGS) or poly (ε-caprolactone) (PCL). There are several scaffold 
designs that have been used in cardiac treatment as engineered cell delivery vectors, which 
are outlined in this section.  
 Cell Patch 
Patches can be placed over a damaged area of heart tissue or used to block openings caused 
by congenital problems. Patches typically comprise of a scaffold supporting a population of 
seeded cells on its surface, however recently cell sheets without scaffolds have been 
investigated as treatment avenues (Narita et al., 2013; Domenech et al., 2016; Moschouris et 
al., 2016). This involves growing a 2D monolayer of cells, and removing them from their 
growth scaffold while retaining their cell surface proteins and ECM connections. These sheets 
can be layered, and can be applied to the wound site without sutures.  
Despite the promising treatment outcomes of patches loaded with MSCs, few of these studies 
quantify the actual number of implanted cells that are retained in the wound site. Heart patches 
seeded with MSCs have shown improved rates of retention within the scaffold over traditional 
cell therapies, however exhibit poor migration into the infarct tissue itself. Freeman et al. 
(2015) showed that on collagen patches seeded with 100,000 hMSCs transplanted into mice 
22 ± 17% were retained within the patch but only 1% penetrated into the damaged tissue after 
2 days, with hMSCs detected in greater concentrations in the stomach and intestine.  Poor 
transfer of hMSCs into mice hearts has also been shown using patches comprised of cardiac 
fibroblasts, with imaged sections of the heart showing minimal transfer after 2 days (Schmuck 
et al., 2014). Longer term studies in rats have shown rates of engraftment reduce to 40 ± 15% 
after 2 weeks and to less than 5% after 4 weeks (Ishikane et al., 2013). As with traditional 
methods, the limited, albeit improved, cell retention of patches are leading to treatments that 
are not meeting their full potential. 
 Injectable Hydrogels 
Hydrogels are water swollen cross-linked polymer networks made from natural or synthetic 
materials (Radisic and Christman, 2013).  Hydrogels have been used in a wide range of tissue 




types such as bone, cartilage, adipose, neural and cardiac (Munarin et al., 2012). For cardiac 
applications hydrogels can be made from components that already exist in the ECS of the 
myocardium such as collagen or fibrin, or from other natural materials such as gelatin or 
alginate (Lee and Mooney, 2001). Hydrogels can be loaded into syringes and injected into the 
infarct, or perfused onto the infarct using a catheter. The material is a viscous liquid at the 
time of injection, but can be made to gelate with the addition of an activating material or a 
change in environmental conditions (Shuman et al., 2013). This gelation must be achieved 
quickly, because the liquid hydrogel/cell solution can be ejected from the injection site similar 
to traditional cell delivery methods (Li and Guan, 2011).  
The mechanical properties of interest are gelation times, stiffness and degradation profile; and 
once implanted the degradation of the hydrogel can be triggered by hydrolysis, enzyme action, 
pH, temperature or electrical fields (Munarin et al., 2012). Synthetic materials such as 
polymers are easier to configure for a specific organ and/or degradation rate than natural 
materials; however synthetic hydrogels are comparatively much softer than heart tissue and 
do not provide sufficient mechanical support to a heart at all points in systole and diastole in 
human subjects (Prabhakaran et al., 2011). In clinical studies wall thickness of the infarct 
region typically increases and dilation of the left ventricle typically decreases, sometimes 
leading to an increase in pumping efficiency (Fujimoto et al., 2009; Tous et al., 2011; Wu et 
al., 2011; Shuman et al., 2013). However in these cases the hydrogel acts like a bulking agent, 
offering no regenerative therapy to the infarcted tissues.  
Cells, drugs, growth factors or gene therapies can be suspended within hydrogel microspheres. 
This has been attempted in vitro using polylactic acid (PLA) microspheres to contain MSCs, 
where in one study the cells maintained their phenotype but the cells grew in inhomogeneous 
clumps within the microspheres (Forte et al., 2009). Another study conducted experiments on 
rat models to investigate encapsulated MSCs in microspheres of RGD modified alginate, 
which led to a significant reduction in infarct size and improved angiogenesis over a 
phosphate-buffered saline (PBS) control (Yu et al., 2010). However, initial cell retention rates 
using microspheres (0.650%) were comparable to traditional MSC injection (0.613%). 
Despite this, after two weeks cells in microspheres were retained in the myocardium (0.576%) 
whereas no injected cells could be detected. The low rates of cell retention may be due to cell 
death during the encapsulation process or caused by an immediate ejection from the point of 
injection in the heart. Using collegen hydrogel loaded with cardiomyoblasts has similarly 
shown improved cell engraftment over 4 weeks compared to injections, however once again, 
initial cell retention at the wound site after 24 hours was no different compared to traditionally 
injected control hearts (Kutschka et al., 2006). If initial cell retention rates could be improved, 
cell therapies delivered this way are likely to have a greater clinical impact.  




 Tubular Thread  
Threads are typically woven from several micro fibres and can offer a three dimensional, 
highly interconnected porous structure to facilitate cell growth and migration into the scaffold, 
leading to the development of ECM components while allowing for diffusion of nutrients, 
oxygen and waste. Cells which are allowed to spread through a scaffold in this way provide 
increased vascularisation to the wound site (Hasan et al., 2016). 
Threads can be attached to needles to act as sutures to assist in wound healing, with several 
FDA approved devices such as Vicryl (Ethicon, 2014), Surgicryl (SMI, 2010), Dexon 
(Covidien, 2016) and Polysorb (Medtronic, 2016) made from PLA, poly(glycolic acid) (PGA), 
or poly(lactic-co-glycolic acid) (PLGA) tailored to a necessary degradation time. Advanced 
versions of these products such as Vicryl Plus (Ethicon, 2014) are coated with an antibacterial 
agent, with future development of sutures to provide anaesthetic or antineoplastic functionality 
(Azimi et al., 2014).  
Polymeric sutures have also been investigated for their drug loading ability within tubular 
scaffolds (Catanzano et al., 2014; Wei et al., 2014; Kang et al., 2015), and are currently being 
investigated as a delivery device for cells seeded on the external surface of the hollow fibre as 
shown in Table 2.8. Higher rates of initial cell retention have been shown using these sutures 
(20% - 45%), however as they are sewn in, shear forces cause the cells to detach from the 
scaffold (Guyette et al., 2013), limiting the therapeutic potential of this treatment. 
 Hollow Fibre Encapsulation 
The limitations of the previously discussed engineered cell delivery methods are outlined in 
Table 2.7 which indicates a common limitation - the number of cells that are initially retained 
at the wound site after implantation are limited. In cellular sheets, attached cells are detected 
in significant quantities in other organs and have poor rates of migration into the damaged 
tissue itself. Injectable hydrogels offer much promise with many tailorable properties and 
improved long term retention, however can suffer from immediate expulsion from the 
injection site if gelation is not achieved quickly – limiting the initial dose. Cells loaded onto 
the surfaces of tubular threads allow cell migration throughout the scaffold, however cells on 








Table 2.7 – Advantages and concerns of current engineered cell delivery systems. 
Construct Advantages Concerns Ref. 
Cell sheet Invasive, but easy to apply;  
Increased vascularisation;  
Long term survival on 
infarct surface. 
Poor integration with host 
tissue;  
Low initial cell retention 
after grafting;  
Difficult to handle. 
Freeman et al. (2015) 
Schmuck et al. (2014) 
Ishikane et al. (2013) 




Minimally invasive;  
Improved long term 
retention of cells. 
Expulsion of cells after 
implantation, prior to 
gelation. 
 
Rufaihah and Seliktar 
(2016) 
Li and Guan (2011) 
Yu et al. (2010) 
Kutschka et al. (2006) 
Tubular 
thread 
Increased vascularisation. Invasive, Requires suturing; 
Cells stripped off suture 
during grafting. 
Hasan et al. (2016) 
Guyette et al. (2013) 
 
Hollow fibres may offer a solution to this problem. Hollow fibres have been previously been 
investigated for their use as devices to encapsulate drug therapies (Ceci-Ginistrelli et al., 2017; 
Chilukuri et al., 2015; Zhu et al., 2007), and if constructed from a biodegradable material a 
timed dosage profile can be customised for the desired treatment schedule (Stubbe et al., 
2004); (Qiu and Zhu, 2001).  
So far, no authors have furthered this line of investigation to determine if hollow fibres can be 
utilised as a device to encapsulate cells for delivery into a wound site. Such a device would 
protect cells from mechanical shear during handling and implantation, and potentially 
overcome the poor initial retention rates that characterise traditionally administered therapies. 
The cells can also be grown prior to implantation within the hollow fibre itself by utilising a 
hollow fibre bioreactor configuration.  
As discussed in Section 2.3.2, hollow fibre bioreactors are typically used to grow a cells on 
its external surface, and have been shown to offer increased rates of MSC growth over other 
bioreactor types due to their larger surface area to volume ratio, favourable shear conditions, 
and high availability of nutrients and oxygen through the porous hollow fibre scaffold. A 
common HFB configuration allows media flowing through the lumen to permeate through the 
hollow fibre into the ECS where the cells are seeded. Instead, this proposed system would 
reverse this, with cells seeded on the inner surface of the hollow fibre, fed by media 
permeation from the ECS.  
Once implanted in vivo such a device would need to be sufficiently porous to allow permeation 
of nutrients and oxygen from diffusion alone. The device would also need to biodegrade so 
that the encapsulated cells could fully assimilate into the host tissue. However, the first step 
in this endeavour is to determine if a HFB can be operated in this configuration and if viable 
cells can be retained in the lumen long term.  
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Table 2.7 – A Sary of studies showing external cell seeding on tubular scaffolds 
Table 2.8 – A summary of studies showing external cell seeding on tubular scaffolds 
 







PGA – Poly (glycolic acid),  PLA – Poly (lactic acid),  PLGA – Poly (lactic-co-glycolic acid),    
PCL – Poly (ε-caprolactone) PETP – Poly (ethylene terephthalate) 
 
 
(Yao et al., 2008; Yao et al., 2011; Yao et al., 2012; Georgiev-Hristov et al., 2012; Reckhenrich et al., 2014; Mertaniemi et al., 2016; Volpe et al., 2014; Casado et al., 2014) 




2.3.4 Scaffold Materials 
It is of vital importance that a suitable scaffold material be selected to ensure biocompatibility 
with the seeded cells and host tissue, and so that the desired cell delivery device can be 
manufactured reliably and safely. Such a material must also be able to allow cell attachment, 
growth and migration throughout its structure, deliver cells to a target area after implantation, 
allow cell nutrients and products to diffuse freely, and be able to break down after being 
implanted in the body. This indicates a dependence on the porosity, tortuosity, pore size, 
biocompatibility, mechanical strength and rate of degradation. Some of these properties are 
dependent on the material the scaffold is made from, as well as the shape and design of the 
scaffold itself. The desired properties may also be inferred depending on medical 
requirements. In this section different biomaterials will be investigated for their application as 
a hollow fibre medical device. 
 Natural Biomaterials 
Utilising materials which are similar to those found in the extracellular matrix is a logical 
starting point when attempting to encourage cell attachment. By emulating the host tissue as 
closely as possible, natural tissue engineered grafts provide excellent biocompatibility and are 
biodegradable. However these materials tend to have poor and inconsistent mechanical 
properties, and will sometimes cause an immune response (Lakshmanan et al., 2012). They 
are typically more expensive than synthetic polymers, have greater batch to batch variation 
and are more susceptible to cross-contamination (Garg et al., 2012). Natural biomaterials with 
applications in heart tissue engineering include proteins such as collagen, fibrin, elastin and 
gelatin, and polysaccharides such as hyaluronic acid, chondroitin sulphate, alginate and 
cellulose (Garg et al., 2012). 
 Synthetic Polymers 
Synthetic polymers provide an alternative to naturally derived materials. They are easily 
processed and manufactured on a large scale, allowing for consistent mechanical and chemical 
properties. They are readily available, have good biocompatibility, can be biodegradable, and 
have much better mechanical properties than natural polymers. One disadvantage is that 
unwanted products can be released during the in vivo biodegradation, leading to inflammation 
of the local tissue if the products are acidic. Another problem is the potential for erosion from 
external flows or movements, and the negative impact that can have on a scaffold with a 
previously understood degradation profile. Biodegradable polymers include PLA, PGA, its 
co-polymer PLGA, PEG, PCL, PGS, poly (L-lactide-co-caprolactone) (PLCL) and 
poly (urethane) (PU); their key properties are listed in Table 2.9   
 





Table 2.9 – List of synthetic polymers used in heart tissue engineering. 





Wide range of degradation rates 
Good bioresorption 
Slow degradation (30-50 weeks) 
Strong mechanical properties 
Hydrophobic 
 
(Xu et al., 2004) 
(Kaiser and Coulombe, 2015) 
PGA FDA approved 
Good biocompatibility 
Good bioresorption 




(Brugmans et al., 2015) 
(Kaiser and Coulombe, 2015) 
 
PLGA FDA approved 




Poor cell seeding surface distribution 
Inflammation caused by acidic by-products 
 
(Makadia and Siegel, 2011) 
(Garg et al., 2012) 
(Chen et al., 2015) 
(He et al., 2016) 




Good elasticity  
Tuneable tensile strength 
 
(Garg et al., 2012) 
(Kaiser and Coulombe, 2015) 
 
PEG Good biocompatibility 
Good surface wetting (hydrophilic) 
Uniform cell seeding 
Offers protection from immune system 
Poor cell adhesion 
Poor stiffness 
 
(Naderi et al., 2011) 
(Simon-Yarza et al., 2013) 




Good mechanical properties 
Good biocompatibility  
 
(Baheiraei et al., 2015) 
(Brugmans et al., 2015) 
PLCL Tuneable degradation rate 
Good biocompatibility 
 




Good physical and mechanical properties 
Small pores formed only 
 
(Gretzer et al., 2003) 
(Siepe et al., 2007) 
(Garg et al., 2012) 





PLGA is a lactide-glycolide copolymer that possesses excellent biocompatibility, tuneable 
biodegradability and good processability; and can be engineered to construct clinically 
applicable microarchitectures such as flat sheets, microspheres, thin films and fibres. PLGA 
has been approved for use in humans by the Food and Drug Administration (FDA) in the 
United States, and has permitted the manufacture of many commercial devices for medical 
use. PLGA is also soluble in many solvents, unlike PLA and PGA, allowing it to be 
manufactured into a desired scaffold design. PLGA is amorphous in its structure, with a glass 
transition temperatures above human body temperature (37°C), allowing its structure to retain 
significant mechanical strength once fashioned into a scaffold (Azimi et al., 2014). 
The ratio of lactide to glycolide within the PLGA copolymer can be altered during formation 
to create a specific form of PLGA which has the desired mechanical and degradation 
properties. PLA and PGA alone both take a greater amount of time to degrade then their 
copolymer, which degrades at its fastest rate at a 50:50 ratio as first discovered by Miller et 
al. (1977), with a longer degradation provided by an increase in glycolide content (Makadia 
and Siegel, 2011).  Table 2.10 shows data from a model for how in vivo drug release profiles 
are affected by the lactide:glycolide ratio. Note that degradation characteristics of PLGA are 
also affected by molecular weight, the properties of the encapsulated treatment, and the design 
of the scaffold; as well as the environment of the host tissue such as temperature, pH and 
enzyme activity (Makadia and Siegel, 2011).The data in Table 2.10 will vary depending on 
those parameters. 










PLGA degrades by hydrolysis, producing molecules of lactic acid and glycolic acid. In vivo 
the former enters the tricarboxylic acid cycle to be metabolised resulting in carbon dioxide 
and water as its products (Crotts and Park, 1998), and the latter is excreted in the kidney 
(Makadia and Siegel, 2011). Toxicological studies show that PLGA can cause inflammation 
of local tissue (Dailey et al., 2006), however these reactions are mild and have not impacted 
its FDA approval.  




Different PLGA ratios have also been tested for their cell attachment and proliferation ability 
on flat sheet scaffolds. Ellis and Chaudhuri (2008) showed a 75:25 lactide to glycolide ratio 
allowed a greater rate of both when compared to a 50:50 ratio. This data is presented to the 
nearest thousand cells in Table 2.11. 







Average SD Average SD 
50:50 12,000 5,000 60% 25% 
75:25 15,000 5,000 75% 25% 
TCP 18,000 5,000 90% 25% 
The desired rate of PLGA degradation would be selected by the clinician to fit the patient’s 
needs. In this work a 75:25 ratio is chosen because of its improved rate of initial cell 
attachment over the 50:50 variant, which is an important factor in acquisition of a higher 
eventual cell number, and because of its longer degradation time. As this work will also 
analyse internal cell encapsulation over a number of days, degradation is undesirable at this 
early stage while still evaluating hollow fibre cell encapsulation as a concept.  
2.3.5  Hollow Fibre Manufacture  
Hollow fibres are typically made by extrusion of melted or dissolved polymer through a 
spinneret that shapes the fibres and determines fibre thickness and lumen size. Production of 
hollow fibres can be achieved through three different methods: melt-spinning, 
electro-spinning and solution-spinning; each of which greatly influence fibre properties and 
scaffold applications (Postema et al., 1990; Ellis and Chaudhuri, 2007).  
 Melt-spinning 
Polymer is heated to its melting point, extruded through a spinneret, cooled with air as the 
fibres emerge, with the resulting fibre wound on a spooler (Fambri et al., 1997; Pivsa-Art et 
al., 2015). With the correct equipment a high throughput is achievable, allowing the 
production of thousands of metres per minute if raw material cost is not an issue. It also does 
not require the use of solvents. PLGA fibres have been successfully spun using this method 
(Xie et al., 2010; Wang et al., 2011b; Cui et al., 2015), however there was no suitable 
equipment to produce PLGA in this way at the University of Bath.  
 Electro-spinning 
In this process a strong electric field is applied to the extruded polymer melt or polymer 
solution. A droplet of polymer emerging from the spinneret has its surface tension 




counteracted by the electric field, and becomes elongated leading to a charged polymer fibre 
that is attracted to a collecting spool. Electrospun PLGA have been manufactured (Bini et al., 
2004; You et al., 2006; Kwak et al., 2016), however the dimensions of the lumen are typically 
only large enough to house therapeutic molecules and not whole cells (Kang et al., 2015; 
Ranjbar-Mohammadi et al., 2016). 
 Solution-spinning 
Solution spinning involves dissolving a polymer into a solvent (also known as a dope) and 
extrusion through a spinneret into a non-solvent environment. Wet-spinning uses a liquid non-
solvent such as water, and dry-spinning is simply at ambient conditions in air. The polymer 
and solvent de-mix when the mixture contacts the non-solvent, leaving behind the desired 
scaffold structure (Azimi et al., 2014). De-mixing can occur instantly or very slowly 
depending on the affinity between the solvent and non-solvent. Dry-formed scaffolds typically 
take longer to form due to the low affinity between solvents and air. While formation of flat 
sheets in this way is achievable, hollow fibres will lose their shape before de-mixing 
completes, so wet-spinning is preferable. 
Typical solvents include 1-methyl-2-pyrrolidinone (NMP), 1,4-dioxane, dichloromethane, 
chloroform and methyl chloride; and typical non-solvents include water, methanol, ethanol 
and propanol. Mixtures with higher affinities de-mix quickly and result in the formation of 
porous networks within the scaffold (Mulder, 2003). Of the listed materials, NMP and water 
have high affinity for each other and are safest (Ellis and Chaudhuri, 2007). Wet-mixing is the 
slowest of the methods listed because spun fibres must be soaked in water for several days to 
ensure full de-mixing, fibre output is also much slower at 1 – 2 m/min, and large quantities of 
non-solvent are required. However this allows fibres with large lumens and thin walls to be 
made, which is necessary for a device suited to encapsulate cells and biodegrade quickly.  
2.3.6 Surface porosity 
Internal porous networks are formed as part of the polymer/solvent de-mixing process during 
wet-spinning; however during this process the outer and inner surfaces of the hollow fibre 
form a non-permeable ‘skin’ layer. To manufacture a hollow fibre for cell encapsulation it 
must be permeable enough to allow nutrient and waste exchange. Surface porosity is a 
property that can be added utilising a specialised manufacturing technique, or by modifying 
an existing mixture using pore forming additives, the most common of which are described in 
this section.    





Sintering involves compacting polymer particles into a desired shape heating to just below 
melting point. This method is traditionally used to provide porosity to ceramic scaffolds, 
however sintering has been used to manufacture cylindrically moulded PLGA composite 
scaffolds for drug delivery (Kim and Jung, 2015; Sidney et al., 2015), and particles used for 
cell delivery (Liang et al., 2014; Rutledge et al., 2014), without the need for solvents. While 
this method allows for the production of a scaffold with tuneable thermal, mechanical and 
surface porosities, it is the most complex of those considered, the most energy intensive, and 
has not been shown to produce hollow fibres of small enough dimensions.  
 Surface Removal 
The impermeable skin layer on some polymer scaffolds can be etched away using plasma 
treatment, which also has the added benefit of improving cell adhesion by modifying the 
surface wetting properties of the scaffold (Hegemann et al., 2003).  Treatment of both internal 
and external surfaces of whole hollow fibre modules (6 x 20 cm) has been achieved (Li et al., 
2013a), with improved gas permeation through hollow fibres in some studies, however this 
only occurred in fibres which already had some initial degree of surface porosity (Huang et 
al., 2016).  By assuming a uniform reduction in the skin layer using this method, the resultant 
underlying porosity would not be accurately predictable or controllable, and instead would be 
a function of the polymer/solvent de-mixing thermodynamics. There is also a concern that 
plasma treatment can be damaging to the bulk structure of the scaffold (Li et al., 2013b). 
The non-porous skin layer could also be removed by physically dissolving the polymer using 
a solvent. Preliminary experiments were conducted by re-exposing a flat sheet PLGA 
scaffolds to NMP briefly, however bulk scaffold structure broke down quickly. De-mixing in 
a weak solvent solution led to an increased de-mixing time and localised surface regions where 
the skin was removed, however this was not replicable during hollow fibre spinning (Acott, 
2014).  
 Particle Leaching 
Particles of salt (Zhang et al., 2013), sugar (Qu and Ding, 2013), gelatin (Wang et al., 2013) 
PEG (Xu et al., 2016) and poly (vinyl alcohol) (PVA) (Meneghello et al., 2009) can be used 
as porogens. These particles are mixed with a polymer dope prior to scaffold manufacture 
remaining undissolved in suspension, and leach out of the dope during wet-spinning when 
exposed to a non-solvent that the particle will readily dissolve into. This provides greater 
interconnection between pores within the scaffold, and imparts porosity to the external 
surfaces. The selected porogen can be sized to provide pores of the required diameter.  




Typically, sodium chloride (NaCl) particles are used in tissue engineering due to their quick 
leaching, customisable sizing, and availability; however traditional grinding and sieving 
methods lead to NaCl particles with wide size distributions (Xin et al., 2016). NaCl particles 
can be grown to a required size by a simple crystallisation procedure, as first achieved by 
Marshall (1940) and further characterised by Tran et al. (2011). Addition of NaCl particles to 
PLGA dopes has been investigated and is shown to be an adequate porogen for use in tissue 
engineering. PLGA scaffolds supplemented with large NaCl particles (300 – 500 µm) have 
shown reduced mechanical integrity, whereas smaller particles (150 – 180 µm) provide a faster 
degradation rate (Kuo and Leou, 2006). Recently, pores in the range of 30 – 60 nm have been 
imparted onto PLGA microspheres used for drug delivery applications (Ilyas et al., 2013).  
Utilising porous PLGA hollow fibres as a biodegradable cell carrier is undocumented in 
literature, and as such some assumptions must be made to determine the required surface pore 
size. As cardiomyocytes are approximately 30 µm in diameter (Calvillo et al., 2003), a surface 
pore size much greater than that would lead to cell spread within the hollow fibre scaffold 
itself, causing potential blocking of internal pores and prevention of media permeation to areas 
of the lumen where the bulk of cells are located. Conversely, a pore size too small could lead 
to jetting of permeating cell media into the cells on the lumen surface, potentially puncturing 
the cell membrane and reduction in overall cell viability. A target pore size of 5 µm has been 
selected to balance these concerns, and because a procedure for the manufacture of 5 µm NaCl 
crystals is available (Marshal, 1940).  
2.4 CONCLUSIONS 
In this literature review a basic overview of the heart, its structure, histology and function was 
described in Section 2.2. The effects of heart disease on heart function was defined, with 
differences between healthy and unhealthy heart behaviour quantified in terms of available 
blood flow rate and oxygen concentration.  
Section 2.3.1 catalogued a number of cell types which have application in cardiac tissue 
engineering, concluding with mesenchymal stem cells sourced from the adipose tissue 
surrounding the heart as a novel area of investigation, with authors claiming that MSCs 
sourced from this region were more likely to differentiate into cardiomyocytes than MSCs 
sourced from other areas. Additionally, MSCs from this source have not yet been investigated 
for their ability to be autographed in human subjects. MSC extraction rates from this source 
were quantified to be approximately 812,800 ± 318,400 cells, requiring expansion to a 
minimum of 50 million cells for traditional cell therapies. 




Section 2.3.2 investigates several bioreactor types, concluding that hollow fibre bioreactors 
provide a quickest MSC growth rate, shortest doubling times, and greatest quantities of cell 
growth, which would allow 50 million MSCs to be grown in the shortest amount of time for 
use in traditional cell therapies. The main drawback of HFBs is their poor initial rates of cell 
attachment compared to other bioreactors (~20%), mainly due to their curved geometry. No 
investigations have been conducted in literature to seek to improve the initial rates of cell 
attachment on hollow fibre bioreactors. Currently 20% cell attachment will yield 50 million 
cells in 12.6 ± 5.2 days, whereas 100% attachment would take 9.1 ± 4.0 days. If higher rates 
of attachment could be obtained it would reduce the time required to grow a traditionally 
administered cell dose. This would be a novel contribution to the field if a new cell seeding 
procedure could be discovered.  
As stated in Section 2.3.3, traditional cell therapies require large doses because of the high 
degree of cell loss, with 90% disappearing in the first few days and less than 2% found at the 
injection site after 4 weeks. This indicates that of the original dose of 50 million cells, only 
1 million cells are retained, a quantity similar to the initial MSC extraction rate of 
812,800 ± 318,400 cells. Despite this, studies have shown improvements in LVEF, reduction 
in infarct size and increased angiogenesis in animal models. Therefore it can be concluded 
that a much smaller initial dose is required so long as it can be retained at the wound site.  To 
that end, Section 2.3.3 continues to suggest alternative engineered methods, suggesting an 
encapsulation within a tubular scaffold to be a novel alternative which protects the entire cell 
population, and can receive nutrients from the host tissue and allow gas exchange via diffusion 
through a porous membrane. This engineered device would aim to encapsulate and retain a 
minimum of 1 million cells to retain parity with traditional therapies, however there is scope 
to encapsulate a larger cell dose expanded separately on externally seeded HFBs which could 
lead to even greater improvements in heart function. The first step in this process is to see if a 
population of cells can survive within the lumen of a hollow fibre over the long term.   
Section 2.3.4 investigates suitable materials for such a device, concluding with PLGA due to 
its FDA approval for use in medical devices, its tuneable biodegradability, and because its 
degradation products can be processed by normal body functions. Section 2.3.5 outlines how 
hollow fibres can be manufactured, choosing a wet spinning method via extrusion through a 
custom designed spinneret to provide fibres with a consistent internal porosity, and because 
of availability of equipment and previous experience in its operation. Section 2.3.6 
summarises how an external surface porosity can be provided to wet-spun PLGA hollow 
fibres, determining that addition of NaCl particles is a simple, well-used and easily 
controllable method to achieve this.  




Exact requirements to sustain a population of cells within a hollow fibre will be dependent on 
the permeability of the produced fibres, with the appropriate external flow rate in the ECS 
selected to ensure sufficient permeation of liquid nutrients and dissolved oxygen. These 
metabolic considerations will be quantified in detail in the appropriate chapter.   
2.5 AIMS AND OBJECTIVES 
The aim of this thesis is to improve the utility of hollow fibre bioreactors. Specifically, to 
decrease the required time to grow appropriate doses of cells on their external surface, and to 
investigate their application as engineered delivery devices encapsulating cells within their 
lumen as a cell therapy to treat damaged heart tissue. To this end, the following objectives 
have been set: 
OBJECTIVE 1: Improve external cell seeding efficiency on hollow fibres. 
OBJECTIVE 2: Manufacture hollow fibre scaffolds with suitable surface porosity and 
liquid permeability. 
OBJECTIVE 3: Sustain a population of cells within the lumen of a hollow fibre. 
A scale schematic of the proposed system is shown in Figure 2.14, displaying the operation of 
a HFB in external cell seeding mode (A), and internal cell encapsulation mode (B). The 
bioreactor is 100 mm long, with an inner diameter of 2.5 mm and an outer diameter of 3.5 mm. 
The hollow fibre itself has the same length and approximate inner diameter of 0.8 mm and 
outer diameter of 1.0 mm. 
Objective 1 will utilise standard PLGA hollow fibres in a bioreactor operating in Mode A to 
determine if external cell seeding efficiency can be improved using a series of dynamic 
seeding regimes. MG63 human osteosarcoma cells will be used as an alternative to MSCs. No 
previous studies aiming to improve cell attachment on hollow fibres in this way have been 
conducted by others, making this a novel endeavour. This is outlined in Chapter 4. 
Objective 2 will augment PLGA hollow fibres with various concentrations of custom made 
NaCl particles in order to obtain fibres with porous internal and external surfaces. This is to 
enable the permeation of liquid media for an encapsulated population of cells. No previous 
studies have characterised the addition of NaCl manufactured using this method to wet-spun 
hollow fibres of PLGA, making this a novel endeavour. This is outlined in Chapter 5. 
Objective 3 will utilise porous PLGA hollow fibres in a bioreactor operating in Mode B to 
encapsulate cells and attempt to sustain them for six days. MG63 human osteosarcoma cells 
will be used as an alternative to MSCs. Media will be pumped through the ECS to enable 
permeation through the fibre and into the lumen. No previous studies attempting to sustain an 
encapsulated population of MG63 cells within a hollow fibre lumen have been conducted by 
others, making this a novel endeavour. This is outlined in Chapter 6.  





Figure 2.14 – A side view and cross section of a HFB operating in external cell seeding mode (A) and internal cell encapsulation mode (B). Flow in mode A is representative of the 
expected configuration for cell growth. Flow is not initiated during static or dynamic seeding.  
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3. CHAPTER THREE: MATERIALS AND 
METHODS 
3.1 INTRODUCTION 
This chapter contains a list of all the materials and an outline of all the methods used for the 
experiments in this thesis, subdivided into experimental, analytical and statistical methods. 
Additional specific variations in experimental methods are explained in relevant chapters. 
3.2 MATERIALS 
All materials are sub-divided into appropriate lists depending on their application: materials 
used for cell culture (Table 3.1), materials used for cell culture analysis (Table 3.2), materials 
used to manufacture scaffolds (Table 3.3), materials used during bioreactor construction 
(Table 3.4), lab consumables (Table 3.5) and lab equipment (Table 3.6). 
Table 3.1 – Materials used for cell culture. 
Item Supplier Ref. No 
Antibiotic-Antimycotic (A/A) Gibco Life Technologies 15240-062 
Dulbecco's modified eagle medium 
(GlutaMAX-l) (DMEM) 
Gibco Life Technologies 32430-027 
Ethanol (EtOH) Sigma Aldrich F203233 
Foetal bovine serum (FBS) Sigma F7524 
MG63 human osteosarcoma Sigma Aldrich 86051601 
Non-essential amino acid solution 100x 
(NEAA) 
Sigma Life Science M7145 
Penicillin-streptomycin (P/S) Sigma Life Science P4333 
Phosphate buffered saline (PBS) Sigma Life Science D8537 
Sodium Pyruvate (NaPy) Sigma Life Science S8636 
Table 3.2 – Materials used for cell culture analysis. 
Item Supplier Ref. No 
λ DNA standard Gibco Life Technologies P7589 
D-glucose assay kit (GOPOD format) Megazyme K-GLUC 
Formaldehyde solution Sigma Aldrich F1635 
L-lactic acid assay kit Megazyme K-LATE 
Methylene blue (MB) Sigma M4159 
MTT cell growth determination kit Sigma Aldrich CGD1-1KT 
Pico fluorescence Quant-iT Picogreen ds 
DNA reagent 
Gibco Life Technologies P7589 
TE buffer (20X) Invitrogen T11493 
Trypan blue stain Gibco Life Technologies 15250-061 
Trypsin-EDTA solution (10x) Sigma Life Science T4174 




Table 3.3 – Materials used for scaffold manufacture.  
Item Supplier Ref. No 
1,4-Dioxane Sigma Aldrich 154822 
Ethanol (EtOH) Sigma Aldrich F203233 
1-Methyl-2-pyrrolidone (NMP) Acros Organics 127630025 
Poly(lactic-co-glycolic acid) (PLGA) Evonik Industries 99024545 
Poly(styrene) (PS) Aldrich 182427 
Sodium chloride (NaCl) 
Sigma Aldrich 31434.500G.
R 
Tetrahydrofuran Fisher Scientific 10174150 
Table 3.4 – Materials used for bioreactor construction. 
Item Supplier Ref. No 
1/16” straight connector Cole-Parmer WZ-30506-00 
1/4" flat bottom to 1/16" barbed to thread 
adaptor 
Kinesis P-668 
3-Stop Pharmed 1.52 mm ID BPT pump 
tubing  
Cole-Parmer WZ-95714-36 
4 mm ID barbed Y-connector  Cole-Parmer EW-06295-10 
8 mm ID Marprene tubing Watson-Marlow 902.0080.I4 
Araldite rapid 2k part A/B Huntsman  2542708 
Ethanol (EtOH) Sigma Aldrich F203233 
Glass bioreactor University of Bath N/A 
Helixmark 1.98 mm ID silicone tubing Helix Medical 45630109 
Male luer lock plug Cole-Parmer WZ-45503-56 
Masterflex 0.8 mm ID platinum L/S 13 
silicone tubing  
Cole-Parmer WZ-96410-13 
Masterflex 1.6 mm ID platinum L/S 14 
silicone tubing  
Cole-Parmer HV-96410-14 
Masterflex 3.1 mm ID platinum L/S 16 
silicone tubing  
Cole-Parmer WZ-96410-16 
Masterflex barbed 1.8” ID to L/S 13/14 
reducer  
Cole-Parmer EW-30616-04 
Omnifit Q-series bottle cap Kinesis 00932Q-3V 
Savona D1 Washing up liquid Premier Products 12006 
Sigmacote Sigma-Aldrich SL2 
Silcoset 151 ACC Silicones 151 
Silicone elastomer sheet Goodfellow SI303200/1 
Slide clamps Qosina 12065 
T-piece 3/32" Cole-Parmer EW-06365-86 
Vircon Antec International P550 
Watson Marlow 1.42 mm ID PVC manifold 
tubing 
Watson-Marlow 980.0142.000 












Table 3.5 – Lab consumables. 
Item Supplier Ref. No. 
Aspirator tip (2 mL) VWR 734-0456 
Autoclave tape Fisher 12370489 
Cell culture flask (150 cm2) Appleton Woods BC302 
Cell culture flask (25 cm2) Appleton Woods BC300 
Cell culture flask (75 cm2) Appleton Woods BC301 
Cell culture plate (12 well)  Fisher 10136810 
Cell culture plate (24 well)  Fisher 10380932 
Cell culture plate (48 well)  Fisher 10065370 
Cell culture plate (6 well)  Fisher 10578911 
Cell culture plate (96 well flat bottom) Fisher 10687551 
Cell culture plate lid Greiner Bio One 656161 
Cell Strainer (70 um) Fisher 11597522 
Centrifuge tube (15 mL) Fisher 11849650 
Centrifuge tube (50 mL) Fisher 11819650 
Conductive carbon tape Agar Scientific AGG3939 
Filter paper (0.2 µm) Sigma-Aldrich WHA10411411 
Forceps Fisher 11562113  
Gloves (Nitrile) Starlab US-INT-L 
Haemocytometer Slides Una Health 87144 
Micro centrifuge tube (0.5 mL) Fisher 11508232 
Micro centrifuge tube (1.5 mL) Fisher 11558232 
Needle (16 G) Appleton Woods BD401 
Needle (18 G) VWR 613-3495 
Needle (21 G) VWR 913-4970 
Needle (27 G) Appleton Woods BD419 
Parafilm VWR 291-1212 
Pipette Tip (1000 µL) Fisher 11592813 
Pipette Tip (20 µL) Greinier 774288 
Pipette Tip (200 µL) Greinier 739288 
Plastic pot (150 mL) Fisher 11399143 
Plastic pot (7 mL) Fisher 12799985 
Scalpel blade Appleton Woods GC683 
Stripette (10 mL) Fisher 10084450 
Stripette (2 mL) Fisher 10288370 
Stripette (25 mL) Fisher 10606151 
Stripette (50 mL) Fisher 10041591 
Syringe (1 mL) Fisher 10142104 
Syringe (5 mL ) Fisher 10080264 











Table 3.6 – Lab equipment.  
Item Full Name Manufacturer 
Angled extractor vent  Plymovent Plymovent 
Aspirator pump VP series aspirator pump KNF Neuberger 
Autoclave (1) Priorclave Tactrol 2 Grant 
Autoclave (2) Boxer 200/40 LR Boxer 
Biohood (1) Heraeus HeraSafe Biohood Heraeus 
Biohood (2) 
Microflow Advanced Biosafety 
Cabinet 
Astec Microflow 
Biohood (3) Safe 2020 Thermo-Scientific 
Bioreactor rotator STR4 rotator drive Stuart 
Bubble column Soap film flowmeter 1-10-100 
mL 
Hewlett-Packard 
Camera Nikon CoolPix 995 Nikon 
Cell Counter Handheld counter tally Fisher 
Cell culture plate (6 well, 
custom) 




Cell culture plate (24 well, 
custom) 




Cell culture plate (96 well, 
custom) 




Cell freezing container Mr Frosty Freezing Container Thermo-Scientific 
Centrifuge (up to 1.5 mL) MSE Micro Centaur (micro-
centrifuge) 
Sanyo 
Centrifuge (up to 50 mL) ALC Centrifuge PK20 DJB Labcare 
Centrifuge tube mixer Whirli Mixer Fisons 
Carbon dioxide cylinder CO2 vapour withdrawal cylinder BOC gases 
Carbon dioxide regulator Multistage Carbon Dioxide 
Regulator 
GCE Group 
Dissolved oxygen probe Orion 083005MD Thermo-Scientific 
Electrochemistry meter Orion Versastar 
electrochemistry meter 
Thermo-Scientific 
Freezer (-20°C) (1) Hotpoint Future RZFM 751 Hotpoint 
Freezer (-20°C) (2) Sparkfree Labfeezer Labcold 
Freezer (-80°C) Scientific -80°C Freezer  New Brunswick 
Freeze-dry bottle 750 mL Fast Freeze Flask Labconco 
Fridge (1) Bosch Exxcel freestanding 
fridge 
Bosch 
Fridge (2) Laboratory Fridge Freezer Lec Medical 
Fume cupboard Fume cupboard S+B, UK 
Gearbox (spinning) Spaggiari Helical Gearboxes Spaggiari  
Glass bottle (50 mL) Pyrex bottle reagent screw neck 
50 mL 
Fisher 
Glass bottle (100 mL) Pyrex bottle reagent screw neck 
100 mL 
Fisher 
Glass bottle (1 L) Flask 1 L glass polypropylene 
cap 
Fisher 
Glass rod Stirring rod button end glass Fisher 
Goniometer Dataphysics Contact Angle 
System OCA 
Dataphysics 
Hot block Hot block QBT2 Grant 




Item Full Name Manufacturer 
Incubator (1) Reach-In CO2 Incubator Thermo-Scientific 
Incubator (2) Galaxy S Incubator  Wolf Labs. 
K'NEX K'NEX K'NEX Ltd 
Liquid nitrogen cell storage Statebourne bio 20 Statebourne 
Magnetic stirrer Magnetic Stirrer SM5 Stuart 
Metal wire Stainless steel wire (30 G) Miltex 
Motor (spinning) RS 440-571 RS Components 
Microscope Nikon Eclipse TS100 Light 
Microscope 
Nikon 
Multi-pipette 300 µL multichannel pipette Rainin 
Needle Valve (permeation) SS Integral Bonnet Needle 
Valve 1/4" 
Swagelok 
Needle valve (spinning) 5,000 PSI Needle Valve - V 
Series 
Parker 
Nitrogen cylinder Nitrogen vapour withdrawal 
cylinder 
BOC gases 
Nitrogen regulator Multistage Nitrogen Regulator GCE Group 
pH probe pH Electrode (General Plastic) Eutech 
Instruments 
Plate reader Fluorospectrometer BioTek 
Synergy HT 
NorthStar Sci. 
Pressure gauge (gas 
permeation) 
0-1 bar pressure gauge Swagelok 
Pressure gauge (liquid 
permeation) 
0-15 psi pressure gauge Omegadyne 
Pressure gauge (spinning) 0-7 bar pressure gauge BOSS 
Pressure vessel 0.15L 250-18 MPT Parker 
Pump (cell proliferation) Ismatech Reglo IIC Ismatech 
Pump (spinning) Masterflex L/S multichannel 
pump 
Cole-Parmer 
Rheometer Bohlin C-VOR rheometer Bohlin 
Rocker Stuart Scientific 3D Rocking 
Platform 
Stuart 
Roller mixer Roller Mixer SRT9D Stuart 
Rotameter (1) MOB 12000 MPB 
Rotameter (2) Platon NGXV Platon 
Scales  Denver Instrument SI04002 Denver Inst. 
Scanning electron microscope 
(SEM) 
Joel JSM 648OLV SEM.  Joel 
Spinneret Spinneret University of 
Bath 
Spinning rig Spinning rig University of 
Bath 
Sputter coater Edwards Sputter Coater S150B Edwards 
Tube Rotator MACSmix Tube Rotator Miltenyi Biotec 
Vacuum Desiccator MicroModulyo Freeze Dryer  Savabt Modulyo 
Water bath (1) Grant Waterbath Grant 
Water bath (2) Sub Aqua 2S Plus Grant 
Water treater (~0.05 µS/cm) DirectQ UV3 Millipore 
Water treater (~15 µS/cm) Midi RO Veolia Water 




3.3 EXPERIMENTAL METHODS 
3.3.1 Scaffold Preparation 
PLGA polymer (75% lactide, 25% glycolide) was dissolved in NMP solvent at a weight ratio 
of 20:80 in a glass bottle. The bottle was placed onto rollers at 37°C for 24 hours to facilitate 
the dissolution of the polymer, and to ensure a homogeneous polymer dope.  
 Flat Sheet Membranes 
Flat sheet membranes were prepared using a wet-spinning phase inversion casting method. 
The flat sheets were made by pouring 5 ml of polymer dope solution onto a flat sheet of glass 
and spreading it using a glass rod (Fisher) (Figure 3.1A). The sheet was kept to a uniform 
thickness by wrapping a strand of 200 µm diameter metal wire (Miltex) around the glass rod 
at each end, raising it 200 µm from the glass. The glass sheet was then immersed into ultrapure 
water from a DirectQ UV3 water purification system (Millipore) at a conductivity of 
0.05 µS/cm (also known as ‘double distilled’ or ddH2O) at 20°C. The water acted as a non-
solvent, causing the NMP to de-mix from the PLGA, leaving behind a flat sheet scaffold 
(Figure 3.1B). This water was replaced twice daily to facilitate the removal of the NMP from 
the flat sheet structure. After three days the flat sheet membrane was removed from the water 
and hung to air dry (Figure 3.1C).  
 
Figure 3.1 – Flat sheet fabrication. (A) prior to immersion, (B) during immersion, (C) after immersion. 
 Hollow Fibres 
Hollow fibres were spun using a spinneret into a water trough (coagulation bath), both custom 
built at the University of Bath. A 150 ml pressure vessel (Parker) containing the polymer dope 
was mounted beside it, with a nitrogen gas inlet supplied to the top, and a polymer exit line 
fitted to the bottom (Figure 3.2). Needle valves were placed at both ends of the pressure vessel. 
The exit line fed polymer into the lower chamber of a spinneret, which had a 1.5 mm diameter 
bore hole at its base.  A second line entering the upper chamber of the spinneret provided 
water to a 22 gauge needle (ID = 0.41 mm, OD = 0.72 mm) at its base, which passed through 
the lower chamber, emerging at the bottom of the spinneret, exposed to air.   





Figure 3.2 – Pressure vessel and spinneret configuration. 
Water was flowed through the needle at a flow rate that provided an unbroken vertical stream 
of liquid, typically at 8 – 12 ml/min. A pressure was applied to the polymer inside the pressure 
vessel to initiate a polymer flow into the lower chamber of the spinneret, typically anywhere 
between 0.5 barg and 4.0 barg depending on the viscosity of the polymer and the type of 
spinneret used. Polymer emerged from the bottom of the spinneret through an annulus between 
the needle and the bore hole, which undergoes internal coagulation from the flow of water 
though the needle. The resulting semi coagulated polymer was fed into the primary 
coagulation bath (Figure 3.3). The gap between the exposed needle and the water bath is 
referred to as the ‘air gap’. Spinning was performed with no air gap.  
The hollow fibre was fed through the primary and secondary baths before being picked up on 
a rotor directing the hollow fibre into a collection bucket of non-solvent. Manufactured fibres 
were typically 75 – 150 µm thick, with ID of 700 – 1,100 µm and OD of 900 – 1,300 µm, with 
these dimensions dependent on the size of the needle, the subsequent size of the exit annulus, 
and the polymer flow rate. This non-solvent was replaced twice daily for three days before the 
batch of fibre was removed to dry. A more detailed operating procedure and schematic is 
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Figure 3.3 – Hollow fibre spinning rig. 
3.3.2 Manufacture of NaCl Porogen 
NaCl crystals (i.e. salt) with a target diameter of 5 µm were made following the method 
outlined by Marshall (1940). A saturated salt solution was made by dissolving 36 g of 
NaCl (Sigma Aldrich) into ddH2O.  25 mL of this solution was diluted by adding another 5% 
of ddH2O by volume, resulting in a volume of 26.25 mL. This was placed into a 50 mL 
centrifuge tube (Fisher) and frozen over dry ice for 1-2 hours. Once frozen the centrifuge tube 
was cracked open, and the resulting frozen salt solution was placed into 500 mL of ethanol 
(Sigma Aldrich) at -20°C.  
The ethanol/salt solution was manually shaken vigorously until the frozen salt solution was 
fully melted, as indicated by the ethanol’s cloudy appearance. The solution was filtered by 
pouring over a 0.2 µm filter paper (Sigma-Aldrich) attached to a vacuum 
pump (KNF Neuberger), allowing the solid salt crystals to be extracted. These were placed 
into a freeze dry bottle (Labconco) and placed in a vacuum desiccator (Savant Modulyo) for 
an hour to remove residual liquid. For manufacture of porous membranes the required quantity 
of salt was distributed in the solvent using a stirring flea on a magnetic stirring device (Stuart) 
prior to the addition of the polymer. It was theorised that scaffold porosity was affected by 





















Table 3.7 – Quantities of salt required to obtain different porosities in a 25 mL polymer dope. 
Proportion 








0% 0.0 5 20 
10% 0.5 5 20 
20% 1.0 5 20 
40% 2.0 5 20 
60% 3.0 5 20 
 
3.3.3 Cell Passaging and Maintenance 
MSC’s have a poor long-term in vitro culturing capacity. After few passages MSCs become 
senescent (Kassem, 2004), reducing their differentiation potential (Chen et al., 2014), and 
increasing the probability of malignant transformation (Rosland et al., 2009). Tao et al. (2014) 
from the Worcester Polytechnic Institute seeds MSCs at passage 4 – 9 on fibrin micro-threads 
for their studies in treating infarcted murine models, however MSC suppliers recommend the 
cells are used by passage 5 (Lonza, 2011). MSCs are also very expensive, priced at £1318 at 
passage 1 (PromoCell, 2014) to £319 at passage 4 (ThermoFisher, 2015) for a million cells. 
As this work only outlines a proof of concept for an implanted hollow fibre device for the 
encapsulation of cells, utilising such an expensive cell for such a study would be wasteful, and 
thus an alternative was chosen. 
MG63 human osteosarcoma cells were used instead of MSCs for all experiments in this thesis. 
MG63 cells grow rapidly, easily forming a monolayer (Heremans et al., 1978). MG63 cells 
have the same risks of becoming senescent over many passages, however some authors have 
used MG63 cells up to passage 91 will no ill effects (Murphy et al., 2001). In addition to their 
long life, their surface integrin subunit profile has been identified as useful for studies of initial 
cell attachment on various materials (Czekanska et al., 2012). MG63 cells are also cheaper to 
purchase, with a million cells costing £329.50 (SigmaAldrich, 2013).Complete media for the 
growth of MG63 human osteosarcoma (Sigma Aldrich) cells was made by mixing by volume 
87% Dulbecco’s modified eagle medium GlutaMAX-l (DMEM) (Gibco Life Technologies), 
10% heat inactivated foetal bovine serum (FBS) (Sigma), 1% penicillin/streptomycin (P/S) 
solution (Sigma Life Science), 1%  sodium pyruvate (NaPy) solution (Sigma Life Science) 
and 1% non-essential amino acid (NEAA) solution (Sigma Life Science).  
Passaging cells from a 75 cm2 cell culture flask (Appleton Woods) was conducted within a 
laminar flow biohood (Astec Microflow) under sterile conditions. All equipment and 
containers were disinfected with 70% ethanol solution prior to placement in the biohood. The 
spent medium was aspirated from the cell culture flask via an aspirating pipette (VWR) 




connected to an aspirator pump (KNF Neuberger), leaving behind the cells attached to the 
bottom surface.  
Cells were washed with 6 mL phosphate buffered saline (PBS) (Sigma Life Science), and 
aspirated away. 3 mL of trypsin/EDTA solution (Sigma Life Science) was added to the flask 
to remove the cells from the surface, then placed in an incubator (Wolf Laboratories) at 37 °C 
and 5% CO2 for 5 minutes. 3 mL of complete media was added to the flask, mixing with the 
3 mL already inside, before the total 6 mL solution was transferred into a 15 mL centrifuge 
tube (Fisher) and centrifuged (DJB Labcare) at 1000 g for 5 minutes.  
The supernatant was aspirated leaving behind a cell pellet. 6 mL of complete media was added 
and was gently sucked up and down the pipette to ensure the break-up of the cell pellet. 50 µL 
of cell solution was mixed with an equal volume of trypan blue 
stain (Gibco Life Technologies) to determine cell viability. 10 µL of this mixture was placed 
on a fast read slide which was placed under a light microscope at 10x magnification. Viable 
and non-viable cells were manually counted. From this the cell concentration was calculated 
and a volume of cell solution was determined to yield a required number of cells over a desired 
surface area for cell attachment. This volume was mixed with 12 mL of complete media in a 
new tissue culture flask, and placed back in the incubator under the same conditions.  
MG63 cells were passaged in duplicate so that a back-up flask was available in case of 
infection. Cells were observed between passages to ascertain their health and commitment to 
their phenotype. MG63 cells continued to proliferate and reach confluence at a predictable 
and rapid rate every 72 hours for the entirety of the study. No infections arose during cell 
passage.   
3.3.4 Cell Attachment on Flat Sheet Membranes 
Flat sheets were prepared as described in Section 3.3.1. Two gaskets of 2 mm thick 
silicone (Goodfellow) and a custom built detachable well plate (University of Bath) were 
washed in vircon (Antec International), rinsed with water treated using a Midi reverse osmosis 
water purification system (Veolia Water) to a conductivity of 15 µS/cm (also known as ‘single 
distilled’ or dH2O), and placed in a Boxer 200/40 LR autoclave (Boxer) at 121 °C and 1 barg 
before being brought into the biohood.  
Flat sheets were soaked in 70% ethanol solution in PBS for 6 hours. Membranes were placed 
in the biohood, washed twice in PBS, and left to dry for a further 6 hours. The flat sheet 
scaffold was then placed in between two silicone gaskets and positioned into a custom well 
plate as shown in Figure 3.4.  





Figure 3.4 – Flat sheet scaffold in custom well plate, top down view (A) and side view (B). 
The well plate featured a two part system where the flat sheet membrane could be placed 
between a bottom layer and a top layer with holes cut through it, allowing cells and media to 
be contained in a well. The well plate was held together by a series of screws. The silicone 
gaskets formed a liquid seal around each of the wells.   
After ensuring that all screws were tight; the exposed areas of membrane were covered by 
complete media for 30 minutes before being aspirated away. Next, a cell suspension was added 
at the desired seeding density for the given area of membrane exposed in the well, fully 
submerging it. The well plate was covered with a cell culture plate lid (Freiner Bio One), 
sealed with Parafilm (VWR), and placed in an incubator at 37°C and 5% CO2 for 6 hours. 
3.3.5 External Cell Attachment onto Hollow Fibres 
 Silicone Bioreactor (Single Fibre) 
Hollow fibres were prepared as described in Section 3.3.1 and placed into a single module 
bioreactor shown in Figure 3.5. This design was first innovated by researchers at Worcester 
Polytechnic Institute (WPI), in Boston, for cell seeding on fibrin micro-threads. Bioreactor 
components were autoclaved at 121°C and 1 barg prior to use. Hollow fibres were cut to a 
length of 3.5 cm and placed within a bioreactor consisting of 6 cm Helixmark standard silicone 
tubing of 1.98 mm inner diameter and 3.18 mm outer diameter (Helix Medical) with a 
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clamp (Qosina) that allowed for easy addition and removal of liquids from the bioreactor. A 
second slide clamp was placed on the bioreactor outlet.  
The hollow fibre was sterilised in situ by injecting 70% ethanol into the bioreactor and storing 
for 12 hours in a fridge (Lec Medical) at 4°C. Ethanol was then removed, the bioreactor 
washed with 1 ml of DMEM three times and left for an hour to soak in DMEM. An inoculation 
of 100,000 cells/cm2 in a volume of 0.1 ml was added to the bioreactor, which was then placed 
into a 50 mL centrifuge tube (Fisher) and onto either a static or rotating device in an incubator 
at 37°C and 5% CO2 for 6 hours. 
 
Figure 3.5 – Single fibre HFB silicone module. 
 Glass Bioreactor (Single Fibre or Fibre Bundle) 
Hollow fibres were prepared as described in Section 3.3.1. Glass bioreactors were made by 
the University of Bath glass blower to desired specifications. Two different sizes of glass 
bioreactor were constructed, a smaller one for single fibre experiments, and a larger one to 
accommodate several fibres. The bioreactors were cylindrical tubes, featuring an inlet/outlet 
at each side of the tube and a two side ports on either end. Bioreactor dimensions for each size 
are shown in Table 3.8. 
 




















Table 3.8 – Dimensions of glass bioreactor modules. 
Bioreactor Dimensions Single Multi 
Tube 
Length (mm) 100 120 
ID (mm) 2.5 7.5 
OD (mm) 3.5 11.5 
Side ports 
Length (mm) 20 25 
ID (mm) 2.5 2.5 
OD (mm) 3.5 5.5 
Distance from end (mm) 20 35 
Total Volume (mL) 0.69 5.54 
Prior to all cell seeding the bioreactor was coated with Sigmacote (Sigma-Aldrich), leaving 
behind a hydrophobic layer inhibiting cell attachment on the glass.  The bioreactor and all 
ancillary parts were cleaned with vircon, rinsed with ddH2O and autoclaved at 121°C and 
1 barg prior to construction in the sterile biohood. Bioreactor assembly differed slightly 
depending on its size. 
 Single Fibre Module 
A fully constructed single fibre bioreactor is shown in Figure 3.6. A hollow fibre was cut to 
12 cm and slotted into the bioreactor leaving 1 cm of fibre protruding out of each end. The 
gap between the end of the glass and the external surface of the hollow fibre were sealed using 
Silcoset 151 adhesive (ACC Silicones). Once dry, 70% ethanol solution was injected into the 
ECS of the bioreactor through a side port to sterilise its internals. The bioreactor was manually 
rocked side to side to ensure removal of air bubbles before capping the side ports and 
bioreactor ends. The bioreactor was removed from the biohood and stored in a fridge at 4°C 
for 12 hours. The bioreactor was then reintroduced into the biohood, the ethanol removed, the 
internals washed three times with DMEM, and soaked in complete media for an hour. 
 
 
Figure 3.6 – Single fibre HFB glass module. 
Silicone adhesive      Hollow fibre          Tube section     Side port 
2 cm 




The media was removed and the desired number of cells in media solution was inoculated into 
the ECS via the side port. The number of cells in this solution was calculated in order to 
achieve a specific cell seeding density onto the exposed external surface of the hollow fibre. 
The protruding fibre was trimmed down and the exposed ends glued shut with silicone glue 
for external seeding. The side ports on the bioreactor were capped. Depending on the 
experiment the bioreactor was either a left static or attached to a rotating device in an incubator 
at 37°C and 5% CO2 for a set period of time to assist in cell distribution and improve seeding 
efficiency.  
 Multi Fibre Module 
Multi fibre bioreactors were prepared identically to the single fibre bioreactors with three 
minor differences. Hollow fibres were cut to 14 cm to account for the slightly larger bioreactor 
length, an annular silicone gasket of thickness 2 mm, ID 4 mm and OD 12 mm was glued onto 
either side of the main tube inlet/outlet to allow easy bundling of the hollow fibres within the 
bioreactor and fibres were individually sterilised with 70% ethanol solution prior to insertion. 
An assembled multi fibre bioreactor is shown in Figure 3.7. 
 
























3.3.6 Internal Cell Proliferation within Hollow Fibres 
Single hollow fibres were fixed into glass bioreactors, sterilised and the lumen seeded with 
cells. The bioreactor was attached via its side ports to a recirculating media perfusion system 
comprised of a multi-head peristaltic pump, a media reservoir and oxygen permeable silicone 
tubing. All equipment was sterilised by pumping 70% ethanol through the system, and 
washing with DMEM.  A support for the bottles, tubing and bioreactors was made out of 
K’NEX (K’NEX Ltd.), a construction toy comprising of plastic rods and connectors shown in 
Figure 3.8. This section continues to describe the rig assembly and operation in more detail. 
 
Figure 3.8 – A selection of K’NEX rods and connectors. 
 Detailed Perfusion Rig Assembly 
Three hollow fibre bioreactor perfusion circuits were assembled simultaneously as described 
below. This allowed for the removal of a seeded bioreactor for analysis at designated time 
points. This method assumes that each step of the procedure is done for all three bioreactors 
consecutively. The K’NEX support was constructed beforehand as shown in Figure 3.9, 
washed with Vircon then ethanol. K’NEX could not be autoclaved. 
 
 
Figure 3.9 – K’NEX support structure. 
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All tubing, lids, fittings and glassware were washed with concentrated Savona D1 washing up 
liquid (Premier Products) using a syringe and soaked for 24 hours, then washed with warm 
tap water and dH2O prior to assembly. 
A 50 mL screw cap glass Pyrex bottle (Fisher Scientific) acted as a reservoir for the perfused 
liquid. Omnifit “Q” Series bottle caps (Kinesis) were used as lids. The lids had three threaded 
holes 1/4” in diameter in the top with plastic tubing fed to the bottom of the bottle. There was 
a hole at the bottom of each thread, approximately 1 mm in diameter, which allowed for inlet 
flow, outlet flow, and gas exchange to the bottle. Images of the reservoir system are shown in 
Figure 3.10. 
 
Figure 3.10 – Media reservoir with Omnifit caps. 
A 1/4” flat bottom to 1/16” barbed to thread adaptor (Kinesis) was screwed into the outlet of 
the reservoir and 18 cm of Masterflex 0.8 mm ID platinum-cured L/S 13 silicone 
tubing (Cole-Parmer) was attached. This connected to 42 cm 3-Stop Pharmed 1.52 mm ID 
tubing (Cole-Parmer), by a 1/16” straight connector (Cole-Parmer) as shown in Figure 3.11. 
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Figure 3.11 – Reservoir outlet to pump tubing. 
Pump tubing was placed in a plastic brace and fitted to a REGLO peristaltic pump (Ismatech). 
10 cm of L/S 13 tubing was fitted to the pump tubing outlet by a 1/16” straight connector. The 
other end of the L/S 13 tubing was fitted with a Masterflex barbed 1.8” ID to L/S 13/14 reducer 
(Cole-Parmer) to allow connection of 3 cm of Masterflex 3.1 mm ID platinum-cured L/S 16 
silicone tubing (Cole-Parmer) as shown in Figure 3.12. L/S 16 tubing was selected because of 
its ability to fit snugly over the ends and side ports of the single fibre glass bioreactor. 
 
 
Figure 3.12 – Bioreactor ECS inlet connector. 
The single fibre bioreactor was constructed by feeding a 12 cm long hollow fibre through the 
module and gluing in place at the ends with Silcoset adhesive. Once set, the protruding 1 cm 
of fibre from each end of the bioreactor was cut. The L/S 16 tubing was fitted over the one of 
the side ports of the single fibre glass bioreactor (the ECS inlet). The adjacent lumen inlet was 
capped with a male luer lock plug (Cole-Parmer) attached to 2 cm L/S 16 tubing as shown in 
Figure 3.13. 
 
Figure 3.13 – Bioreactor ECS inlet.  
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Both the ECS outlet and lumen outlets were fitted with 3 cm L/S 16 tubing and joined to 15 cm 
L/S 13 tubing by a Masterflex barbed 1.8” ID to L/S 13/14 reducer. The outlets of both of the 
L/S 13 tubes were connected to 1.5 cm Masterflex 1.6 mm ID platinum-cured L/S 14 silicone 
tubing (Cole-Parmer) by a 1/16” straight connector. Both streams were joined at a 4 mm ID 
barbed Y-connector (Cole-Parmer), which in turn was attached to 1.5 cm L/S 14. Into this a 
1/16” straight connector was fitted and 1.5 cm L/S 13 tubing attached. This assembly is shown 
in Figure 3.14 and Figure 3.15.  
 
Figure 3.14 – Bioreactor outlets joined at Y-connector. 
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The bottom of the Y connector was then attached to a 1/4” flat bottom to 1/16” barbed to 
thread adaptor and screwed into the reservoir inlet port, completing the recycling perfusion 
loop. A plastic hollow bored 1/4” threaded screw is fitted into the final hole in the lid from 
which a Whatman Hepa-vent filtration unit (Sigma-Aldrich) was attached via 3 cm of 8 mm 
ID Marprene tubing (Watson-Marlow) allowing for gas exchange with the system. 
Once assembled, the reservoir was filled with 20 mL 70% ethanol solution. The system was 
primed and left to sterilise at a flow rate of 10 µL/min for 18 hours. The system was drained 
of ethanol, and the bottle replaced with another containing 20 mL DMEM. The tubing was 
then primed, and the system washed at 30 µL/min for 6 hours. DMEM was drained and 
replaced with a bottle of complete cell media of volume ranging from 20 – 40 mL. 
For seeding, each bioreactor was disconnected from the circuit and their end caps removed. 
100,000 cells were inoculated into the lumen of the hollow fibre from the exposed ends. The 
ends were glued shut with Silcoset adhesive, the bioreactor flipped 180°, and then another 
layer of adhesive was applied. Once dry the fibre outlet was reopened and each bioreactor was 
re-fitted back into the circuit, and the system placed in an incubator at 37 °C and 5% CO2. 
Media flow of 10 or 50 µL/min was initiated for 1, 3 or 6 days. A fully assembled bioreactor 
system in duplicate on the K’NEX support is shown in Figure 3.16. An alternative 
configuration using the same tubing, fittings and methodology was constructed for a non-
recirculating variant with separate reservoirs for inlet and outlet media. 
 
Figure 3.16 – Fully assembled bioreactor circuit (in duplicate). 
5 cm 




At the desired time, the pump was stopped, the pump inlet tubing disconnected from the 
Omnifit lid and the plastic pump brace removed. The tubing and bioreactor were lifted to allow 
residual media to drain back into the reservoir. The reservoir, bioreactor and tubing were 
removed from the incubator and a media sample removed for testing. A syringe needle was 
used to cut the hollow fibre from the glass module, which was analysed for cell number and 
viability. The pump was then resumed to allow the experiment to continue for subsequent days 
on the remaining bioreactors.  
3.4 ANALYITICAL METHODS 
3.4.1 Cell Culture Analysis 
 Manual Cell Counting 
A sample of cells in media solution was mixed in equal measure with trypan blue dye. 10 µL 
of this solution was pipetted into a fast read haemocytometer slide (Una Health) which 
contained a grid of squares visible under a light microscope at 10x magnification. Each 3 x 3 
grid contained 0.1 µL, and the cells within this grid were manually counted using a handheld 
counter (Fisher) and scaled up to yield a cell concentration of the original sample. Cells with 
damaged membranes allowed the dye to penetrate into the cell cytoplasm and organelles, 
which were stained blue, indicating they were non-viable, and were excluded from the count 
unless experimentally relevant. Three to six separate samples were taken and an average was 













  × 10,000[𝑚𝐿] 
Equation 3.1 – Calculation of cell concentration from manual counting 
 Picogreen Assay 
Picogreen assay (Gibco Life Technologies) was used to quantify the presence of 
deoxyribonucleic acid (DNA) from attached cells on or within scaffolds. Samples of scaffold 
along with their attached cells were placed in 1x Tris & EDTA (TE) buffer (Invitrogen) and 
underwent two freeze-thaw cycles between -80 °C and 25 °C to lyse the cells. Picogreen 
reagent was diluted in sterile 1x TE buffer solution in a 1:200 ratio and 75 µL mixed in equal 
measure with the DNA/TE buffer solution in a well of a 96 well plate.  
Samples of known concentrations of DNA were also mixed with the picogreen reagent 
solution in the same conditions in order to provide a calibration curve to compare the results 
to. Samples of known cell number also underwent the freeze-thaw cycle and were mixed with 
picogreen to form a standard curve of cell number verses picogreen absorbance. The well plate 




was placed in a fluorospectrometer (NorthStar Scientific) at 480 nm excitation and 520 nm 
reading. The resulting absorbance reading was compared to the DNA standard curve (Figure 
3.17), and the resulting DNA concentration was compared to the readings from the specific 
cell standard curve (Figure 3.18) to calculate the quantity of DNA that was present in each 
cell. Both standard curves were calculated from triplicate assays (n = 3) replicated on four 
separate days (N = 4). From this the overall number of cells attached was calculated, as well 
as the efficiency of attachment to the scaffold.   
 
Figure 3.17 – DNA standard curve for picogreen assay (n=3, N=4, error = SD). 
 
Figure 3.18 – MG63 cell line standard curve for Picogreen Assay (n=3, N=4, error = SD). 
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 Dissolved O2 and pH Readings 
Media samples were tested for their dissolved oxygen content and pH to determine if any 
changes occurred as a result of cell proliferation or otherwise. When media bottles were 
removed from the HFB perfusion rig at the end the experiment outlined in Section 3.3.6, the 
valves in the “Q” Series Omnifit lids were shut. The media in the bottles was left to reach 
25°C before testing. The lid was removed, the dissolved oxygen probe (Thermo-Scientific) 
input, and the bottle neck wrapped in Parafilm to maintain a seal. Readings are displayed on 
an Orion Versastar advanced electrochemistry meter (Thermo-Scientific) and were noted after 
stabilising over 5 minutes.  This process was repeated with the pH probe (Eutech Instruments). 
Both probes were cleaned with ethanol and ddH2O before and after use. Readings for oxygen 
and pH were used to characterise the health of the circulating media and determine if the 
system was infected. In-line readings of oxygen and pH within the ECS and the lumen of the 
HFB were not able to be taken.  
3.4.2 Scaffold Analysis 
 SEM Imaging 
Prior to being placed in a scanning electron microscope (SEM), samples were submerged in 
liquid nitrogen for one minute, removed, then cut using a scalpel into pieces no more than 
5 mm in length for flat sheet samples, or 2 mm in height for hollow fibre cross sections. 
Scaffolds were mounted onto stubs using double sided conductive carbon 
tape (Agar Scientific), coated with gold using an Edwards Sputter Coater S150B (Edwards) 
and placed into a Joel JSM 648OLV SEM (Joel).  
 ImageJ Analysis 
SEM images of porous scaffolds were analysed using ImageJ software (version 1.48). ImageJ 
allowed modification of raw SEM photos into binary black and white images to accentuate 
the contrast and differentiate pores on the surface, which ImageJ sized and counted. A macro 
was written to facilitate this process due to the large number of images to be analysed. Figure 
3.19 shows a standard SEM image, and Figure 3.20 shows its final form after modification. 
An in depth tutorial can be found in Appendix B. 





Figure 3.19 – An SEM image of porous PLGA. 
 
Figure 3.20 – An example of pore counting and sizing using ImageJ. 
 Gas Permeation 
A bundle of three hollow fibres was potted into a cylindrical metal module using araldite 
glue (Huntsman) and supplied with a flow of N2 at a set pressure via a sequence of metal pipes, 
fittings and pressure gauges (Swagelok) as shown in Figure 3.21. The bundle was glued such 
that N2 passed through the central lumen at the inlet of the module, and exited radially through 
the fibre wall at atmospheric pressure, and not the fibre outlet (dead end mode). The flow rate 
of air (Q) exiting the module was measured using a bubble column (Hewlett-Packard) for 
0 – 50 mL/min, an ‘MOB 12000’ rotameter (MPB) for 30 – 300 mL/min or a Platon NGCV 
rotameter (Platon) for 200 – 2000 mL/min. 





Figure 3.21 – Hollow fibre gas permeation apparatus. 
This was repeated for at least five other inlet pressures ranging between 1.03 – 1.42 bar 
(absolute). Darcy’s law (Equation 3.2) was used to calculate gas permeability κG of the hollow 
fibre, using its surface area (A), thickness, N2 viscosity (µ) and pressure difference (ΔP) acting 








Equation 3.2 – Darcy’s law. 
 Liquid Permeation 
A single hollow fibre was glued into a single glass bioreactor module as outlined in Section 
3.3.5, leaving the hollow fibre lumen exposed. The bioreactor was connected to an apparatus, 
shown in Figure 3.22, allowing its liquid permeability to be determined. Liquid was pumped 
from a 1 L glass bottle (Fisher) through the hollow fibre lumen using a 205U peristaltic 
pump (Watson Marlow) with 1.42 mm ID PVC manifold tubing pump 
tubing (Watson Marlow). Liquid exiting the lumen was collected in a glass beaker on a set of 
weighing scales (Denver Instruments). Back pressure was applied using a needle 
valve (Swagelok) at the outlet. Liquid flow out of the ECS was controlled by slide clamps 
attached to silicone tubing connected at the bioreactor side ports. Pressure 
transducers (Omegadyne) were connected to the inlet and outlet of the bioreactor via a 
Bubble column                            Pressure gauges             Gas Inlet
     Module                    Gas control valves 
5 cm 




T-piece (Cole-Parmer). The scales and pressure transducers were connected to a computer 
running Labview software (National Instruments), where the data was logged. Permeability 
was calculated using Darcy’s Law (Equation 3.2).  
 
 
Figure 3.22 – Hollow fibre liquid permeation apparatus. 
Flow rate was set to 1 ml/min and each experiment was run for 90 minutes. Prior to the 
experiment the pump was calibrated by pumping water though a non-porous hollow fibre 
bioreactor and the effluent mass measured on set of weighing scales. Mass readings were 
transferred to a data acquisition module and output on a computer display using LabVIEW 
software. A density value of the liquid used, dependant on ambient temperature, was manually 
written into the software to convert liquid mass to volume. The software accumulated data 
from the scales and pressure transducers every 0.5 seconds and output an average value 
dependent on the time interval set by the user. The larger the time interval, the more accurate 
the average measurement was. The time interval was set to 5 minutes. 
The value for inlet flow rate of liquid on the pump was set in the software, which would match 
the calculated retentate outlet flow rate measured on the scales so long as no permeation 
through the membrane wall occurred. Discrepancies in retentate flow rate were attributed to 
liquid permeating through the membrane. This allowed calculation of retentate and permeate 
flow rates, as well as the volume fraction of each stream.  
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3.5 STATISTICAL METHODS 
Captions describing experimental results in figures or tables display the number of 
experimental trials (n), replicates (N) and error. All error bars are as described in their 
respective figure captions. Error is either standard deviation (SD) from the mean due to 
uncertainty in repetition of experimental results, or a percentage value calculated from the 
propagation of uncertainty from performing calculations using several values derived from 
experimental, measurement or human error. Error propagation is calculated as shown in 
Equation 3.3 and Equation 3.4: 
 
If:  𝑍 = (𝑎 ± 𝛿𝑎) + (𝑏 ± 𝛿𝑏) − (𝑐 ± 𝛿𝑐) − (𝑑 ± 𝛿𝑑) 
Then:  𝛿𝑍 =  √(𝛿𝑎)2 + (𝛿𝑏)2 + (𝛿𝑐)2 + (𝛿𝑑)2 
Equation 3.3 – Error propagation when adding or subtracting values. 
 

























Equation 3.4 – Error propagation when multiplying or dividing values. 
A Student’s t-test was used to determine significant differences between two data sets and a 
one way analysis of variance (ANOVA) was used for comparison between three or more 
independent samples using a post hoc Tukey range test. Samples were considered significantly 
different if there was a 95% confidence (P < 0.05) that this was true. Analyses were carried 
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4. CHAPTER FOUR: CELL ATTACHMENT ON 
EXTERNAL HOLLOW FIBRE SURFACES 
4.1 INTRODUCTION 
When growing cells in a bioreactor, it is important to ensure that there is a known initial 
quantity of cells within the bioreactor to obtain a predictable quantity of product. This is 
especially important when cultivating rare or expensive cell populations. In the case of the 
works described in this thesis, 50 million mesenchymal stem cells (MSCs) need to be grown 
for use as a traditionally administered cell therapy for the regeneration of human heart 
myocardium. As previously described in Section 2.3.1, MSCs have been utilised within 
biodegradable scaffolds for use in heart tissue engineering applications. Purchasing these cells 
can be costly, and the isolation of these cells from human patients provides yields of 
812,800 ± 318,400. Because of their clinical usefulness and their cost it is paramount to ensure 
a high and consistent level of initial cell attachment onto the scaffold in order to minimise any 
wastage of these cells. The scaffolds in question are polymeric hollow fibres. Hollow fibres 
are manufactured as described in Section 3.3.1 and placed within a bioreactor module for 
external seeding as described in Section 3.3.5 and shown in Figure 3.5. 
When seeding on flat sheet membranes, a known concentration of cells within a solution of 
growth media is inoculated onto the surface and left for a set time. During this time the cells 
will sink through the liquid and reach the membrane at the bottom where they will attach and 
be reasonably well distributed. Attempting to seed onto a hollow fibre within a 
bioreactor (HFB) is more complex as the cells will once again sink due to the force of gravity, 
but can potentially miss the scaffold completely while settling. This leads to poor utilisation 
of the inoculated cells and rates of cell attachment of around 20%. The hollow fibre is a 
cylindrical 3D (three-dimensional) scaffold located throughout the entire length of the 
bioreactor, leading to a more complex seeding methodology compared to with 2D (two-
dimensional) flat sheet scaffolds if similar degrees of cell attachment are desired. Cells which 
fail to contact with the hollow fibre and fall to the bottom of the HFB have no possibility of 
attaching to the scaffold and are wasted if the reactor is kept in static conditions. HFBs seeded 
with 812,800 ± 318,400 MSCs with 20% efficiency would take 12.6 ± 5.2 days to grow to 
50 million cells. If 100% efficiency could be achieved, this would reduce growth time to 
9.1 ± 4.0 days. Therefore there is scope to seek alternative methods for seeding cells in HFBs. 
This chapter proposes a dynamic seeding regime to encourage a greater degree of cell mixing 
in the bioreactor and allow multiple opportunities for cells to contact the hollow fibre and 
potentially attach. Such an investigation has not been attempted before, making this a novel 
endeavour.  




A number of cell attachment experiments were undertaken using MG63 human osteosarcoma 
cells on scaffolds of poly (lactic-co-glycolic) acid (PLGA), with a 75:25 poly(lactic acid) 
(PLA) to poly(glycolic acid) (PGA) ratio, in a solution with N-Methyl-2-pyrrolidone (NMP) 
solvent. Polymer to solvent ratio is 20:80 by weight. As a control, cell attachment was done 
on static flat sheet membranes placed within custom well plates as described in Section 3.3.4 
to confirm the ability of cells to attach to the PLGA material over a number of different time 
frames. A series of static cell attachment experiments was then done on a single PLGA hollow 
fibre scaffold (Figure 4.1). Afterwards a series of dynamic cell attachments were conducted 
by attaching the HFB onto a rotating drum (Figure 4.2) at a horizontal, diagonal or vertical 
orientation set at of 2, 6 and 8 rotations per minute (RPM) (angular velocities of 0.25, 0.63 
and 0.86 s-1 respectively). Finally HFBs were attached to a MACSmix rotator drive (Figure 
4.3) that rotated for 1 minute at 10 RPM (1.05 s-1) and paused for 4 minutes. Seeded single 
fibre HFB modules were placed into 50 mL centrifuge tubes to allow for easy placement onto 
these devices. A comparison was drawn with the static methods and the most effective 
combination of conditions for dynamic cell attachment was found. Afterwards experiments 
on bundles of hollow fibres were conducted to determine how scale up of the system affects 
cell attachment. 
 
Figure 4.1 – Bioreactors in a static position. 
 
Figure 4.2 – Bioreactors attached to a Stuart STR4 rotator drive. 
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5 cm 





Figure 4.3 – Bioreactors attached to a MACSmix periodic rotating device. 
It was hypothesised that a novel dynamic regime would allow a greater degree of cell 
attachment onto the hollow fibre scaffold due to the increased number of opportunities a cell 
would have to make contact with the scaffold. The aim of this chapter was to determine if a 
novel dynamic cell seeding regime provided a greater rate of cell attachment on hollow fibre 
scaffolds compared to static seeding. This aim was achieved by conducting seeding 
experiments on flat sheet scaffolds to determine the most efficient time for cell attachment, 
followed by studies on single HFB modules seeded statically and dynamically to find what 
parameters affected attachment, then concluding with work on dynamic seeding of a hollow 
fibre bundle in a bioreactor.  
4.2 CELL ATTACHMENT THEORY 
4.2.1 Static Seeding 
 Single Hollow Fibre Modules 
The maximum rate of static cell attachment in the HFB system can be predicted by 
determining the number of cells that come into contact with the hollow fibre. As the hollow 
fibre does not take up the entire volume of the bioreactor and the cells are left to settle due to 
gravity, the cells receive one opportunity to come into contact with the hollow fibre. The 
collective area surrounding the hollow fibre within the bioreactor is the extra-capillary space 
(ECS). Assuming the inoculated cells are well mixed and settle directly downwards there will 
be small fraction of cells located above the scaffold that will fall directly onto it and a larger 
fraction that will miss the scaffold entirely if located adjacent to or beneath the module. This 
is illustrated in in Figure 4.4, along with the dimensions of a single fibre bioreactor. The length 
of the hollow fibre (LF) in this system is 35.0 ± 0.1 mm.  
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Figure 4.4 – Cross section of a single HFB module displaying the predicted cell contact area.  
The volume of the green shaded region in Figure 4.4 can be calculated from shape geometry 
using trigonometry. While the cells are settling in three dimensions, taking the cross section 
of the HFB will yield an area that is proportional to the overall volume of that section. The 
areas in question are labelled in Figure 4.5 below: 
 
Figure 4.5 – Single HFB module geometry labelled in segments. 




Area A is the cross sectional area of the inner wall of the HFB, with a diameter of 
2.00 ± 0.05 mm. Area B is the cross sectional area of the hollow fibre with an outer diameter 
of 1.00 ± 0.05 mm. Areas C and D are chords of equal area that touch the outermost points of 
Area B while moving vertically downwards. Areas E and F remain, with Area E being the 
region of interest directly above the hollow fibre. This area is calculated in Equation 4.1, with 
rOF representing the outer fibre radius, and rIB representing the inner bioreactor wall radius.  
𝐴𝑟𝑒𝑎 𝐴 =  𝜋𝑟𝐼𝐵
2 =  𝜋12 = 𝜋 
𝐴𝑟𝑒𝑎 𝐵 =  𝜋𝑟𝑂𝐹
















− sin 𝜃) 
𝐴𝑟𝑒𝑎 𝐸 = Area 𝐴 − Area 𝐵 − Area 𝐶 − Area 𝐷 − Area 𝐹 
𝐴𝑟𝑒𝑎 𝐹 = 𝐴𝑟𝑒𝑎 𝐸 , therefore: 
𝑨𝒓𝒆𝒂 𝑬 =








Equation 4.1 – Derivation of Area E to determine theoretical cell attachment. 
The angle (θ) in Equation 4.1 is the central angle of the chord (c) within the circle. Area D is 
a circle segment that can be calculated using the internal radius of the bioreactor (rIB) and the 
central angle of the segment. With reference to Figure 4.6 this angle can be calculated as 
shown in Equation 4.2: 
 
Figure 4.6 – A representation of the variables required to calculate segment area in a single HFB module. 
















) = 60° 
𝜽 = 𝟏𝟐𝟎° ± 𝟑° 
Equation 4.2 – Calculation of the segment angle of a chord. 
By inserting the known dimensional values of the HFB system, the segment Area E can be 
calculated, and by multiplying the segment area by the hollow fibre length (LF,) the volume 
of the segment can be found, as shown in Equation 4.3: 
𝐴𝑟𝑒𝑎 𝐸 =




180 − sin(120 ± 3))
2
= 0.564 ± 0.104 𝑚𝑚2 
𝑉𝑜𝑙𝑢𝑚𝑒 𝐸 = 𝐴𝑟𝑒𝑎 𝐸 × 𝐿𝐹 
𝑉𝑜𝑙𝑢𝑚𝑒 𝐸 = 0.564 ± 0.104 [𝑚𝑚2] × 35 ± 0.05 [𝑚𝑚] 
𝑽𝒐𝒍𝒖𝒎𝒆 𝑬 = 𝟏𝟗. 𝟕 ± 3.6 𝒎𝒎𝟑 
Equation 4.3 – Calculation of available ECS volume for cells to naturally settle onto the hollow fibre. 
Volume E can then be taken as a percentage of the total available volume in the ECS:  
  𝐶𝑒𝑙𝑙 𝑆𝑝𝑎𝑐𝑒 = (𝐴𝑟𝑒𝑎 𝐴 − 𝐴𝑟𝑒𝑎 𝐵)  × 𝐿𝐹 
𝐶𝑒𝑙𝑙 𝑆𝑝𝑎𝑐𝑒 = (𝜋 − 0.25𝜋)[𝑚𝑚2] × 35 ± 0.05[𝑚𝑚]
= 82.5 ± 0.12 [𝑚𝑚3] 
𝑉𝑜𝑙𝑢𝑚𝑒 𝐸 =
19.7 ± 3.6 [𝑚𝑚3]
82.5 ± 0.12 [𝑚𝑚3]
× 100% 
𝑽𝒐𝒍𝒖𝒎𝒆 𝑬 = 𝟐𝟒% ± 4% 
Equation 4.4 – Calculation of available ECS percentage for cells to naturally settle onto the hollow fibre. 
Assuming that: the hollow fibre is completely straight and resides in the very centre of the 
bioreactor, the cells in the media are well mixed throughout the entire cell space and do not 
interact with one another, and that cells settle due to the force of gravity directly downwards, 
this model indicates that a maximum 24% ± 4% of cells will have a chance to attach to the 
hollow fibre in this module. However this does not take into account the fact that cell 
attachment on the hollow fibre will become more difficult the steeper the gradient of the 




available surface is. This means that cells that make fibre contact close to the chords shown 
in Figure 4.5 will be unlikely to attach. Therefore maximum cell attachment is likely to be 
smaller than 24% ± 4% 
 Multi Hollow Fibre Modules  
Utilising the same methodology for a single hollow fibre in a bioreactor, the likelihood of a 
cell making contact with a bundle of hollow fibres in a larger bioreactor can be calculated.  
At this point it was important to outline a new region of interest, the hollow fibre zone (HFZ). 
The HFZ is defined as the area in the centre of the bioreactor which may contain a hollow 
fibre. In the multi-fibre experiments shown later in this chapter, five hollow fibres were placed 
in the bioreactor through holes of radius 2.50 ± 0.05 mm at either end as described in 
Section 3.3.5. From this it is assumed that the cylinder which could be made from the hole of 
this radius along the length of the bioreactor is a volume where a hollow fibre can reside during 
the experiment; however it is anticipated that this method will over-estimate the area available 
for cell contact via gravity settling. 
It was important to establish this volume because the hollow fibres were not placed into the 
bioreactor in the exact same position each time i.e. the bioreactors were not axisymmetric. 
The theoretical efficiency of any cell attachment is dependent on the cells reaching this HFZ, 
which is shown in the cross section in Figure 4.7: 
 
Figure 4.7 – Cross section of a multi HFB module displaying the predicted cell contact area. 




Again, the area in green represents the space a cell must be located in order to have an 
opportunity to attach to the hollow fibre. Using the same equations for a single fibre bioreactor, 
the green area in Figure 4.7 equates to 30% ± 1%. of the total available volume for cells to 
reside after inoculation. Step by step calculation of this value is shown in Appendix C.  
This value is dependent on the same assumptions as stated for the single hollow fibre 
bioreactor module: the hollow fibres are completely straight and reside in the very centre of 
the bioreactor, and the cells in the media are well mixed throughout the entire cell space and 
do not interact with one another. This model indicates that a maximum 30% ± 1%. of cells 
will have a chance to attach to a hollow fibre but cell attachment is likely to be smaller than 
this due to low likelihood of attachment at extreme gradients near the chords of the HFZ.  
 Gravity Settling of Cells 
While it has been assumed that the cells are well mixed, it is also important to consider that 
cells may be hindered in their rate of settling due to cell-cell collisions. To determine this, an 
unhindered settling velocity must first be obtained. Settling velocity can be calculated by 
conducting a force (F) balance on a single cell as shown in Figure 4.8 and using cell, liquid 
and system properties summarised in Table 4.1.  
 
Figure 4.8 – A force balance on a single cell. 
 




Table 4.1 – Values of various parameters in the force balances. 
 Property Value Error Units Source 
Cell  
Radius (rC) 1.79E-05 5% m (Pautake et al., 2004)  
Density (ρC) 1,115 1% kg/m3 (Grover et al., 2011) 
Volume (VC) 2.38E-14 9% m3  Derived 
Mass (MC) 2.65E-11 9% kg  Derived 
Media 
Density (ρL) at 20 °C 1,000 1% kg/m3 
(Invitrogen, 2015) 
Viscosity (µL) at 20 °C 9.80E-04 1% kg/(m.s) 
System Gravity (g) 9.81 1% m/s2  Constant 
After inoculation each cell has an opportunity to settle to the bottom of the bioreactor due to 
gravity (Fg), but each cell is resisted by its drag through the liquid (Fd) and its intrinsic 
buoyancy (Fb). As the cells have very small diameters and are moving in liquid of low 
viscosity it has been assumed that the cell Reynolds number (ReC) is less than 0.2, therefore 
the Stoke’s drag force is equal to 6𝜋𝑟𝐶µ𝐿𝑢𝐶 (Richardson et al., 2002), with rC equal to the 
radius of a spherical cell, µL being the viscosity of the cell media and uC the cell settling 
velocity. This assumes that the cell in the fluid is subjected to laminar flow, that the cell is a 
perfectly smooth and ridged sphere, and that the cells do not collide with one another 
(Richardson et al., 2002). 
The resulting force acting on each cell is calculated by subtracting cell drag and buoyancy 
forces from gravitational force. Force is equal to a mass of a body multiplied by the applied 
gravity, and mass is equivalent to the product of the volume and density. At a uniform settling 
velocity resultant force is zero (Richardson et al., 2002). Equation 4.5 shows how a force 
balance on a cell can be re-arranged to determine the cell settling velocity (uC), using a volume 
of a sphere to express the volume of a cell with a known radius: 
𝑅𝑒𝑠𝑢𝑙𝑡𝑎𝑛𝑡 𝑓𝑜𝑟𝑐𝑒            = 𝐹𝑔 − 𝐹𝑏 − 𝐹𝑑 
0                    = 𝑉𝐶  𝜌𝐶  𝑔 − 𝑉𝐶  𝜌𝐿 𝑔 − 6 𝜋 𝑟𝐶  𝜇𝐿  𝑢𝐶   









(𝜌𝐶 − 𝜌𝐿)𝑔 
Equation 4.5 – Derivation of cell settling velocity equation. 
 
 




The values shown in Table 4.1 are inserted into the Equation 4.5 to yield the cell settling 
velocity (Equation 4.6):  
𝑢𝐶 =
2 × (1.79 × 10−5)2[𝑚]2
9 × (9.80 × 10−4) [
𝑘𝑔
𝑚. 𝑠]
× (1115 − 1000) [
𝑘𝑔
𝑚3




𝒖𝑪 = 𝟖. 𝟏𝟒 × 𝟏𝟎
−𝟓  ± 𝟎. 𝟓𝟗 × 𝟏𝟎−𝟓 𝒎/𝒔 
Equation 4.6 – Calculation of cell settling velocity. 
As the cell of diameter 3.58E-05 (±5%) m (dC) is moving through a liquid of density 
1,000 (± 1%) kg m-3 and viscosity 9.80E-04 (± 1%) kg m-1s-1 at the above settling velocity, 
the particle Reynolds number of the cell (Rec) can be calculated and shown to be less than 0.2 
in Equation 4.7. This confirms the previous assumption to be true and validates the settling 









] × 8.14 × 10−5 [
𝑚
𝑠 ] × 3.58 × 10
−5[𝑚]




𝑹𝒆𝑪 = 𝟎. 𝟎𝟎𝟑 ± 𝟑 × 𝟏𝟎
−𝟒 
Equation 4.7 – Calculation of particle Reynolds number of a settling cell. 
 
 Single Hollow Fibre Modules 
Given that a cell travels a known distance from the top of the bioreactor to the bottom, the 
maximum settling time can be calculated using Equation 4.8 knowing the settling velocity and 
the inner radius of the single HFB module: 




𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝑆𝑒𝑡𝑡𝑙𝑖𝑛𝑔 𝑇𝑖𝑚𝑒 =
2 × 0.001 [𝑚]




𝑴𝒂𝒙𝒊𝒎𝒖𝒎 𝑺𝒆𝒕𝒕𝒍𝒊𝒏𝒈 𝑻𝒊𝒎𝒆 = 𝟐𝟓 ± 𝟐 𝒔 
Equation 4.8 – Calculation of maximum settling time in a single HFB module. 
 
 




It takes 25 ± 2 seconds for a cell at the very top of the single HFB module to fall 2 mm to the 
very bottom. As they descend any given cell may fall on top of a hollow fibre and subsequently 
attach. It is assumed the rest of the cells accumulate at the bottom of the reactor. Given that 
the unhindered settling velocity is now known, the hindered settling velocity can be 
determined using Equation 4.9: 
𝒖𝑯 = 𝒖𝑪(𝟏 − 𝒇)
𝒚 
Equation 4.9 – Equation for hindered settling velocity (Richardson and Zaki, 1997).. 
Where uH is the hindered settling velocity, uC is the calculated cell settling velocity without 
hindering effects, y is an exponent dependent on the cell particle Reynolds number, and f is 
the volume fraction of the cells in suspension. For a Reynolds number less than 0.2, y has been 
empirically derived to be 4.65 (Richardson and Zaki, 1997). The cell volume fraction can be 
calculated by the division of the total volume of all the cells in the bioreactor by the volume 
of media within the bioreactor (Equation 4.10). For single HFB modules, 110,000 ± 18,480 
cells were to be inoculated in a volume of 82.5 mm3 media at a surface density of 
100,000 ± 16,800 cells/cm2 for external seeding on a single PLGA hollow fibre 0.5 ± 0.05 mm 
in outer radius, 35 ± 0.05 mm in length and surface area of 1.1 ± 0.2 cm2: 
𝑓 =
𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙𝑠 × 𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑜𝑛𝑒 𝑐𝑒𝑙𝑙







8.25 × 10−8 [𝑚3]
= 0.032 ± 0.007 
Equation 4.10 – Calculation of the volume fraction of cells within the inoculant. 
Once found, f, along with all other factors can be placed into the hindered cell velocity 
equation (Equation 4.9) to calculate a value for hindered cell velocity, shown in Equation 4.11: 
𝑢𝐻 = 𝑢𝐶(1 − 𝑓)
𝑦 




] × (1 − 0.032)4.65 
𝒖𝑯 = 𝟕. 𝟎𝟎 × 𝟏𝟎
−𝟓  ± 𝟏. 𝟔𝟎 × 𝟏𝟎−𝟓 𝒎/𝒔 
Equation 4.11 – Calculation of hindered settling velocity in a single HFB module. 
This hindered settling equation is an excellent tool in describing the characteristics of 
sedimenting concentrated suspensions (Di Felice and Kehlenbeck, 2000). In the single hollow 
fibre module, hindered settling is present and reduces the settling velocity by 14%. Using this 
new cell settling velocity value in Equation 4.8, calculates that this increases maximum 




settling time to 29 ± 7 seconds. Such a change is due to the high cell concentration in this 
model, and would not be as apparent at smaller cell concentrations. 
 Multi Hollow Fibre Modules 
Following the same methodology, cell settling properties can be calculated for multi HFB 
modules. The physical properties of the cells and the media remain unchanged, and as such 
the maximum settling velocity remains at 8.14E-05 ± 0.59E-05 m/s. However, these 
bioreactors do have a larger inner radius of 3.75 ± 0.05 mm. The maximum settling time from 
the top of a multi HFB module to the bottom is recalculated using Equation 4.8 and is 92 ± 7 s 
for this system. 
As they descend, any given cell may fall on top of a hollow fibre or within the gaps between 
individual fibres and subsequently attach. It is assumed the rest of the cells accumulate at the 
bottom of the reactor. The volume of cell inoculant must be greater to accommodate for the 
larger volume in the ECS of multi HFB modules, which requires a recalculation of the 
hindered settling velocity. 735,000 ± 69,090 cells were to be seeded in an inoculant of 4.5 mL 
media, at a density of 30,000 ± 2,820 cells/cm2 for attachment on a bundle of five hollow 
fibres 0.65 ± 0.05 mm in outer radius, 120 ± 0.05 mm in length, and with total external surface 
area of 24.5 ± 1.9 cm2. Using Equation 4.10, the volume fraction of cells in the inoculant (f) 
is calculated to be 0.004 ± 6.50E-04, and thus using Equation 4.11 the hindered settling 
velocity is 7.99E-05 ± 1.42E-05 m/s. This is a reduction in settling velocity of 2%, owing to 
the smaller concentration of cells within the whole bioreactor volume. A summary of the 
values calculated throughout this section is shown in Table 4.2:  
Table 4.2 – List of system parameters and calculated values for single and multi HFB modules. 
Parameter 
Single Multi 
Value Error (±) Value Error (±) 
HFB inner radius (mm) 1.0 0.05 3.75 0.05 
Fibre outer radius (mm) 0.5 0.05 0.65 0.05 
Fibre length (mm) 35 0.05 120 0.05 
Number of fibres (-) 1 - 5 - 
Total external surface area (cm2) 1.1 0.2 24.5 1.9 
Cell number (-) 110,000 18,480 735,000 69,090 
Inoculant Volume (mL) 0.0825 0.0058 4.5 0.3 
Cell surface density (cells/cm2) 100,000 16,800 30,000 2,820 
Cell volume fraction (-) 0.032 0.007 0.004 6.5E-04 
Unhindered settling velocity (m/s) 8.14E-05 0.59E-05 8.14E-05 0.59E-05 
Unhindered maximum settling time (s) 25 2 92 7 
Hindered settling velocity (m/s) 7.00E-05 1.60E-05 7.99E-05 1.42E-05 
Hindered maximum settling time (s) 29 7 94 7 
Percentage of cells to contact the hollow fibres 24% 4% 30% 1% 
 




4.2.2 Dynamic Seeding 
Cell settling velocity can be calculated in the same way as shown in the previous section, 
however for these experiments it is important to try and explain theoretically how centrifugal 
forces affect the movement of cells, and hence discover where they may travel during mixing 
and if they contact the hollow fibres. When attached to a rotating device gravity pulls the cells 
downwards to the bottom of the bioreactor (Fg), but this is counteracted by a centrifugal force  
(Fc) pushing the cells to the outermost point of the bioreactor, and the buoyancy force (Fb) of 
the media around the cell. A diagram of these forces on a particle in the rotating HFB system 
is shown in Figure 4.9. 
 
Figure 4.9 – Forces acting upon an individual cell at a specific time point (not to scale). 
When a particle is moving in a liquid as the result of centrifugal action, gravitational forces 
are relatively small and can be neglected (Richardson et al., 2002). The movement of cells 
due to centrifugal action is calculated by replacing gravitational acceleration (g), with 
centrifugal acceleration (Rω2) in the force balance, whilst assuming that the inertial 
acceleration terms can be neglected (Richardson et al., 2002). This follows the same principle 





(𝜌𝐶 − 𝜌𝐿)𝑔     
for a given time  







(𝜌𝐶 − 𝜌𝐿)𝑅. 𝜔
2 
Equation 4.12 – Conversion of cell settling equation to account for centrifugal forces. 
ur is equivalent to the change in radial position over time, or dR/dt., and R is the radius of 
rotation which is the sum of the drum radius, bioreactor thickness and the distance travelled 
during time t. In order to standardise the speed of rotating devices and allow comparisons to 




be drawn with other studies, their RPM setting is converted into the linear velocity (ν) and 
angular velocity (ω) using Equation 4.13 and Equation 4.14 respectively. An error of 1 second 
is assumed when determining RPM, and measurements of distance have an error of 1 mm 
𝐿𝑖𝑛𝑒𝑎𝑟 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦 (𝜈)      =    
𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒
𝑇𝑖𝑚𝑒
    = 𝐶𝑖𝑟𝑐𝑢𝑚𝑓𝑒𝑟𝑒𝑛𝑐𝑒 × 𝑅𝑃𝑀  
Equation 4.13 – Linear velocity equation. 
𝐴𝑛𝑔𝑢𝑙𝑎𝑟 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦 (𝜔)  =    
𝐿𝑖𝑛𝑒𝑎𝑟 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦
𝑅𝑎𝑑𝑖𝑢𝑠
   
Equation 4.14 – Angular velocity equation. 
For the dynamic cell seeding experiments in this chapter, the Stuart STR4 rotator drum was 
set to one of three rotational velocities. RPM was manually tracked and converted into angular 
velocity using Equation 4.13 and Equation 4.14  to allow the calculation of cell settling 
velocity at a given angular velocity. As before with static cell settling, cell hindrance is taken 
into account using Equation 4.9 to calculate an accurate settling velocity. This data is shown 
in Table 4.3: 










Value Error Value Error Value Error Value Error 
Single 
2.4 2% 0.023 2% 0.25 3% 4.13E-08 23% 
6.0 2% 0.057 2% 0.62 3% 2.58E-07 23% 
8.2 2% 0.078 2% 0.86 3% 4.82E-07 23% 
Multi 
2.4 2% 0.023 2% 0.25 3% 4.96E-08 18% 
6.0 2% 0.058 2% 0.63 3% 3.10E-07 18% 
8.2 2% 0.079 2% 0.86 3% 5.78E-07 18% 
Linear and angular velocities between bioreactor types vary slightly due to the different 
thicknesses of their bioreactor walls, resulting in different radii of rotation (90.5 cm and 
92.0 cm respectively). Hindered settling velocities also vary between reactor types, as the 
concentration of cells used for both sets of experiments is different (Table 4.2). 
The calculated hindered settling velocities in Table 4.3 are those which occur initially. As time 
goes on the cells are expected to move outwards, away from the point of rotation. This causes 
the value of R to increase over time, leading to an increase in cell velocity. Given this 
relationship, the centrifugal cell settling equation can be further modified to calculate the 
distance a given cell can travel over a set time at a constant angular velocity. The distance 




from the central point of rotation (rX) a cell reaches for time t is derived from Equation 4.12 















− ((𝜌𝐶 − 𝜌𝐹) 𝜔
2)𝑅 = 0 
Which is of the form:  
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(𝜌𝐶 − 𝜌𝐿) 𝜔
2  𝑡 
Taking the exponent and rearranging for rX 








Equation 4.15 – Derivation of an equation to determine the radial position of a cell at a given time under 
centrifugal force. 
The expected distance a cell travels under these dynamic seeding conditions for a given cell 
attachment time is useful in order to calculate the likelihood of cells making contact with a 
hollow fibre in the bioreactor. The hollow fibre zone (HFZ) is a set distance away from the 
wall of the bioreactor. If it is assumed that the cells which miss the fibre on their initial first 
static pass all accumulate at the bottom of the reactor, then it can also be assumed that these 
cells would all move outward from this region, travelling from one side of the bioreactor to 
the other under the centrifugal conditions created by the rotating drum.  
For ease of analysis, it is assumed that upon starting rotation the unattached cells will move 
outwards from the bioreactor wall, and spread out to form a linear front of cells. This cell front 
will continue to move outwards towards the opposite side of the bioreactor for the duration of 
rotation. During this movement, a portion of this cell front will make contact the HFZ. The 
continuing centrifugal force from rotation would keep the contacted cells pressed onto the 
surface of any fibre in the HFZ and aid cell attachment. The parts of the cell front that do not 
contact the HFZ will continue to move outwards, eventually meeting the bioreactor wall on 
the opposite side. This is illustrated in Figure 4.10. Analysis of experimental dynamic cell 
attachment data will determine the validity of this theory.  





Figure 4.10 – Cross section of a single HFB module showing a moving cell front. 
Assuming the linear front consisted of all non-attached cells distributed evenly, the ratio of 
the HFZ and inner bioreactor diameters (± 0.1 mm) could be used to determine what 
percentage of the cell front would contact the HFZ. This projected area for attachment would 
be half (50% ± 3%) of the unattached cells in a single fibre bioreactor, and two-thirds 
(67% ± 3%) of unattached cells in a multi-fibre bioreactor. 
4.2.3 MACSmix Rotator for Single HFB Modules 
Given the theoretical analysis in this chapter so far, up to 24% ± 4% of all cells will make 
contact with the single hollow fibre on one cell settling pass lasting 29 ± 7 seconds. The 
MACSmix rotator drive enabled 1 minute of rotational force at angular velocity 
1.05 ± 0.03 s-1, followed by 4 minutes of no rotation, i.e. 5 minutes per cycle. As the position 
of the bioreactor after 1 minute was approximately 180° from its starting position, this could 
allow multiple opportunities for cells to re-settle and make contact with the hollow fibre, 
whilst providing 4 minutes to allow a portion of these cells to attach. If it is assumed that 
24% ± 4% % of cells will contact the hollow fibre, and a given proportion of those cells 
actually attach during each pass, a theoretical time for sufficient cell attachment can be 
calculated for any 5 minute cycle (t). The number of attached cells follows Equation 4.16 













  𝐴𝑡𝑡𝑎𝑐ℎ𝑚𝑒𝑛𝑡 → 100% 
𝑎𝑠 𝑡 → ∞
 
Equation 4.16 – Theoretical cell attachment on the MACSmix rotator at a given time. 





Figure 4.11 – Theoretical mean cell attachment of a hollow fibre bioreactor in a MACSmix rotator over 
time. 
From Figure 4.11 it can be seen that the total number of cells attaching to the scaffold would 
increase over time as t → ∞.  This model assumes that cells are well distributed throughout 
the bioreactor after being mixed for one minute, and that cells that have attached to the hollow 
fibre are not removed due to agitation. Experimental data will be compared to this model to 
determine if the MACSmix Rotator at a 5 minute cycle time is appropriate to facilitate 
acceptable rates of cell attachment.  
4.3 RESULTS 
4.3.1 Seeding Time Selection  
To determine the minimum duration necessary for cells to settle onto a scaffold and attach in 
sufficient quantities, an experiment was carried out on a flat sheet membrane of PLGA placed 
inside a custom designed detachable 96 well plate. Each column of the plate represented one 
of ten different time points between 5 minutes and 4 hours conducted in octuplicate (n=8). 
This experiment was performed once (N=1). Each well was 6.80 ± 0.05 mm in diameter, 
5.00  ± 0.05 mm in height, 0.180 ± 0.004 mL in total volume and a surface area of 
0.363 ± 0.008 cm2.  
Cell viability tests using trypan blue indicated that 94.5% of seeded cells were viable. Cells 
were seeded at 20,000 ± 2,000 cells/cm2, requiring an inoculant of 7,400 ± 740 cells 
in 0.100 ± 0.002 ml cell media. 56% ± 2% of the well was filled, indicating a media depth of 
2.78 ± 0.08 mm. Hindered cell settling velocity was calculated as 7.00E-05 ± 1.60E-05 m/s 
for this system using Equation 4.11, and maximum cell settling time was calculated to be 
40 ± 10 seconds using Equation 4.8. Given the short length of settling time, and the relatively 




long time taken to seed all the wells for this experiment, it is likely that all cells had settled to 
the bottom of each well when the timing started.  The seeded scaffold was placed in an 
incubator at 37°C and 5% CO2.  
At each time point the corresponding column of wells were drained of residual cell media, 
washed with 0.1 ml phosphate buffered saline (PBS) and manually counted for cells that did 
not attach. Afterwards the scaffold was immersed in 0.1 ml trypsin and washed again with 
0.1 ml PBS before being counted to determine the number of cells that had settled and attached 
during that time. The exact methodology for fixing the scaffold into the well plate, as well as 
cell seeding is described in Section 3.3.4. 
Cell counts of both the unattached cells in media and attached cells from trypsin are shown in 
Table 4.4.  A calculated rate of cell attachment for each time point is displayed in Figure 4.12.  
Table 4.4 – Experimental cell attachment on PLGA flat sheet over time (n=8, N=1, error = SD). 
Time 
(min) 
Average Cell Count Average Cell 
Attachment 













5 2,002 38.5% 8,236 17.3% 10,238 42.2% 20% 11% 
10 1,060 18.6% 8,756 25.4% 9,816 31.5% 11% 4% 
20 3,376 30.1% 6,706 8.6% 10,082 31.3% 34% 15% 
30 4,240 24.3% 3,821 22.5% 8,061 33.2% 53% 22% 
45 6,478 18.9% 2,597 24.6% 9,075 31.1% 71% 26% 
60 3,769 23.7% 3,228 18.9% 6,997 30.3% 54% 21% 
90 4,240 28.8% 2,189 24.4% 6,429 37.7% 66% 31% 
120 5,771 16.5% 2,189 22.7% 7,960 28.0% 73% 24% 
180 6,454 23.9% 1,177 14.3% 7,631 27.8% 84% 31% 
240 6,596 10.8% 1,261 38.1% 7,857 39.6% 84% 35% 
 





Figure 4.12 – Cell attachment on PLGA flat sheet over time (n=8, N=1, error = SD). 
Figure 4.12 shows a general increase in the number of cells attached to the scaffold over time 
which corresponds with an associated decrease in the number of cells counted in the remaining 
cell medium. The data also shows wide error bars from the compound error of octuplet trypsin 
and media cell counts, which indicates an inherent variation in cell attachment that is not 
limited to the duration of cell attachment. This also led to an unequal mass balance where the 
number of cells seeded into each well (7,400 ± 740) did not equal the sum of the cells 
recovered from the residual media and the scaffold surface (Table 4.4).  
4.3.2 Static Cell Attachment on Hollow Fibres 
Hollow fibres were placed into a custom designed single HFB silicone module, constructed 
as described in Section 3.3.5 and shown in Figure 3.5. The available surface area on the fibre 
for cell attachment was calculated as 1.1 ± 0.2 cm2 from the product of the fibre length (LF) 
fibre diameter (dF) the number of fibres in a bundle (NF) and pi. 110,000 ± 18,480 MG63 cells 
were seeded at a density of 100,000 ± 16,800 cells/cm2 into the bioreactor in a static 
environment; a much higher density than the 20,000 ± 2,000 cells/cm2 in the previous study. 
This was to attempt to mitigate the impact of error of unaccounted cells. The bioreactors were 
placed in an incubator at 37°C and 5% CO2.  The duration of static cell attachment was set to 
2 hours based upon the results found in Section 4.3.1, as this provided 73% ± 24% attachment 
on static flat sheets. While greater rates of static attachment were found at longer times as 
displayed in Figure 4.12, 2 hours was selected because it made the timing of experiments 
easier at the expense of only a small increase in attachment.  




A single hollow fibre was selected to provide the simplest geometry for cell attachment and 
act as a baseline for all subsequent tests on larger bundles of hollow fibres. The efficiency of 
cell attachment was measured by comparing the cells removed from the scaffold surface using 
trypsin, and the cells initially seeded into the bioreactor. Following on from the theoretical 
analysis conducted in Section 4.2.1, a maximum rate of cell attachment of 24% ± 4% was 
expected as only that proportion of cells would have an opportunity to make contact with the 
fibre as they settled. Combined with the cell attachment time course data from Section 4.3.1, 
in 2 hours only 73% ± 24% of those cells that contact the scaffold will actually attach. This 
lowers the theoretical maximum static settling rate of cell attachment on PLGA hollow fibres 
to 18% ± 4%. 
 Control Experiments 
Prior to the cell attachment a series of control experiments without hollow fibres present were 
undertaken in order to discount certain sources of cell loss. The first was conducted to 
determine if any cells would attach to the silicone bioreactor housing in addition to the hollow 
fibre scaffold. A vacant single HFB silicone module was inoculated with the same quantity of 
cells and left for 2 hours. After this time the bioreactor was drained, washed with PBS, and 
then trypsinised. A cell population equivalent to 2% ± 3% (n=9) of inoculated cells was found 
to remain in the bioreactor. Sigmacote could not be used to coat the bioreactor internals and 
prevent cell adherence because it led to the deformation of silicone bioreactor housing. The 
manufacturer describes this particular tubing as non-adherent, however Figure 4.13 shows 
evidence of cell attachment within the tubing. Cells were fixed with formalin as described in 
Section 3.4.1 to acquire the image.   
 
Figure 4.13 – Image of residual cells on inner walls of HFB module (x30).  
1 mm 




Next, an experiment to calculate the number of cells lost during inoculation and cell removal 
was conducted. Bioreactors containing no hollow fibre were seeded and then immediately 
drained. Cell loss of 20% ± 14% (n=9) was determined. The final control test was to determine 
if any cells were lost due to leakage. A full 2 hour static attachment experiment was conducted, 
comparing the cell number before and after the experiment. The initial cell population had 
decreased by 20% ± 5% (n=3). This data is presented in Table 4.5: 
  Table 4.5 – Cell loss in a single HFB module after zero and two hours.  
Source of Cell Loss 
Cell loss Number 
of Trials 
(n) Average SD 
Bioreactor attachment 2% ± 3% 9 
Experimental error 20% ± 14% 9 
Bioreactor leakage 20% ± 5% 3 
 
As cell losses from bioreactor leakage were within the range of error from cell losses due to 
experimental error, and as no leakages were visible on inspection after 2 hours, it can be 
concluded that no leakage occurs. The quantity of cells that attach to the silicone bioreactor 
inner wall were in addition to those lost from experimental error, and therefore 2% ± 3% of 
attached cells must be discounted from all future single fibre bioreactor studies. 
From these results it was assumed that during a 2 hour experiment 20% ± 14% of cells were 
lost, indicating that anywhere between of 6% - 34% of the initial 110,000 cells did not have 
an opportunity to attach by virtue of not being seeded in the first place. It is inferred that this 
would decrease the initial cell number and thus have an impact on the rate of cell attachment, 
as displayed in Table 4.6: 
Table 4.6 – Cell loss and subsequent number available for attachment. 
Degree of Cell Loss 
Cells Available 
For Attachment 
Zero Cell loss 0% 110,000 
Minimum Cell Loss 6% 103,400 
Median Cell Loss 20% 88,000 
Maximum Cell Loss 34% 72,600 
This range of error increased the degree of uncertainty in all subsequent cell attachment 
experiments on hollow fibres. Calculated rates of cell attachment would be an average value 
with an associated standard deviation that would be ultimately dependent on the initial number 
of cells inoculated.  
 




 Static Experiments 
After 58 trials the average rate of cell attachment on statically seeded single hollow fibre 
bioreactors was 18% ± 16%. The error includes the loss of 20% ± 14% of the initial inoculant, 
and also accounts for the 2% ± 3% of cells attached to the bioreactor housing. Experimental 
cell attachment is similar to the calculated theoretical maximum of 18% ± 4% for static 
seeding, and to the value of 20% found in other works.  
4.3.3 Dynamic Cell Attachment in Single and Multi-Fibre Bioreactors 
In order to provide multiple instances of cells coming into contact with the external hollow 
fibre surface, single hollow fibre silicone modules and multi hollow fibre glass modules were 
attached to rotating devices at various speeds and orientations to determine if a dynamic 
environment would improve cell attachment on the hollow fibres. A dynamic seeding regime 
could allow the cells that settled to the bottom of the bioreactor another opportunity to make 
contact with the fibre and potentially attach. 
Single fibre modules were constructed and seeded as described in Section 3.3.5. Hollow fibres 
were 35 ± 0.05 mm long and had an outer radius of 0.5 ± 0.05 mm for a total external surface 
area of 1.1 ± 0.2 cm2.  For the single fibre bioreactor 110,000 ± 18,480 cells were seeded at a 
density of 100,000 ± 16,800 cells/cm2.  Single fibre silicone bioreactors were attached to one 
of two rotating devices after inoculation: a Stuart STR4 rotator drive (Figure 4.2) or a 
MACSmix rotator (Figure 4.3), and placed in an incubator at 37°C and 5% CO2. In the case 
of the former, the rotating drum was set to rotate at one of three different rotational speeds (2, 
6 or 8 RPM / 0.25, 0.63 or 0.86 s-1, error = 1.7%) with the bioreactors consistently positioned 
horizontally to determine how changing angular velocity affected cell attachment. A second 
experiment was conducted with the drum set to a constant 6 RPM (0.63 s-1) and the bioreactors 
orientated either horizontally (a), diagonally (b) or vertically (c) as shown in Figure 4.14. 
Finally, a MACSmix rotator device was used set to provide one minute of rotation followed 
by four minutes of pause to the bioreactor. Cells were allowed 2 hours to attach. 
 





Figure 4.14 – A schematic of the rotating drum with attached bioreactor (not to scale). 
Cell attachment on the single hollow fibre was quantified by performing a cell mass balance 
over the bioreactor using cell trypsinisation to remove attached cells, followed by manual 
counting. The values for cell loss calculated in Section 4.3.2 for static seeding were applied to 
single fibre dynamic seeding experiments. Rates of dynamic cell attachment were compared 
to the static rate of cell attachment calculated previously to be 18% ± 16% on average.  
For multi-fibre experiments, bundles of 5 hollow fibres mounted in a large glass bioreactor 
were seeded and constructed as described in Section 3.3.5. Fibres were 120 ± 0.5mm long and 
had an outer radius of 0.65 ± 0.05 mm, providing a total external surface area of 24.5 ± 1.9 cm2. 
In multi-fibre bioreactors, 735,000 ± 69,090 cells were seeded, resulting in a cell surface 
density of 30,000 ± 2,820 cells/cm2. Cells were allowed 6 hours to attach. Bioreactors were 
attached to the Stuart STR4 rotator drive at the same angular velocities and orientations as 
single fibre bioreactor modules, however were not attached to the MACSmix rotator because 
they could not be adequately supported and frequently became dislodged. Cell attachment was 
quantified by calculating the difference between the manually counted initial cell inoculation 
and the number of unattached cells in the residual cell media after 6 hours.  
The inner walls of the multi fibre glass bioreactor module was coated with Sigmacote to inhibit 
cell adhesion. A control experiment seeding bioreactors with no fibres fitted showed no cell 
attachment to the bioreactor inner surface. Cell losses of the magnitude found in the single 
fibre silicone bioreactors were not anticipated, as the entire volume of cell inoculant was 
successfully transferred into and out of the multi-fibre bioreactors. Static experiments were 
not conducted on multi fibre bioreactors; instead a projected value for cell attachment based 
off of the single fibre experiments was used. Assuming no cell loss and a proportional increase 
of attached cell number to reflect this, a static cell attachment of 19% ± 14% was calculated 








 Single Fibre Bioreactors 
All dynamic rates of cell attachment on single fibre bioreactors for each configuration, along 
with standard deviation and range are shown in Table 4.7 and graphed on Figure 4.15. None 
of the rates of cell attachment are significantly different from one another to a 95% confidence. 






Static  58 18%  ± 16% 
Horizontal (6 RPM) 12 10% ± 7% 
Diagonal (6 RPM) 12 12% ± 8% 
Vertical (6 RPM) 12 9% ± 5% 
2 RPM (horizontal) 12 13% ± 8% 
6 RPM (horizontal) 12 10% ± 7% 
8 RPM (horizontal) 12 9% ± 5% 
MACSmix 9 10% ± 4% 
 
 








The theory of centrifugal settling was outlined Section 4.2.2, and described the movement of 
a linear front of cells moving further outwards through the bioreactor over time as a result of 
centrifugal action, and characterised further attachment of cells by the need to reach a 
designated hollow fibre zone (HFZ) in the allotted rotation time. Using Equation 4.12 and 
Equation 4.15 the initial hindered settling velocity and the distance a given cell can travel as 
a result of centrifugal action is calculated for each set rotational velocity. The time that the 
cell front takes to make contact with the HFZ, and the duration the cell front is pressed against 
the hollow fibre is also calculated. All data is shown in Table 4.8. 


















Value Error Value Error Value Error Value Error Value Error Value Error 
2 2% 0.25 3% 4.13E-08 23% 0.3 23% 2:53 23% 0:00 23% 
6 2% 0.63 3% 2.58E-07 23% 2.2 23% 0:28 23% 1:32 23% 
8 2% 0.86 3% 4.82E-07 23% 4.1 23% 0:15 23% 1:45 23% 
Following this model at 2 RPM the linear cell front travels 0.3 mm outwards from the inner 
bioreactor wall in 2 hours due to centrifugal motion. As the start of HFZ begins 0.5 mm from 
the inner bioreactor wall (Figure 4.5), this model indicates that additional cells would not come 
into contact with the hollow fibre. Contact would only be initiated after 2 hr 53 minutes of 
rotation. At 6 RPM and 8 RPM the increased radial velocities allow the cell front to make 
contact with the HFZ 28 minutes and 15 minutes into the experiment, and keep cells on the 
surface of the HFZ for 1 hour 32 minutes and 1 hour 45 minutes respectively. Errors for the 
values stated here are shown in Table 4.8. 
 Multi Fibre Bioreactors 
All rates of dynamic cell attachment on hollow fibre bundles for each configuration, along 
with standard deviation and range are shown in Table 4.9 and graphed on Figure 4.16. 
Significant differences between horizontal and both diagonal and vertical orientations to a 
95% confidence are indicated (*). A value for static cell attachment assuming similar 















Static  58 19% 14% 
Horizontal (6 RPM) 4 39% 12% 
Diagonal (6 RPM) 3 15% 11% 
Vertical (6 RPM) 4 16% 1% 
2 RPM (horizontal) 3 31% 7% 
6 RPM (horizontal) 4 39% 12% 
8 RPM (horizontal) 3 22% 6% 
 
 
Figure 4.16 – Rate of cell attachment in bundled HFBs at different seeding conditions. 
The theory of centrifugal settling was outlined Section 4.2.2, and Equation 4.12 and Equation 
4.15 were used to calculate the duration of time cells were in contact with the HFZ for multi-
fibre bioreactors. This is shown in Table 4.10. 


















Value Error Value Error Value Error Value Error Value Error Value Error 
2 2% 0.25 3% 4.96E-08 18% 1.1 18% 6:51 18% 0:00 18% 
6 2% 0.63 3% 3.10E-07 18% 7.1 18% 1:06 18% 4:54 18% 
8 2% 0.86 3% 5.78E-07 18% 13.6 18% 0:35 18% 5:25 18% 




At 2 RPM the linear cell front travels 1.1 mm outwards from the inner bioreactor wall in 
6 hours due to centrifugal motion. As the start of HFZ begins 1.25 mm from the inner 
bioreactor wall (Figure 4.7), this model indicates that cells would not come into contact with 
the hollow fibre. Contact would only be initiated after 6 hr 51 min of rotation at that velocity. 
At 6 RPM and 8 RPM the increased radial velocities allow the cell front to make contact with 
the HFZ 1 hr 6 min and 35 min into the experiment, and keep cells on the surface of the HFZ 
for a total of 4 hr 54 min and 5 hr 25 min respectively. Errors for the values stated here are 
shown in Table 4.10. 
 Theoretical Maximum Cell Attachment 
Theoretical and experimental data can be combined to determine a theoretical maximum rate 
of cell attachment on single and multi-fibre bioreactors resulting from dynamic seeding. In 
this section, dynamic seeding of a horizontal single hollow fibre module at 6 RPM is used as 
an example for calculation of the theoretical maximum cell attachment. From the theory 
outlined in Section 4.2.1 only 24% ± 4% of inoculated cells will initially settle onto a hollow 
fibre prior to starting rotation. There was approximately a 5 minute gap between cell 
inoculation, fixing the bioreactor to the drum, and the start of rotation; which from Figure 4.12 
in Section 4.3.1 for cell attachment on flat sheets would allow 20% ± 11% attachment of the 
cells that settled onto the surface prior to rotation. Therefore the static cell attachment in this 
initial 5 minutes prior to rotation can be calculated using Equation 4.17: 
𝑆𝑡𝑎𝑡𝑖𝑐 𝑃ℎ𝑎𝑠𝑒
𝐶𝑒𝑙𝑙 𝐴𝑡𝑡𝑎𝑐ℎ𝑚𝑒𝑛𝑡 5 𝑚𝑖𝑛
   =




𝐶𝑒𝑙𝑙 𝐴𝑡𝑡𝑎𝑐ℎ𝑚𝑒𝑛𝑡 5 𝑚𝑖𝑛
  
𝑆𝑡𝑎𝑡𝑖𝑐 𝑃ℎ𝑎𝑠𝑒
𝐶𝑒𝑙𝑙 𝐴𝑡𝑡𝑎𝑐ℎ𝑚𝑒𝑛𝑡 5 𝑚𝑖𝑛
   = 24% ± 4% × 20% ±  11%  
𝑺𝒕𝒂𝒕𝒊𝒄 𝑷𝒉𝒂𝒔𝒆
𝑪𝒆𝒍𝒍 𝑨𝒕𝒕𝒂𝒄𝒉𝒎𝒆𝒏𝒕 𝟓 𝒎𝒊𝒏
= 𝟓%± 𝟑% 
Equation 4.17 – Calculation of cell attachment within initial 5 minutes prior to rotation. 
It is assumed that the forces of rotation do not remove these attached cells, therefore a single 
hollow fibre will have 5% ± 3% of the inoculated cells already attached during the 2 hour 
rotational seeding phase. It is proposed in Section 4.2.2 that the remaining unattached cells 
move outward in a linear front due to centrifugal action, and come into contact with the hollow 
fibre resulting in additional cell attachment. This is dependent three main factors: the time 
taken for the cell front to reach the hollow fibre, the projected surface area of the hollow fibre 
that ensures a successful hit, and the contact time once the cell front reaches the hollow fibre. 




This theoretical data is outlined for single and multi-fibre modules in Table 4.8 and Table 4.10 
respectively.  
In this example, upon starting rotation for 2 hours it takes 28 minutes for the cell front to make 
contact with the hollow fibre, allowing a total of 1 hour 32 minutes for attachment. Assuming 
the flat sheet data shown on Figure 4.12 in Section 4.3.1 is comparable, this results in 
66% ± 31% attachment of cells that make contact with the fibre for 90 minutes. As the 
diameter of the single fibre is 50% ± 3% that of the inner bioreactor diameter, the projected 
area of the hollow fibre is such that only 50% ± 3% of the cell front will make contact with 
the fibre. As previously mentioned, the cell front is comprised of all unattached cells. Taking 
into account the 5% ± 3% that have theoretically attached already, the cell front consists of 
95% ± 3% of the total cell inoculant. Given this information, the degree of theoretical cell 
attachment from centrifugal action can be calculated as shown in Equation 4.18: 
𝐷𝑦𝑛𝑎𝑚𝑖𝑐 𝑃ℎ𝑎𝑠𝑒
𝐶𝑒𝑙𝑙 𝐴𝑡𝑡𝑎𝑐ℎ𝑚𝑒𝑛𝑡








𝐶𝑒𝑙𝑙 𝐴𝑡𝑡𝑎𝑐ℎ𝑚𝑒𝑛𝑡 90 𝑚𝑖𝑛
   
𝐷𝑦𝑛𝑎𝑚𝑖𝑐 𝑃ℎ𝑎𝑠𝑒
𝐶𝑒𝑙𝑙 𝐴𝑡𝑡𝑎𝑐ℎ𝑚𝑒𝑛𝑡
   = 95% ±  3% × 50.0% ±  3%  × 66% ±  31%  
𝑫𝒚𝒏𝒂𝒎𝒊𝒄 𝑷𝒉𝒂𝒔𝒆
𝑪𝒆𝒍𝒍 𝑨𝒕𝒕𝒂𝒄𝒉𝒎𝒆𝒏𝒕
= 𝟑𝟏% ± 𝟏𝟓%   
Equation 4.18 – Calculation of cell attachment from centrifugal action. 
This can be combined with the cell population on the fibre from the initial 5 minutes of static 












=  5% ± 3%+ 31% ±  15%   
𝑻𝒐𝒕𝒂𝒍 𝑻𝒉𝒆𝒐𝒓𝒆𝒕𝒊𝒄𝒂𝒍
𝑪𝒆𝒍𝒍 𝑨𝒕𝒕𝒂𝒄𝒉𝒎𝒆𝒏𝒕 
=  𝟑𝟔%±  𝟏𝟓%   
Equation 4.19 – Calculation of total theoretical cell attachment. 
From these equations it can be determined that using the theories and assumptions outlined in 
Section 4.2, the maximum theoretical rate of cell attachment of MG63 cells in a dynamically 
seeded, horizontally orientated, single hollow fibre module rotated at 6 RPM is 36% ± 15%. 
Following this method, maximum theoretical cell attachment on horizontal single and multi-




fibre bioreactors for all three rotational settings can be calculated. This data is shown in Table 
4.11. 
Limitations with this calculation include allowing for the possibility that too low a rotational 
velocity would not provide enough centrifugal force for the cell front to make contact with the 
hollow fibres. This occurs on 2 RPM experiments for single and multi-fibre modules, where 
the only cell attachment would be from the initial cell settling before rotation was initiated. It 
also does not take into account if the cells that missed the fibre during the dynamic phase re-
settle onto the fibre after the rotating device is stopped and the experiment ended. In that case, 
cell attachment could be higher than theorised. Also, no distinction could be drawn between 
the 6 RPM and 8 RPM settings on multi-fibre bioreactors because flat sheet cell attachment 
was shown to reach a maximum after 3 hours; so the additional time that cells in the 8 RPM 
system would have to attach during the dynamic phase did not provide any additional cell 
attachment. This method has not been performed for vertical or diagonal orientations because 
cell movement from centrifugal action is harder to predict using the equations in Section 4.2.2. 
Differences between theoretical and experimental cell attachment will be explained in the 
Discussion section of this chapter.  









Single (Horizontal) Multi (Horizontal) 
2 RPM 6 RPM 8 RPM 2 RPM 6 RPM 8 RPM 
Value Error Value Error Value Error Value Error Value Error Value Error 
Static Phase 
Cell contact from initial settling 
on hollow fibre 
24% 4% 24% 4% 24% 4% 30% 1% 30% 1% 30% 1% 
Time before initiating rotation 
(min) 
5 - 5 - 5 - 5 - 5 - 5   
Cell attachment after this time 
on flat sheets 
20% 11% 20% 11% 20% 11% 20% 11% 20% 11% 20% 11% 
Cell attachment on hollow 
fibre 
5% 3% 5% 3% 5% 3% 6% 3% 6% 3% 6% 3% 
Dynamic 
Phase 
Unattached cells on bottom of 
bioreactor 
95% 3% 95% 3% 95% 3% 94% 3% 94% 3% 94% 3% 
Total rotation time (hours) 2 - 2 - 2 - 6 - 6 - 6 - 
Projected fibre surface area 
relative to bioreactor 
50% 3% 50% 3% 50% 3% 67% 3% 67% 3% 67% 3% 
Time cells in contact with fibre 
due to centrifugal action (hours) 
00:00 - 01:32 - 01:45 - 00:00 - 04:54 - 05:25 - 
Cell attachment after this time 
on flat sheets 
0% 0% 66% 33% 69% 28% 0% 0% 84% 35% 84% 35% 
Cell attachment on hollow 
fibre 
0% 0% 31% 15% 33% 13% 0% 0% 53% 22% 53% 22% 
Total 
Cell Attachment From Initial 
Settling 
5% 3% 5% 3% 5% 3% 6% 3% 6% 3% 6% 3% 
Cell Attachment From 
Centrifugal Action 
0% 0% 31% 15% 33% 13% 0% 0% 53% 22% 53% 22% 
Total Theoretical Dynamic 
Cell Attachment 
5% 3% 36% 15% 38% 13% 6% 3% 59% 22% 59% 22% 




4.3.4 Summary of Results 
A table outlining the best rates of theoretical and experimental cell attachment with on single 
and multi-fibre bioreactors, seeded statically and dynamically, is shown in Table 4.12:  
Table 4.12 – Summary of theoretical and experimental values for static and dynamic cell attachment. 
Mode Scaffold Data Value Error Orientation Setting 
Static 
Flat Sheet 
Theoretical 100.0% - N/A N/A 
Experimental 84% 35% N/A N/A 
Single Hollow 
Fibre 
Theoretical 18% 4% Horizontal N/A 
Experimental 18% 16% Horizontal N/A 
Multi Hollow 
Fibre 
Theoretical 19% 14% Horizontal N/A 




Theoretical 38% 13% Horizontal 8 RPM 
Experimental 14% 8% Horizontal 2 RPM 
Multi Hollow 
Fibre 
Theoretical 59% 22% Horizontal 6 & 8 RPM 
Experimental 39% 12% Horizontal 6 RPM 
Table 4.12 shows that theoretical and experimental values for statically seeded, horizontal, 
single fibre bioreactors are similar; likely due to the simplicity of the gravity settling model. 
For dynamic single and multi-fibre seeding, theoretical values are greater than experimental 
values. This is likely due to the over-simplification of complex cell mixing behaviours in a 
dynamic environment, leading to an idealised theoretical value, the assumptions of which may 
not be fully applicable to this rotating regime. This will be further discussed in the next section.  
Static flat sheets of PLGA show the greatest rates of cell attachment. This is to be expected 
because of their favourable geometry. However, as previously described in Section 2.3.2, 
hollow fibre bioreactors are proven to grow cells at a faster rate and allow the growth of a 
greater total number of cells than other bioreactor types (including flat sheets).  
4.4 DISCUSSION 
4.4.1 Static Seeding of Flat Sheet Scaffold 
While MG63 cell attachment studies have been conducted on PLGA scaffolds, many of them 
did not characterise the initial rates of attachment (Pamula et al., 2011; Park et al., 2012; 
Cheng et al., 2013). Some showed attachment efficiency after 24 hours, however it is unclear 
if cells had started to proliferate within that time, increasing the apparent rate of attachment. 
This included studies yielding ~100% attachment (Vandrovcova et al., 2011), ~40% 
attachment (Wojak-Cwik et al., 2013) and ~25% attachment (Khang et al., 2002). Many others 
do not provide comparable data because they lack normalisation to a cell number or percentage 
cell attachment (Petricca et al., 2006; Linh et al., 2013; Son et al., 2013; Kim et al., 2014; 
Zuber et al., 2014). 




One study indicated 94% ± 7% attachment of MG63 cells on a porous PLGA ‘tablet’ scaffold 
after 4 hours, however this was only evaluated indirectly by measuring the number of cells 
remaining in the cell media (Mou et al., 2011), which has been shown in Table 4.4 (Section 
4.3.1) to be a poor method of determining cell attachment. Similarly, 89% ± 7% attachment 
of MG63 cells was found after 4 hours in a separate study, with attached cells directly counted 
after trypsinisation of the scaffold (Su et al., 2010), which is a more reliable method than 
indirect measurements of remaining cells in the media . A time course study featuring 
attachment of 10,500 fibroblasts/cm2 on poly (ε-caprolactone) (PCL) films confirmed using 
MTT assay showed cell attachment increasing between 20 minutes and 1 hour, with 
attachment levelling off between 1 and 2 hours (Li et al., 2014). This matches the behaviour 
of MG63 cells attaching on PLGA flat sheets over time as shown in Figure 4.12 (Section 
4.3.1). 
4.4.2 Static Seeding of Single Hollow Fibre Scaffold 
During control experiments of cell attachment on single fibre bioreactors it was found that 
20% ± 14% (n=9) of cells were lost over the course of the 2 hour attachment, primarily from 
the cell seeding/removal steps. This systematic error arose due to the method of seeding the 
bioreactors. An inoculant of 0.1 mL was injected into each bioreactor via a syringe. To 
accelerate the seeding of multiple bioreactors per experiment, the required cell concentration 
was drawn up in a syringe to approximately 1 mL, and 0.1 mL of this was injected into 
bioreactors one after the other. Due to this method, a quantity of the 0.1 mL inoculant was not 
injected into the silicone tubing part of the bioreactor, instead it remained within the syringe 
needle. This effectively led to a number of cells that were not given an opportunity to come 
into contact with the hollow fibre, and the main contributing factor for the 20% ± 14% cell 
loss outlined in Section 4.3.2 . 
Static cell attachment experiments showed an average rate of cell attachment of 18% ± 16% 
(n=58). This was consistent with the theoretical maximum cell attachment efficiency of 18% 
± 4% after 2 hours calculated in Section 4.3.2. Given the number of trials, the wide standard 
deviation indicates that this method of cell attachment was inherently more inconsistent than 
postulated in theory. There was also some degree of external agitation when the bioreactor 
was moved from the biohood to the incubator which also may have affected the movement of 
the cells as they settled. 
Once again, evaluating data against literature offers limited insight due to the incomparable 
cell quantification techniques. Single hollow fibres of PLGA spun using the same method 
outlined in Section 3.3.1 have been successfully seeded in well plates with human adipose 
stem cells under static conditions (Diban et al., 2013). Studies typically focus on bundles of 




hollow fibres in a bioreactor instead of single hollow fibres. No paper on cell attachment could 
be found that provided results as comprehensive in terms of error analysis and control 
experiments as those outlined in this chapter. 
4.4.3 Dynamic Seeding of Single Fibre Scaffold 
All dynamic methods of seeding on single fibre bioreactors yielded lower values of cell 
attachment compared to the static method. This indicated that mixing regimes established by 
the movement of the Stuart STR4 rotator drive were either insufficient to facilitate 
improvements in contact between cells and hollow fibre, or that the dynamic regime was 
sufficient to establish contact however the continuous motion of the cells made it difficult 
form an attachment to the hollow fibre. As previously described, the large error bars shown in 
Figure 4.15 arose due to cell losses during the cell inoculation and/or the media removal 
process.  
Of the tested single fibre bioreactor orientations a diagonal positioning showed the greatest 
cell attachment of any dynamic method averaging at 12% ± 8%, however this was not much 
greater than horizontal (10% ± 7%) or vertical (10% ± 5%) attachment (Figure 4.15), so should 
not be taken as indicative of any trend. None of the different dynamic or static seeding 
configurations displayed in Figure 4.15 are statistically different from one another using a one 
way ANOVA and a post hoc Tukey’s test. From experiments, dynamic cell attachment was 
greatest at lower drum angular velocity, with 13% ± 8% achieved at 2 RPM (0.25 s-1) and 
worsening to 10% ± 7% at 6 RPM (0.63 s-1) and 9% ± 5% at 8 RPM (0.86 s-1). Cell attachment 
was worse than that achieved under static conditions (18% ± 16%), indicating that the presence 
of dynamic forces in this system prevented additional cell attachment over the course of 
2 hours and may have actively caused the detachment of any cells initially attached between 
cell inoculation and rotation. The theorised centrifugal movement of settled unattached cells 
(Table 4.11) indicated that at 2 RPM the linear cell front would not reach the hollow fibre to 
facilitate another opportunity to attach. The cells that did attach were exclusively from cells 
which made contact with the fibre during the initial settling after inoculation, providing a 
maximum theoretical attachment of 5% ± 3%. It was theorised that cell-fibre contact would 
be facilitated at 6 RPM and 8 RPM because the cell front would move further as a result of 
the higher rotational velocity, leading to a maximum theoretical cell attachment of 36% ± 15% 
and 38% ± 13% respectively (Table 4.11); however the experimental data showed that the rate 
of cell attachment was not improved, and actually worsened, indicating that the greater 
rotational velocity prevented further cell attachment and actively removed previously attached 
cells.  




Despite the postulated theory that the rotating and pausing regime provided by the MACSmix 
rotator would allow multiple opportunities for cells to encounter the hollow fibre, Figure 4.15 
showed an average cell attachment of 10% ± 4%. This decrease in cell attachment may be 
evidence that the bioreactor was not left static for enough time to allow firm cell attachment 
to the hollow fibre. Static seeding on flat sheet PLGA membranes showed 20% ± 11% 
attachment after 5 minutes (Figure 4.12), which was greater than the attachment achieved 
using the MACSmix rotator that in theory would have allowed several opportunities for cells 
to fall onto the hollow fibre and attach.  An explanation for this discrepancy could be due to 
the differing scaffold types, with a potential for cells to roll off the hollow fibre once contact 
was made lowering the effective proportion of cells that could attach from simple settling. 
This can be visualised referring back to Figure 4.4, assuming a narrower green region above 
the hollow fibre. Cells which did attach to the fibre after 5 minutes may have also been 
subsequently detached during the next period of rotation. If the model outlined in Figure 4.11 
is applied to the experimental data, the net cell attachment per 5 minute rotation cycle is only 
0.3% of available cells. This number can be increased if the hollow fibre were to take up a 
larger proportion of the bioreactor space to reduce the number of cells that fall past the hollow 
fibre on each pass. A larger pausing time would also likely allow cells to form stronger 
attachments to the fibre, such that fewer would be removed due to forces of rotation, however 
by default the MACSmix rotator could not be set to pause for a longer time.  
Other publications using the same single fibre silicone bioreactor design and a MACSmix 
rotator at the same setting for seeding on collagen/fibrin micro-threads and have shown total 
attachment of 12% ± 4% cells (n=20)  after seeding 100,000 human MSCs and trypsinising 
the bioreactor interior after 24 hours rotation (Guyette et al., 2013). Attachment is greater in 
that study compared to this one, however control experiments similar to those described in 
Section 4.3.2 were not conducted. Assuming a similar degree of cell loss as described in this 
work, a comparable cell attachment of 15% ± 5% can be calculated, a value still larger than 
10% ± 4% found in this work. This could be attributed to the longer seeding time, however 
differences in cell type and scaffold may account for this. Fibrin is produced naturally by the 
body to assist in wound healing, providing binding sites for attachment and migration of 
monocytes, fibroblasts and endothelial cells that PLGA lacks (Clark, 2001). No studies 
utilising a Stuart STR4 rotator drive, or other similar devices, for cell seeding of a single 
module HFB could be found.  
 




4.4.4 Dynamic Seeding of Multi Fibre Scaffold 
For multi-fibre modules the rate of attachment on horizontally orientated fibres that are 
dynamically seeded was shown to be superior to the static regime. The theoretical rate of cell 
attachment under static conditions is 19% ± 14%, whereas dynamic seeding via rotation at  
2 RPM (0.25 s-1), 6 RPM (0.63 s-1) and 8 RPM (0.86 s-1) yielded experimental cell attachments 
averaging 31% ± 7%, 39% ± 12% and 22% ± 6% respectively. Of the three bioreactor 
orientations tested at constant rotational velocity, horizontal orientation provided significantly 
greater cell attachment (39% ± 12% ) compared to diagonal (15% ± 11%) and vertical (16% 
± 1%) positioning. Angling the HFB to a vertical or diagonal orientation would have increased 
the gradient of the surface where the cells make contact, and increased likelihood of cells 
rolling off and not attaching.  For a horizontal orientation an average gradient would be smaller 
and be more accommodating for cell attachment.  
Error bars, representing standard deviation, are narrower for the seeding of multi fibre 
bioreactors than those for single fibre bioreactors. This is primarily due to the easier method 
of seeding the larger glass bioreactors. The entirety of the 4.5 mL cell inoculant/media solution 
was simply injected into the bioreactor via a side port, with none remaining in the syringe 
afterwards. The increased complexity of the single fibre silicone bioreactor, with its fixed 
syringe needle input port and smaller inoculant volume (0.1 mL) led to increased rates of cell 
loss at the expense of much smaller volumetric losses in that system.  
There was no obvious correlation between drum rotational velocity and the rate of cell 
attachment on multi fibre bioreactors. For single fibre bioreactors was it was discussed that 
the increasing radial velocities would provide increasingly unfavourable shear conditions that 
prevented cell attachment and actively removed cells which had previously attached when 
initially seeded. Given the theoretical rate of static attachment on multi fibre bioreactors (19% 
± 14%) was the lowest in comparison to horizontally orientated dynamically seeded 
bioreactors, it can be postulated that dynamic cell attachment improves rates of cell attachment 
in this case.  
The HFZ in the multi fibre bioreactor was a greater proportion of the total bioreactor volume 
(44%) compared to the single fibre bioreactor (25%), and as a result had a higher projected 
surface area for cells to make contact with. The HFZ in the multi fibre bioreactor is comprised 
of a bundle of 5 hollow fibres. It is likely that a higher cell attachment rate occurred in multi 
fibres because cells settled between the fibres and were shielded when rotation was initiated. 
During rotation the settled cells at the bottom of the bioreactor moved outwards in a linear 
front up to the hollow fibre bundle, where again, cells infiltrated the bundle and were protected 
from subsequent removal.  




Also, multi fibre bioreactors were rotated for 4 hours longer than single fibre bioreactors, 
allowing more time for cells pressed against the fibre due to centrifugal action to attach. 
Unfortunately, this means that attachment on single and multi-fibres are not directly 
comparable. However, single fibre attachment for 6 hours can be extrapolated theoretically. 
At 6 hours rotation the cell front would be in contact with the hollow fibre would be for 3:07h, 
5:32h and 5:45h (at 2 RPM, 6 RPM and 8 RPM), and from the flat sheet cell attachment time 
course (Figure 4.12) any time over 3 hours provides the same degree of cell attachment 
(~84%). Following the methodology described in Table 4.11, theoretical cell attachment for 
each rotational setting with single fibres would be 45% ± 17%, which is still less than the 
theoretical maximum for multi-fibre bioreactors at 59% ± 22%. A similar table with values is 
provided in Table D.1 in Appendix D. However given the discrepancy between the theoretical 
and experimental data for dynamic single hollow fibres (Table 4.12), this extrapolation is 
likely to have a similar margin of error.  
A horizontal multi fibre bioreactor rotating at 6 RPM provided the optimum conditions to 
facilitate the highest rate of cell attachment. It is possible that higher rotational velocities 
(8 RPM) may have also led to detachment of previously attached cells that had infiltrated into 
the space between fibres. 
Bundles of hollow fibres inside a bioreactor have been used to cultivate cells of several types; 
however studies typically focus on the final cell quantity that can be harvested instead of initial 
cell seeding rates and optimisation. Rates of seeding density typically vary depending on cell 
type, the required final cell number, or if there is a time constraint. Studies using commercially 
available HFBs have been seeded for 24 hours (Nold et al., 2013) or 48 hours (Roberts et al., 
2012) under static conditions, with cell health gauged over time by measuring concentrations 
of D-glucose and L-lactic acid, which were not quantified into a representative cell number. 
Others initiate a slow initial perfusion of cells in media through the HFB and ancillary 
equipment before increasing flow rate (Pinzon et al., 2013; Cao et al., 2014; Tapia et al., 
2014). Researchers using these perfused systems also do not typically quantify cell 
attachment, either directly through trypsinisation, or indirectly by counting unattached cells in 
the circulating media.  
4.4.5 Comparisons, Limitations and Error Analysis 
Comparing both the single and multi-fibre dynamic attachment data for each drum speed and 
bioreactor orientation shows a greater rate of attachment on multi fibre bioreactors in every 
case. Performing a student’s t-test between pairs showed that horizontal, 2 RPM, 6 RPM and 
8 RPM configurations are significantly greater to a 95% certainty. The reasons for this could 
be due to the increased relative volume that the bundle of 5 hollow fibres took up in the larger 




glass bioreactor compared to the single fibre in the silicone bioreactor. Of the total volume 
available inside a module the hollow fibre zone takes up 25% of a single, and 44% of a multi-
fibre bioreactor.  
With the centrifugal settling model outlined in this chapter, the maximum rate of cell 
attachment would be equal to the number of cells that have the opportunity to contact the fibre 
when they initially settle after inoculation, plus the proportion of unattached cells in the linear 
cell front that make contact with the HFZ. This would be a maximum cell attachment of 
38% ± 13% for single fibre modules (horizontal at 8 RPM for 2 hours) and 59% ± 22% for 
multi-fibre modules (horizontal at 6 or 8 RPM for 6 hours) as outlined in Table 4.12. Whilst 
for multi-fibre bioreactors the best experimental dynamic attachment of 39% ± 12% 
(horizontal at 6 RPM for 6 hours) is within the margin of error of the theoretical maximum, 
single fibre bioreactors show the best rate of experimental dynamic attachment to be 13% ± 
8%, which below the range of the maximum theoretical attachment. From this discrepancy it 
can be concluded that flaws in the model must be present. The assumption of a linear cell front 
is an over-simplification, as cell collisions and interactions would cause cell distribution in 
three dimensions, perhaps in a spiral. The validity of using centrifugal particle settling 
equations is also questionable, given that the rotational speed is relatively low, and no 
published data using a similar method is available; but in and of itself this work is still useful 
even if parts of the theoretical analysis did not match the experimental data.    
The equations used to calculate the rates of settling were derived from first principle force 
balances on a particle and were expressed in chemical engineering textbooks such as Coulson 
& Richardson’s Chemical Engineering Volume 2 (Richardson et al., 2002). The authors of 
this book placed several caveats on the application of those equations by way of assumptions. 
One such assumption was that the settling of a single particle was not affected by the presence 
of other particles in the fluid, i.e. free settling. Whilst every attempt was made to mix the cell 
solution into a homogeneously distributed cell suspension for inoculation, it was likely that 
the cells in the solution were not evenly spread away from each other and may in fact have 
remained in small agglomerates. This would affect the settling equation as the buoyancy force 
of several cells clumped together would be greater than that of a single cell. Another 
assumption was that the walls of the reactor did not exert an appreciable retarding effect. This 
was mitigated in multi-fibres by applying Sigmacote to the glass reactor walls so that no cells 
attached to their surface; however this was not possible in the single fibre bioreactor system. 
The next assumption was to consider the fluid as a continuous medium with the cells being 
large compared to the mean free path of the molecules that make up the fluid itself, i.e. that 
the movement of the molecules of the fluid did not affect the settling velocity of the cell. This 
was accounted for by calculating the hindered settling velocity. The final main assumption 




was that the diameter of the cell was so small that its movement through the fluid can be 
characterised by a Reynolds number which was less than 0.2, thus falling within the remit of 
Stokes’ law and allowing the use of a simplified drag force factor for the settling velocity 
calculation. Other assumptions include the fluid media as a Newtonian fluid and that the cells 
were perfect spheres all possessing the same radii, volume, density and mass.  
With settling due to centrifugal action it was again assumed the cell was obeying stokes law 
in the fluid. A second derivative acceleration term in the equation of motion for the Stokes’ 
law region was excluded because it was assumed that the cell would never acquire an 
equilibrium velocity in the fluid. This source also posed no restrictions on the minimum 
angular velocity required to be able to use the equation of motion in a centrifugal field, 
however it was likely that at lower angular velocities the force of gravity cannot be neglected. 
More investigation needs to be undertaken to ascertain if the slow movement of cells by 
centrifugal action postulated in this section is a valid model to explain the results shown in 
this chapter. 
No other papers could be found which used a similar dynamic method for cell attachment as 
described in this report. Some computational models have been developed for rotating HFB 
systems, which deal with determining the speed of rotation that provides the most 
homogeneous mixture of cells in media, but does not model how cells may attach to hollow 
fibres in this system (Consolo et al., 2009). In this case a HFB of length 11 cm and radius 
3.6 cm is rotated about its central point tangentially for 300 seconds and determines that a 
homogeneous distribution of initially settled cell aggregates is achieved at 30 RPM, but does 
not offer a rate of cell attachment. This was converted to a linear velocity of 0.057 m/s and an 
angular velocity of 3.142 s-1. Their linear velocity is identical to that in the dynamic rotating 
drum system in this study; but the angular velocity is approximately five times greater, 
implying that the rotational forces in the rotating drum system studied in this chapter are not 
enough to ensure a homogeneous mixture. However this model was only run for 300 seconds 











From the experiments outlined in this chapter it was concluded that: 
i) Cell attachment on flat sheet PLGA scaffolds increased over time from 
20% ± 11% after 5 minutes to 85% ± 31% after 3 hours, after which cell 
attachment plateaued at a maximum value, as shown by 84% ± 35% attachment 
after 4 hours.   
 
ii) Experimental results for 6 hour dynamic seeding in multi-fibre bioreactors 
showed that the best rate of cell attachment was 39% ± 12% at 6 RPM and at a 
horizontal orientation. This was double the values of 20% cell attachment found 
in other works. 
 
iii) Experimental results for 2 hour dynamic seeding in single fibre bioreactors 
showed that all configurations provided less cell attachment than the static 
comparison (18% ± 16%); with the best cell attachment of 13% ± 8% at 2 RPM 
and at a horizontal orientation.  
 
iv) Back calculation of cell attachment from determining the number of unattached 
cells in the media was shown to be an inaccurate method, as at least 20% ± 14% 
cells were lost during the seeding process. 
This study has shown that for seeding single hollow fibres only a simple static regime is 
necessary, and could be further improved by simply inverting the bioreactor every 3 hours to 
provide the maximum rate of cell attachment over a greater surface area. During this work it 
became apparent that there was a high degree of error associated with large quantities of cell 
data. Analysing the uncertainties of the experimental method and cell counting procedures 
was important to put results in the correct context, which other authors tend to avoid.  
For future work on cell seeding, improvements on the experimental method should be sought 
to mitigate error. A static control experiment should also be undertaken on the seeding of 
bundles of hollow fibres to check that the dynamic regime still leads to improvements. A much 
simpler seeding regime of manually turning bioreactors to allow cells to settle onto the fibre 
as many times as necessary should also be investigated to see if it matches the flat sheet data. 
Alternative methods of seeding should also be explored, including modifying the MACSmix 
rotator to allow longer static periods, and perfusion of cells through the hollow fibre 
bioreactor.  




The improved rate of cell attachment will allow an accelerated growth of the dose of MSCs 
required for traditionally administered cell therapies. Initial cell attachment of 39% ± 12% of 
the 812,800 ± 318,400 MSCs yielded from patients would now allow 50 million MSCs to be 
grown in 11.2 ± 4.7 days, 1.4 days quicker than before. The novel dynamic cell attachment 
methodology outlined in this chapter will enable cell therapies to be administered to patients 
faster.  In order to enable cell expansion in HFBs porous hollow fibres need to be 
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5. CHAPTER FIVE: SODIUM CHLORIDE 
PARTICLES USED FOR MANUFACTURE OF 
POROUS PLGA SCAFFOLDS  
5.1 INTRODUCTION 
Hollow fibre bioreactors (HFBs) were chosen as the desired method for cell culture. This was 
due to their ability to operate in a continuous configuration, improved surface area to volume 
ratio, and the ability to emulate flow conditions in vivo. HFBs also provide the quickest rates 
of mesenchymal stem cell (MSC) growth compared to other bioreactor designs.  A hollow 
fibre bioreactor can be operated in several configurations, however the most useful mode 
allows media to be perfused through the central lumen and slowly permeate through to the 
outer surface where cells have attached. This reduces the shear forces that cells are exposed 
to, which if too high could damage cells or lead to their detachment from the membrane 
surface. The previous chapter focussed on methods of improving cell attachment onto the 
outer surface of hollow fibres to increase the number of cells available to grow and maximise 
cell harvest rates. 
Poly (lactic-co-glycolic acid) (75% lactide, 25% glycolide) scaffolds (PLGA) manufactured 
by phase inversion immersion precipitation in this study yielded non porous external surfaces 
as a result of formation of a thick skin layer. Beneath this layer exists access to a tortuous 
network of pores through which fluids would permeate through if made accessible. Standard 
PLGA scaffolds manufactured in this study lacked access to this sublayer, making them 
unsuitable for cell culture in this circumstance. Before culturing cells on PLGA hollow fibres 
this skin layer must be removed or penetrated.  
Experiments involving changing the non-solvent, adding polyethylene glycol and partial 
re-dissolution of the membrane surface were all trialled to facilitate partial or complete 
removal of the primary skin layer, but all failed. A technique to manufacture a porogen with 
a desired size and a narrow size distribution from sodium chloride (NaCl) particles was found, 
and this material was added in an attempt to introduce pores onto PLGA membrane surfaces. 
This is the first time this manufacturing technique has been used to introduce pores to PLGA 
fibres made via immersion precipitation. This method is described in Section 3.3.2. 
This chapter features the introduction of different quantities of NaCl porogen, to a 
PLGA/N-Methyl-2-pyrrolidone (NMP) mixture. Flat sheet and hollow fibre membranes were 
manufactured and imaged to determine if surface porosity formed on their surfaces. Pore 
number and area were analysed to determine how different quantities of NaCl altered the 




external surfaces of membranes. Hollow fibre membranes made from different amounts of 
NaCl were analysed using gas and liquid permeation experiments to determine permeability. 
5.2 PERMEATION THEORY 
Permeability of hollow fibres (and other scaffold types) to fluid flow can be calculated from 
different equations depending on the internal structure of the membrane. Generally, the ability 
to permeate through a structure is inversely proportional to pore length, and proportional to 
pore radius (Richardson et al., 2002), however several other factors are also considered. 
Examples of characteristic pore geometries are shown in Figure 5.1, with black and white 
illustrating fibre structure and void space respectively.  
 
Figure 5.1 – Examples of characteristic pore geometries. (a) Parallel cylindrical pores, (b) close packed 
spherical structure, (c) spongy tortuous network. White regions represent open voids, black regions 
represent solid fibre structure. 
Several equations were investigated for their applicability in modelling these structures and 
are outlined in Table 5.1. All equations are based on the principle equation that permeation 
flux (J) is equal to the product of a permeability constant (κ) and a pressure gradient driving 
force. Flux equations are converted into permeation flow rate (Q) using fibre geometry terms. 
Table 5.1 – Equations used to characterise different porous statures in membranes. 
Darcy’s law is used as a very simple equation to calculate permeability without consideration 
for the geometries inside the hollow fibre. If general fibre properties such as length (L), 
radii (r) and thickness (x) are known, as well as fluid properties such as viscosity (µ) and 
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permeation rate, then permeability can be determined. Permeation is dependent on pore radius, 
tortuosity and surface coverage. For Darcy’s law the permeation term is a ‘black box’ because 
pore geometry cannot be accurately defined. 
Pores shaped as those shown in Figure 5.1a are described as a number of parallel cylindrical 
pores either perpendicular or oblique to the surface of the membrane. In this model all pores 
have equal length, pass through the whole of the membrane, and possess the same radius (rp). 
Flux through this pore system can be described using the Hagen-Poiseuille equation, with 𝜖s 
as the surface porosity (i.e. pore coverage) and τ the tortuosity of the pore (equal to unity for 
cylindrical perpendicular pores). This equation assumes an incompressible and Newtonian 
fluid with laminar flow and constant cross-sectional area.  
The permeability of a packed bed structure shown in Figure 5.1b can be calculated using the 
Carman-Kozney equation, assuming that fluid flow is laminar. The surface area per unit 
volume of particle (S), the fractional voidage of packed bed (εb), and the Carman constant (K) 
are required to calculate a permeability term using intrinsic fibre knowledge. The Carman-
Kozney equation is expressed in terms of superficial velocity (uS), as calculation of a flow rate 
is not particularly useful. 
Figure 5.1c shows a tortuous network that may have interconnectivity and varying pore radii. 
There is no one equation suitable to fit geometry of this type. Both Hagen-Poiseuille and 
Carman-Kozney can be used (Mulder, 2003), however care should be taken in drawing 
conclusions based on intrinsic pore properties. Using Darcy’s law to provide a value for 
permeability without the need to specify how the pore structure is formed, is most applicable 
in this case where geometry is uncertain.   
5.2.1 Modelling Hollow Fibres 
The phase inversion method of scaffold manufacture leads to regions with different pore 
geometries throughout the fibre cross-section, typically increasing in size from the water-
exposed side of manufacture towards the centre of the fibre wall. This is shown in cross-
section SEM images of flat sheets and hollow fibres throughout this chapter. An example 
image illustrating this phenomena is shown in Figure 5.2. 
As both the lumen and outer walls are exposed to water during manufacture of hollow fibres, 
they both form a non-porous skin layer. From both walls moving inwards there are three 
regions of porosity with different ranges of pore diameter: 0.5 – 1 µm (primary),   
2 – 5 µm (secondary), and 20 – 30 µm (tertiary) pores that join together in the centre of the 
fibre structure forming large macrovoids.   





Figure 5.2 – Cross-section of hollow fibre wall with a ‘non-porous’ layer, narrow pores (Knudsen) and 
wide pores (viscous flow). 
The non-porous skin layer will likely be the rate determining step as it provides the most 
resistance to fluid flow. If the skin layer could be made permeable, the rate limiting step would 
be determined by the primary pore layer, as it offers the smallest sized pores. This is visualised 
in Figure 5.3, showing the three porous regions in white with an equivalent pore thickness 
dotted through the fibre if the primary pore layer was considered to be rate limiting (not to 
scale). 
 
Figure 5.3 – Pore layers in hollow fibre with comparable structure if primary layer is rate limiting. 
Assumes removal of non-porous skin layer. For illustration only. Pores are not to scale or proportionally 
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Assuming the primary pore layer is the rate limiting step, and a certain amount of it is exposed 
via permeablising the skin layer with surface pores, the Hagen-Poiseuille equation shown in 
Table 5.1 could be applied to the model shown in Figure 5.3, but would yield unrealistic values 
for pore tortuosity. Darcy’s law could be applied without using the described model with no 
consideration for the pore geometry to simply yield a value for permeation that would still be 
comparable to other works. 
As the pore structure does not resemble that of a packed bed, the Carman-Kozney equation 
was not chosen. A permeation value calculated using Darcy’s law could be applied to known 
packing materials to find an equivalent value, which may be useful if using the same PLGA 
scaffold in a packed bed bioreactor. 
 Consideration of Knudsen Flow 
Knudsen flow arises exclusively in low pressure gas flows through membranes with pore 
diameters less than 0.2 µm. In these environments gas molecules possess a mean free path 
comparable or larger to that of the pores, increasing the likelihood of molecule-wall collisions 
which increases flow resistance; as opposed to viscous (Poiseuille) flow where molecule-
molecule collisions dominate. The mean free path of a nitrogen molecule (λ) is calculated in 
Equation 5.1 with diameter 370 pm (Hirschfelder, 1955), at 1 bar gauge pressure and 298 K 
can be calculated using the Boltzmann constant (kB) to determine if Knudsen flow is in effect: 





𝑀𝑒𝑎𝑛 𝐹𝑟𝑒𝑒 𝑃𝑎𝑡ℎ =
1.381 × 10−23 [
𝑚2𝑘𝑔
𝑠2𝐾
] × 298 [𝐾]





𝑴𝒆𝒂𝒏 𝑭𝒓𝒆𝒆 𝑷𝒂𝒕𝒉 = 𝟎. 𝟎𝟕 𝝁𝒎 
Equation 5.1 – Calculation of the mean free path of a nitrogen molecule. 
As the primary layer has pores of 0.5 – 1 µm diameter, and the mean free path of nitrogen at 
the above conditions is 0.07 µm, it can be concluded that Knudsen flow is not applicable in 
this PLGA membrane.  
5.2.2 Permeation 
Darcy’s law was used to calculate both gas permeability (κG) and liquid permeability (κL) of 








Equation 5.2 – Darcy’s law. 




The thickness of the hollow fibre can be represented as the difference between the outer radius 
(rOF) and inner radius (rIF), or dr. Fibre surface area (A) is the available area for gas transfer 
and is equivalent to the surface area of a cylinder (2πrL). Equation 5.2 is rearranged to make 
permeability the subject in the following derivation, and integrating using outer and inner fibre 

































Equation 5.3 – General equation for permeation through a hollow fibre wall. 
The driving force that causes permeation (ΔP) can be simplified by changing the inlet pressure 
and retentate pressure values into terms of atmospheric pressure (PA) and applied gauge 
pressure (PG). It is assumed that membrane properties are uniform along the length of the fibre. 
 Gas Permeation 
For gas permeation tests the hollow fibre is operated in a dead-end mode as shown in Figure 
5.4, where there no retentate flow is possible. Therefore the driving force (ΔP) is equivalent 
to the pressure difference between the inlet and permeate streams. The module outputs the 
permeating nitrogen gas to atmospheric pressure. Equation 5.4 shows how ΔP can be defined 
in this system: 
 
Figure 5.4 – A schematic of a single hollow fibre in dead-end mode for gas permeation. 
𝛥𝑃 = 𝑃𝐼𝑛𝑙𝑒𝑡 − 𝑃𝑃𝑒𝑟𝑚𝑒𝑎𝑡𝑒 
𝛥𝑃 = (𝑃𝐴 + 𝑃𝐺) − 𝑃𝐴 
𝜟𝑷 = 𝑷𝑮 
Equation 5.4 – Quantification of ΔP for gas permeation in dead-end mode. 
The driving force of gas permeation is dependent on the applied gauge pressure.  




 Liquid Permeation 
For liquid permeation tests the hollow fibre is operated in a cross-flow mode as shown in 
Figure 5.5, where an applied back pressure at the retentate exit enables a permeate flow across 
the fibre wall. Equation 5.5 shows how ΔP can be defined in this system: 
 
Figure 5.5 – A schematic of a single hollow fibre in cross-flow mode for liquid permeation. 
𝛥𝑃 = 𝑃𝐼𝑛𝑙𝑒𝑡 − 𝑃𝑅𝑒𝑡𝑒𝑛𝑡𝑎𝑡𝑒 
𝛥𝑃 = (𝑃𝐴 + 𝑃𝐺𝐼𝑛𝑙𝑒𝑡) − (𝑃𝐴 + 𝑃𝐺𝑅𝑒𝑡𝑒𝑛𝑡𝑎𝑡𝑒) 
𝜟𝑷 = 𝑷𝑮𝑰𝒏𝒍𝒆𝒕 −𝑷𝑮𝑹𝒆𝒕𝒆𝒏𝒕𝒂𝒕𝒆 
Equation 5.5 – Quantification of ΔP for liquid permeation in cross-flow mode. 
For liquid permeation, ΔP is equivalent to the difference between the inlet and retentate gauge 
pressures.  
As fibre liquid permeability depends on the change in pressure along its length it is important 
to isolate any other sources of pressure loss in the hollow fibre. Loss of pressure is a 
phenomenon that occurs in all incompressible fluids flowing through a pipe, and is caused by 
frictional forces between the fluid and the pipe surface. Pressure drop can be calculated using 
the Darcy-Weibach equation (Equation 5.6): 







Equation 5.6 – Darcy-Weibach equation. 
This is the product of the aspect ratio of the fibre length (L) and lumen diameter (D), the 
kinetic energy in the system and the dimensionless Darcy friction factor fD shown in Equation 
5.7: 








Equation 5.7 – Darcy Friction Factor. 
Where Re is the Reynold’s number of the fluid flowing through the hollow fibre lumen. 
Pressure lost in the fibre is also dependent on the physical roughness of the surface, however 
at low laminar Reynold’s number this is not a factor and only starts to noticeably cause 
pressure loss at Re>4000 (Coulson and Richardson, 1999). The value for pressure loss must 
be taken into account to ensure that pressure losses can be exclusively attributed to permeation 
of liquid through the hollow fibre wall. 
 Other Factors 
An alternative to stating how permeable a material is to fluid flow is expressing the resistance 
of a material to permeation. The resistance (Ω), with units m-1, is membrane thickness divided 





Equation 5.8 – Equation expressing resistance to permeation. 
Equations for permeability and resistance are only valid when flow through the pores is 
laminar (Mulder, 2003), therefore a Reynolds number less than 2000 is required. Reynolds 
number for a given pore is calculated as shown in Equation 5.9 using superficial velocity (uS), 
derived from the outlet flow rate divided by the total surface area of the pores available on the 
inner hollow fibre surface. The average pore diameter (dP) is also required, obtained from 














5.3.1 Visual Analysis of PLGA Fibres with added NaCl Porogen 
Previous attempts to manipulate PLGA have involved modifying the behaviour of 
polymer/solvent demixing by changing the properties of the non-solvent, or the addition of 
supplementary polymers to alter the polymer composition. Spinning hollow fibres using 
1, 4-dioxane as a non-solvent provided localised removal of the primary skin layer, exposing 
the porous sublayer, however this method failed to remove or penetrate the skin along the 
entire polymer surface. An image of this scaffold is shown in Figure E.1 in Appendix E. 
In a further attempt to add pores to the surface skin layer, a porogen was added to the polymer 
dope. The use of porogen in polymers used for biomedical applications is outlined in Section 
2.3.6, but in short, NaCl crystals were selected due to their insolubility in NMP, their solubility 
in water, and the ability to be made to a desired size. NaCl crystals were manufactured as 
outlined in Section 3.3.2. NaCl crystal sizes were confirmed by EVOS microscopy (Figure 
5.6) and an average crystal diameter of 8.8 ± 2.7 µm was measured over 121 samples. Pore 
dimensions of this magnitude were desired to ensure that cells would not migrate into the 
scaffold structure itself, while also not being damaged by high velocity media flow exiting the 
pores. 
 
Figure 5.6 – NaCl crystals imaged using an EVOS microscope. 
This results subsection outlines the addition of varied concentrations of NaCl to a PLGA/NMP 
mixture, and the resulting changes in structure of flat sheet and hollow fibre scaffolds.  By 
weight percentage of PLGA in the polymer dope, 10%, 20%, 40% and 60% NaCl was added. 
Flat sheet and hollow fibre PLGA scaffolds were produced and pores on both external surfaces 
quantified by ImageJ analysis of SEM images.  
100 µm 50 µm




 SEM Images 
 
 
Figure 5.7 – SEM images of the top surface of PLGA flat sheets with 10%, 20%, 40% and 60% NaCl.  
 










Figure 5.9 – SEM images of the cross section of PLGA flat sheets with 10%, 20%, 40% and 60% NaCl. 
 


























5.3.2 Hollow Fibre Dimensions 
Dimensions of the hollow fibres shown in Figure 5.12 are measured using the scale bars on 
each image. An average of four measurements for both the inner and outer diameters, and a 
calculated thickness value are shown in Table 5.2 
Table 5.2 – Dimensions of hollow fibres. 
 
 Surface Pore Analysis 
Whilst the surfaces of both scaffold types can be distinguished qualitatively by observing SEM 
imagery, comparisons between different degrees of NaCl content for those surfaces required 
a quantitative analysis. SEM images were analysed using ImageJ software to count the number 
of pores on a given surface and to analyse the dimensions of these pores. The procedure used 
is outlined in Appendix B. Three random SEM images were taken for both sides of each 
scaffold surface for each quantity of NaCl. The total number of pores across the triplicate 
images were counted, their surface area quantified, and a percentage pore coverage and density 
on each scaffold calculated using the area of the SEM image. The top surface of flat sheets 
were not included as it was apparent from Figure 5.7 that they were non-porous. Data is 
presented in Table 5.3, with standard deviation error.  




0% 10% 20% 40% 60% 
Value SD Value SD Value SD Value SD Value SD 
Average Outer 
Diameter 
1.350 1.9% 1.250 5.7% 0.938 5.7% 1.050 2.4% 0.988 1.8% 
Average Inner 
Diameter 
1.140 2.2% 0.913 5.8% 0.738 2.4% 0.900 2.8% 0.713 2.5% 
Average 
Thickness 


















10% 0.48% 0.08% 221 13 21.8 18.0 5.3 4.8 
20% 0.34% 0.06% 221 49 15.4 10.6 4.4 3.7 
40% 1.77% 0.26% 749 75 23.6 13.8 5.5 4.2 





10% 0.25% 0.10% 120 5 21.1 16.8 5.2 4.6 
20% 0.34% 0.15% 115 17 29.6 18.9 6.1 4.9 
40% 0.82% 0.36% 260 83 31.5 21.1 6.3 5.2 





10% 0.15% 0.01% 101 15 14.6 5.7 4.3 2.7 
20% 0.13% 0.03% 84 37 15.4 10.3 4.4 3.6 
40% 0.23% 0.06% 270 71 8.4 4.0 3.3 2.3 
60% 0.17% 0.05% 149 62 11.1 7.7 3.8 3.1 




A one way ANOVA with post hoc Tukey test was implemented to determine any statistical 
differences between the properties of the pores on scaffolds with different NaCl percentages, 
as well as any differences in the properties of pores found on different surface types at constant 
NaCl content. Direct comparison of the different surfaces for each NaCl percentage indicated 
that the bottom of flat sheets had the greatest pore density, followed by the inner then outer 
hollow fibre surfaces. Pore density on flat sheets was statistically greater than both fibre 
surfaces for all salt types.  
Average pore density on the bottom of PLGA flat sheets is significantly similar between 
10% - 20% and 40% - 60% NaCl data sets but both pairs are statistically dissimilar from each 
other. This illustrates a sudden increase in surface porosity between 20% and 40% NaCl doses.  
The same relationship is seen on the inner surface of hollow fibres, but not on the outer surface.  
Average pore surface areas between all 10% NaCl surfaces were not significantly different. 
The pore area on inner surfaces of hollow fibres with 20% NaCl significantly larger than the 
other two surfaces; and for 40% NaCl and 60% NaCl all pore areas were significantly different 
from one another, with inner hollow fibre surface pores the largest followed by flat sheet and 
outer hollow fibre pores.  
Average pore area differs between all NaCl percentages, but did not form any kind of 
correlation. As pore density between both 10% - 20% and 40% - 60% NaCl pairs were so 
similar, any significant difference in average pore area would affect overall pore coverage of 
the hollow fibre. Pore coverage on the bottom of flat sheets attained from 
10% NaCl (0.48% ± 0.08%) was greater than that attained from 20% NaCl (0.34% ± 0.06%) 
and 40% NaCl (1.77% ± 0.26%) yielding a larger pore coverage than 
60% NaCl (1.44% ± 0.20%).  Average pore area on the inner surface of hollow fibres was 
larger with 40% NaCl, leading to a total pore coverage (0.82% ± 0.36%) greater than its 60% 
NaCl counterpart (0.68% ± 0.24%).  The pores on the outer surface of 40% NaCl hollow fibres 
were significantly larger than those found on corresponding 10% and 20% fibres, leading to 
the largest pore coverage on that surface (0.23% ± 0.06%). 
5.3.3 Gas and Liquid Permeation of Hollow Fibres 
PLGA hollow fibres manufactured with 0%, 10%, 20%, 40% or 60% NaCl content were tested 
to indicate their permeability to nitrogen gas and ‘double distilled’ (ddH2O) water, as outlined 
in Section 3.4.2, as well as their resistance and Reynolds number. These properties were 
compared for each fibre type at different ΔP. All experiments were repeated three times using 
fibres from their same respective batch. This was undertaken to determine if the porous surface 
indicated in SEM imagery provided penetration through the whole hollow fibre or whether 




the changes were only cosmetic. Average dimensions of each hollow fibre type are shown in 
Table 5.2. All data was normalised to account for fibre surface area, pore properties and the 
number of fibres per module. 
For gas permeation X-axis error from manual pressure gauge readings was 0.01 bar. Error on 
the Y-axis for the parameter in question was calculated from compound error as explained in 
Section 3.5, originating from error from the standard deviation of triplicate membrane outlet 
flow rate readings and measurements of membrane dimensions. Results were presented by 
averaging values of three repeat experiments at an applied ΔP for each fibre type. Y-axis error 
from the standard deviation of these average values dominate over those found from 
compound error.  
For liquid permeation inlet and outlet pressure transducers allowed pressure measurements to 
be continuously measured and an average was output every 5 minutes, allowing ΔP to be 
calculated per time point. From comparison with the manufacturer’s calibration data, the 
pressure transducers had an error of 0.2%, as shown on the X-axis. A 1% error was observed 
during permeation experiments with 0% NaCl PLGA fibres (i.e., zero permeation) which was 
applied as a standard degree of fluctuation of actual retentate mass measured on the scales 
when zero permeation was achievable. This is included in the as Y-axis error. A valve at the 
exit of the liquid permeation system was manipulated to impose a back pressure onto the 
system to increase ΔP and encourage an increased permeation. During pre-experimental 
testing it was discovered that the valve was not sensitive enough to allow fine control of back 
pressure, making experimental repeats at identical ΔP impossible. Additionally, pressure in 
the system never reached stable values after back pressure was applied. Pressure would slowly 
increase in the system until reaching the maximum allowable operating pressure of the 
transducers, whereupon the valve was manually re-opened to de-pressurise the system.  
A range of set pressures were used for gas permeation, allowing changes in permeation to be 
observed at different applied ΔP. However in liquid permeation tests, due to the pressure 
control issues, ΔP could not be set at a repeatable stable single value. As a result all ΔP vs 
permeation, resistance or Reynolds number data points calculated for liquid permeation over 
the duration triplicate experiments (n=18, N=3) were averaged to provide a single value for 
all three properties.  
Due to the un-centred lumen of manufactured hollow fibres shown in Figure 5.12, and the 
high dependence of permeability and resistance values on the thickness of the fibres, an 
average value for fibre thickness was calculated, as shown in Table 5.2. It was assumed that 
this would account for higher permeation through thinner, and lower permeation through 
thicker, parts of the fibre wall.  




 Gas Permeation 
Gas permeability for hollow fibres manufactured with different weight percentages of NaCl 
is shown in Figure 5.13. Resistance of each fibre type, taking into account its average 
thickness, is displayed on Figure 5.14. Reynolds number of nitrogen gas permeating through 
the fibre is shown on Figure 5.15. Average values for all are summarised in Table 5.4. 
 
Figure 5.13 – Permeation of nitrogen through PLGA hollow fibres with different NaCl content. 
X error = 0.01 bar, Y error = SD (n=3). 
 
Figure 5.14 – Resistance of PLGA hollow fibres with different NaCl percentage to nitrogen permeation. 























































Figure 5.15 – Reynolds no. of nitrogen permeating through PLGA hollow fibre walls with different NaCl 
content. X error = 0.01 bar, Y error = SD (n=3). 
 
 
Table 5.4 – Average gas permeability, resistance and flux of fibres with different NaCl content between 
0.03 – 0.42 barg. 
NaCl 
Permeability (m2) Resistance (m-1) Flux (m3m-2h-1bar-1) 
Average Error Average Error Average Error 
0% 0 N/A ∞ N/A 0 N/A 
10% 7.16E-17 20.3% 2.46E+12 21.8% 14.6 19.7% 
20% 8.28E-16 22.1% 1.25E+11 15.0% 163.7 24.8% 
40% 5.11E-16 32.2% 1.57E+11 19.4% 127.2 21.5% 
60% 1.38E-15 34.6% 1.07E+11 20.0% 193.8 19.9% 
For each fibre, permeability decreases with increasing ΔP. Permeability generally increased 
with NaCl content, aside from an inconsistency between 20% and 40% NaCl where 20% NaCl 
fibres offered greater permeability than 40% NaCl fibres. This was also reflected in the 
calculated values for resistance. A corresponding average nitrogen flux, normalised per unit 
surface area and pressure, showed a similar pattern. All permeation values were significantly 
different from one another. The resistance of 10% NaCl fibres was significantly greater than 
the other fibre types.  Reynolds number increased with ΔP, and all values were low enough to 

































 Liquid Permeation 
Liquid permeability for hollow fibres manufactured with different weight percentages of NaCl 
is shown in Figure 5.16. Resistance of each fibre type, taking into account its average 
thickness, is displayed on Figure 5.17. Reynolds number of liquid water permeating through 
the fibre is shown on Figure 5.18. Average values for all are summarised in Table 5.5. 
 
Figure 5.16 – Permeation of ddH2O through PLGA hollow fibres with different NaCl content. 
X error = SD (n=54), Y error = SD (n=54). 
 
 
Figure 5.17 – Resistance of PLGA hollow fibres with different NaCl percentage to ddH2O permeation. 
























































Figure 5.18 – Reynolds number of nitrogen permeating through PLGA hollow fibres with different NaCl 
percentage. X error = SD (n=54), Y error = SD (n=54). 
 
Table 5.5 – Average liquid permeability, resistance and flux of fibres with different NaCl content between 
0.001 – 0.004 barg. 
NaCl 
Permeability (m2) Resistance (m-1) Flux (m3m-2h-1bar-1) 
Average Error Average Error Average Error 
0% 0 N/A ∞ N/A 0 N/A 
10% 4.33E-16 22.8% 4.10E+11 22.7% 1.21 33.7% 
20% 1.59E-15 17.1% 6.52E+10 21.1% 7.23 25.9% 
40% 3.45E-16 48.7% 2.88E+11 64.8% 2.00 60.1% 
60% 1.91E-15 50.5% 9.61E+10 54.9% 6.63 77.2% 
 
The fibre with the greatest NaCl content provided the largest permeation value. Fibres with 
other NaCl content yielded an inconsistent trend, with permeability decreasing in order of 
60%, 20%, 10% then 40% NaCl. All average permeation values were significantly different 
from one another except between 10% and 40% NaCl fibres.  Resistance of 20% fibres was 
the lowest of all types, followed by 60%, then 40% and 10% NaCl content. All average 
resistance values were significantly different from one another except between 20% and 60% 
NaCl fibres. Reynolds number was largest through 20% NaCl fibres, as was liquid flux. Liquid 





























5.4.1 Membrane Morphology 
SEM images in this chapter illustrated how porous surfaces could be manufactured during the 
phase inversion immersion precipitation process of PLGA/NMP mixtures supplemented with 
NaCl crystals of varying quantities. From visual inspection of these images it can be concluded 
that the pores on PLGA flat sheets form in limited quantities on the topside of the membrane 
(Figure 5.7), and primarily form on the underside (Figure 5.8).  Pores form on both the inner 
surfaces (Figure 5.10) and outer surfaces (Figure 5.11) of PLGA hollow fibres, but are more 
numerous on the inner surface. 
The non-porous flat sheet top surface could be attributed to the delayed demixing of PLGA 
and NMP in water. After immersion the PLGA remained attached to the glass support and 
slowly changed from a highly viscous transparent film to an opaque solid PLGA sheet (Figure 
3.1). This occurred over a period of an hour. The increase in opacity was due to the 
PLGA/NMP demixing process continuing over time as the NMP diffused out of the film and 
the non-solvent (ddH2O) penetrated downwards from the top surface to the bottom. The top 
of the casted polymer film was exposed to the non-solvent immediately after immersion, and 
took approximately two minutes to show signs of increasing opacity. During this time the 
NaCl on the polymer surface could be readily dissolved in the ddH2O before demixing on the 
PLGA surface had fully concluded, leaving adequate time for the PLGA/NMP solution to re-
fill the pores created from the vacant NaCl particles.  
The NaCl in the PLGA/NMP mixture below the exposed top layer remained in solution as the 
PLGA/NMP solution around it demixed and a solid scaffold was formed. Once the flat sheet 
came away from the glass support the NaCl on the bottom surface dissolved. The flat sheet 
was left for approximately 3 days in ddH2O with regular water changes to drive out any excess 
NMP and allow salt to leach out of the PLGA. Pores near exclusively only appeared on the 
bottom surface of flat sheets, indicating that the NaCl only leached out of the flat sheet 
downwards. This could also be attributed to the inherent buoyancy of flat sheet membranes in 
general, causing scaffolds to float.  The top side was partially submerged, but was often 
exposed to air, while the underside was completely consistently submerged. The small 
quantity of pores that did appear on the surface would have formed in the first hour of 
immersion in water, as the PLGA flat sheet was still attached to the glass plate during this 
time while only the top side was exposed to water. However, casting flat sheets of other 
polymers with NaCl additive, which demixed instantly and were also prone to floating, yielded 
both a porous top and bottom surface (Argyle, Unpublished). In this case the surface demixing 
occurred at a faster rate than NaCl dissolution, allowing pores to form on the top surface.  




Pores were present on both the inner and outer surfaces of hollow fibre membranes, although 
in reduced number compared to the underside of flat sheets. Due to the method of manufacture, 
both the inner and outer surfaces were exposed to non-solvent simultaneously when passed 
through the spinneret, allowing the demixing process to take affect from two directions and 
occur instantaneously. This allowed the formation of pores on their non-solvent exposed 
surfaces. Hollow fibres were also less thick than flat sheets, further increasing the rate at which 
the entire scaffold was demixed. 
Formation of macrovoids in the cross sections of flat sheets (Figure 5.9) and hollow fibres 
(Figure 5.12) are independent from the NaCl additive (Mulder, 2003). Initially small voids 
were created as a by-product of the demixing process near the polymer surface. These voids 
increased in size due to diffusion of solvent and non-solvent, growing until polymer 
concentration surrounding the macrovoid was high enough to solidify. The main factors that 
affected macrovoid formation were the solvent/non-solvent pair chosen and the polymer 
concentration, which both affected the thermodynamics of demixing (Mulder, 2003). Small 
pores were also formed on inner surfaces throughout the cross section of flat sheets and hollow 
fibres as a result of NaCl leaching. 
The non-proportional increase in pore number with NaCl content for each surface can be 
attributed to the manufacturing process. In regards to flat sheets, the method outlined in 
Section 3.3.1 did not form a membrane with uniform thickness. Flat sheets of thicknesses 
between 135 – 200 µm were formed during this study. This could be due to pouring 
inconsistent volumes of polymer solution onto the glass before submerging in water; however, 
as the polymer dope was continuously mixed on rollers prior to casting, a proportional quantity 
of NaCl should have been present regardless of the volume poured. All scaffolds were 
immersed in water for 3 days, allowing equal time for salt leaching to occur.  
During setup of the hollow fibre spinning process the polymer dope was poured into the 
pressure vessel to be extruded through the spinneret. In the lag time between this step and the 
commencement of extrusion the NaCl began to settle out, leading to the initial length of fibre 
potentially having a greater concentration of NaCl than anticipated, decreasing gradually as 
the fibre was spun. Such a situation was unavoidable given the required size of the NaCl 
particles for cell growth applications and the excessive time required to initialise the spinning 
process. For future works a greater proportion of polymer mixed in with the solvent may 
increase its density enough to sufficiently slow the settling velocity of the NaCl; however this 
would increase the viscosity of the polymer, requiring a greater pressure to force it through 
the spinneret. Three random sections of the spun fibre for each NaCl quantity were imaged to 
determine if this effect caused differences in surface porosity along the length of the whole 




fibre batch. Given the consistency in pore number between 10% - 20% and 40% - 60% NaCl 
samples on the bottom of flat sheets and inner fibre surfaces, NaCl prematurely settling is not 
a concern. 
Neither of these methodological inconsistencies provide sufficient reason why on both 
scaffold types there was an obvious similarity between the two pairs of samples with differing 
NaCl content but near identical pore surface density. NaCl concentration seemed to affect the 
demixing process in such a way that an upper limit on the pore surface density was present. 
The four-way relationship between PLGA/NMP/water/NaCl has led to complex 
thermodynamic and kinetic behaviours during scaffold formation. 
If one wished to model the thermodynamic and kinetic changes that arose from the demixing 
process in this system, all changes would have to be measured considering a moving boundary 
of opposing diffusion fluxes penetrating through the thickness of the film over time. The fluxes 
of solvent/non-solvent at a given thickness and time were dependent on the permeability of 
the polymer film and chemical potential (partial molar free energy), the latter of which acts as 
the driving force for mass transfer. Calculation of the Gibbs free enthalpy in this system 
requires knowledge of the number of moles and volume fraction of each component, as well 
as Flory-Huggins interaction parameters to determine how each component interacts with one 
another (Flory, 1953). Locating comparable values for the latter from literature was not 
possible due to the complexity of the quaternary system considered here and the sheer number 
of potential variables that arise between different studies (Mikos et al., 1994; Fashandi and 
Karimi, 2014). Such variables include (but are not limited to) scaffold formation method, 
polymer type (including co-polymer ratios), choice of solvent and non-solvent, addition of 
pore-formers or other adjuncts and temperature. 
Studies such as addition of PVA pore-former to hydroxyapatite scaffolds (Gallegos-Nieto et 
al., 2015) and use of hydroxypropylcellulose pore-former on ethylcellulose coated pellets 
(Wang et al., 2015) show increasing quantities of porogen yielding greater degrees of porosity. 
A study adding 20%, 40%, 60% and 80% polyethylene glycol (PEG) by weight to PLGA 
(85:15) to manufacture flat sheet membranes through air drying showed an increasing pore 
number up to 60% (Krok and Pamula, 2012). At 80% PEG surface porosity was worsened due 
to increasing continuity between regions of PEG in the membrane, an explanation that would 
not apply to the relationship outlined in Section 5.3.1.  It was also observed that for each 
percentage PEG added the air dried side was always less porous then the surface in contact 
with the glass, similar to the SEM imagery shown in Section 5.3.1 however not as severe. 




5.4.2 Hollow Fibre Permeability 
The dimensions of each fibre type, assuming an average thickness for permeation, are shown 
in Table 5.4. Average dimensions are inconsistent between fibre types due to manufacturing 
inconsistencies between batches of fibre. The variation of thickness and the available surface 
area on the inner and outer fibre surfaces for permeation to occur were all normalised when 
calculating permeability, resistance and Reynolds number for both gas and liquid permeation.  
Gas permeability of each fibre type over a ΔP of 0.03 – 0.42 barg is shown in Figure 5.13 
(with the exception of 10% fibres tested to 0.32 barg), and an average permeation calculated 
over that range with associated error is displayed in Table 5.4. Hollow fibres with zero NaCl 
content yielded no value for gas permeability between the applied pressures of 
0.03 – 0.42 barg; no flow rate of nitrogen gas was measured exiting radially from the fibres. 
Both gas and liquid permeation did occur in some fibres with zero NaCl, however these fibres 
were found to contain one or two larger holes of approximately 0.5 mm in diameter that were 
visible by eye. Imperfections in the fibre arose from transient issues in the spinning process 
and were excluded from the results if tested.  
10% NaCl hollow fibres had an average gas permeability of 7.16E-17 m2 (± 20.3%) and 
displayed a positive correlation, increasing permeability with ΔP. The porosity in this fibre 
was such that at the minimum applied pressure no permeation was detected. From 
0.08 – 0.32 barg permeability increased by 78.9%.  This pattern was consistent between 
replicates of each fibre for each of these fibre types. Hollow fibres with 20%, 40% and 60% 
NaCl content yielded an average gas permeability of 8.28E-16 m2 (± 22.1%), 
5.11E-16 m2 (± 32.2%) and 1.38E-15 m2 (± 34.6%), and are all shown to start at an initially 
higher permeation value at 0.03 barg, before suddenly dropping and then slowly decreasing 
between 0.08 – 0.42 barg by 5.0%, 16.7% and 18.8% respectively. This pattern was consistent 
between replicates of each fibre for each of these fibre types. All average gas permeabilities 
for each fibre type are significantly different from each other with a 95% confidence with 
n = 21 for 10% NaCl fibres, and n = 27 for 20%, 40% and 60% NaCl fibres.  
Permeating gas flow was also measured when fibres were deformed and damaged due to 
prolonged exposure to higher pressures. This was characterised by a sudden spike of gas flow 
occurring at pressures of 0.5 – 1.0 barg. Data for these modules was retained up until the point 
of fibre collapse, but are only shown up to 0.42 barg to allow consistent comparisons between 
different fibre types.  
Correcting for fibre thickness in Figure 5.14, 10% fibres possessed an average resistance of 
2.46E+12 m-1 (± 21.8%) decreasing between 0.08 – 0.32 bar by 44.2%; and 20%, 40% and 




60% fibres having an average resistance of 1.25E+11 m-1 (±15.0%), 1.57E+12 m-1 (± 19.4%), 
and 1.07E+11 m-1 (± 20.0%), all increasing by 5.5%, 19.4% and 23.2% respectively over 
0.03 – 0.42 barg. Resistance of 10% fibres is significantly different from the other fibre types, 
which have no significant differences between each other. 
Figure 5.16 displayed liquid permeability of each fibre type. For 10% NaCl fibres average 
permeability was 4.33E-16 m2 (± 22.8%) at 0.003 barg (± 17.6%), 20% fibres was 
1.59E-15 m2 (± 17.1%) at 0.001 barg (± 13.7%), 40% was 3.45E-16 m2 (± 48.7%) at 
0.003 barg (±24.9 %) and 60% fibres was 1.91E-15 m2 (± 50.5%) at 0.002 barg (±41.3%). All 
are significantly different from one another with a 95% confidence, except when comparing 
10% and 40% fibres. N=3 and n = 54 for all samples as shown in Table 5.5. 
Resistance of each fibre type to water flow is shown in Figure 5.17. 10% NaCl fibres had a 
resistance of 4.10E+11 m2 (± 22.7%) at 0.003 barg (± 17.6%), 20% fibres had 
6.52E+10 m2 (± 21.1%) at 0.001 barg (± 13.7%), 40% had 2.88E+11 m2 (± 64.8%) at 
0.003 barg (± 24.9 %) and 60% fibres had 9.61E+10 m2 (± 54.9%) at 0.002 barg (±41.3%). 
All are significantly different from one another with a 95% confidence, aside from comparison 
of 20% and 60% fibres. N = 3 and n = 54 for all samples. 
A pressure loss through the bioreactor was to be expected before factoring in fibre 
permeability. For a fluid flowing through a pipe there is an expected loss of energy due to 
frictional forces between the fluid and pipe wall. This was accounted for using the Darcy-
Weibach equation for pressure loss in a pipe with incompressible fluid flow, as outlined in 
Section 5.2. As discussed in that section, pressure losses are mainly dependant on lumen 
diameter. Maximum pressure loss for both gas and liquid flow was 3.97 Pa. The pressure 
losses for each fibre were calculated and accounted for in the graphs shown in Section 5.3.3. 
Over the course of liquid permeation experiments ΔP fluctuated anywhere between 
approximately 0.001 – 0.004 barg, a range of 300 Pa. Large fluctuations across this range were 
seen between experiments, and minor fluctuations in this range occurred over a single 
experiment at a constant 1 ml/min inlet flow rate. Pressure fluctuation was attributed to 
changes in ambient temperature and pressure, and/or a minor elevation change along the 
bioreactor.  It was these larger day to day environmental changes that led to such wide x-axis 
error bars in liquid permeation data (Figure 5.16 – Figure 5.18) for comparisons between each 
NaCl percentage for permeability, resistance and Reynolds number respectively.  
Figure 5.13 and Figure 5.14 give the impression that fibre gas permeability and resistance was 
stabilising independent of ΔP, however a consistent increase in Reynolds number with ΔP 
shown in Figure 5.15 shows that this was not the case. A stabilisation effect would indicate 




that gas flow through the fibre had reached a critical point where the total pore area for gas 
transport had become a rate-limiting factor. However, given the high compressibility of 
nitrogen gas, this issue would not arise until a pressure well beyond that at which the fibre 
could operate before failure.  As discussed previously, calculation of Reynolds number was 
required to validate permeation data because Darcy’s law’s applicability was limited to 
laminar flow conditions, which was confirmed for all gas and liquid experiments (Figure 5.15 
– Figure 5.18 respectively) with Reynolds number being less than 2000 in every circumstance. 
The positive Reynolds number trend with ΔP was expected for gas permeation because for 
each fibre the gas viscosity and density are assumed to be constant at constant temperature, 
superficial gas velocity is a function of applied pressure, and average pore area and pore 
number are constant for a given fibre type. Such a trend would also be expected for liquid 
permeation had readings at several values of ΔP been achievable.  
Data for gas permeation generally showed increased permeation, decreased resistance and 
increased Reynolds number respectively as NaCl content increased. However on all three 
graphs the 20% and 40% plots were either out of sequence with this relationship or very close 
to one another. Liquid permeability also has 20% and 40% fibres out of step with the expected 
trend, with resistance and Reynolds number showing no correlation with NaCl content.  
From the results of ImageJ analysis on fibre surfaces shown in Section 5.3.1 the surface 
differences between 20% and 40% fibres were the most pronounced out of all ascending 
comparisons. As discussed in Section 5.3.1 on the inner fibre surface the pore coverage of a 
20% NaCl fibre (0.34 ± 0.15%) was significantly lower than a 40% NaCl fibre (0.82 ± 0.36%), 
and outer surface pore coverage for 20% NaCl (0.13 ± 0.06%) was less than 
40% NaCl (0.23 ± 0.05%) although not significantly so. No data displayed in Table 5.3 
indicates a reason why gas and liquid permeation of 20% and 40% fibres would be out of 
sequence with the general trend. From this is can be concluded that there are other intrinsic 
factors to the fibre that control permeability.  
5.4.3 Comparisons, Limitations and Error Analysis 
A property that was controlled poorly was fibre thickness. Manufacture of hollow fibres led 
to a non-central lumen, which yielded a non-uniform membrane thickness. Given the 
dependence of membrane thickness to calculate permeability and resistance, this leads to a 
high source of error which is not reflected in the error bars of the graphs in Section 5.3.3 as 
these assume an average thickness to correct for the manufacturing defect. In reality, 
permeation is most readily to occur through a path of least resistance, which is dependent on 
surface porosity, fibre tortuosity, and thickness. A sensitivity analysis investigating how 
recalculating permeation, resistance and Reynolds number data for the minimum and 




maximum thickness of the fibres (Appendix F), showed the same patterns were shown in 
Section 5.3.3 for average fibre dimensions. From this it can be concluded that the membrane 
thickness was not a limiting factor in gas and liquid permeation in this study. The fibre cross 
sections in Figure 5.12 showed an increased prevalence of macrovoids in thicker regions of 
the fibre; and as discussed in Section 5.2.1 the rate limiting layer of a hollow fibre is its primary 
porous layer (assuming penetration of the non-porous skin). Therefore the existence of 
macropore regions in the structure of hollow fibres with greater thicknesses does not restrict 
fluid flow. 
While it is apparent that the addition of NaCl allowed hollow fibres to gain pores which allow 
permeation to occur through their walls, it has not been confirmed as to what extent an open 
surface pore allows access to the porous centre of the fibre, which also connects with another 
open pore on its opposite surface. SEM imaging shows the existence of pores, and experiments 
have shown permeation, but this is not a proportional relationship. To some extent a degree of 
uncertainty during the phase inversion and NaCl leeching process is present that led to the 
non-proportional differences between permeation and NaCl content. In the case of 40% NaCl 
fibres the number of successful penetrations to the porous sublayer was fewer than that found 
in 20% NaCl fibres. Tortuosity must be considerably different between 20% and 40% fibres 
due to this. 
While the primary objective was to provide porosity to the non-porous outer skin layers of the 
fibres, a secondary effect of additional internal porosity was also noted. This is most obviously 
shown in cross sections of flat sheet membranes, where pores of similar dimension to those 
found on the outer surfaces can be seen on the inner surfaces. These inner pores would provide 
additional pathways for fluid to permeate through, and reduce the tortuosity of the fibre. 
Despite this occurrence, the addition of more NaCl during fibre manufacture should also 
increase the number of these internal pores as seen on both the bottom flat sheet and inner 
hollow fibre surfaces. Tortuosity of a membrane cannot be determined from 2D cross-
sectional imaging alone, so a value cannot be provided to compare between fibres with 
different NaCl content; however it can be concluded that any internal porosity gained from 
the additional NaCl is not significant enough to affect permeation if successful penetrations 
through the skin layer do not occur initially. 
Given the multitude of different methods used to make hollow fibres, the variations in 
manufacturing for the chosen method of wet spinning, polymer dope composition, 
solvent/non-solvent chosen, temperature and so on, a comparison with literature that may be 
misleading if many differences are present between fibres in this work and others.  




A batch of PLGA hollow fibre (50% DL-lactate/50% glycolide) was made from a dope 
containing 25% (w/w) of polymer in NMP, spun at 20 °C at a rate of 0.1 ml/min (Diban et al., 
2013). Spinneret needle and outer hole had diameters 0.6 mm and 1.2 mm respectively, with 
distilled water as the inner bore liquid at 0.30 ml/min and ethanol as the non-solvent in the 
coagulation bath. This led to manufacture of PLGA hollow fibres with 386 ± 34 µm ID and 
495 ± 35 OD, much smaller than the fibres featured in this chapter. No porogen was added. 
SEM imagery showed external pores in the region of 5 – 10 µm, non-uniformly distributed in 
localised regions of the fibre, indicating pore formation primarily occurring due to 
manufacturing inconsistencies. The author noted that while a high weight percentage of PLGA 
is required to give the dope the required viscosity to be spun, as stated by Ellis and Chaudhuri 
(2007), this also contributed to the low degree of surface porosity. Liquid permeation 
experiments were conducted, washing in 70% ethanol solution before applying ultrapure water 
at several pressures in a dead-end configuration. Permeation flux through this fibre was 
measured at 3.7 m3m-2h-1bar-1 ± 32.4%. This indicated that the porosity gained using the 
method outlined in Diban et al (2013) yielded a greater permeation flux then fibres with 
10% (1.21 m3m-2h-1bar-1 ± 33.7%) and 40% (2.00 m3m-2h-1bar-1 ± 60.1%) NaCl, however 
fibres with 20% (7.23 m3m-2h-1bar-1 ± 25.9%) and 60% (6.63 m3m-2h-1bar-1 ± 77.2%) NaCl 
showed greater permeation flux than (Diban et al., 2013). Back-calculating the permeation 
flux from Diban et al (2013) to obtain values for permeability using the average pressure drop 
for each fibre type shows 20%, 40% and 60% fibres made in this chapter have greater values 
for liquid permeation then Diban et al (2013) (Appendix G). 
Other works do feature manufacture of PLGA either with or without addition of additives to 
increase porosity. Some model the porosity using nitrogen gas permeation (Morgan et al., 
2007; Meneghello et al., 2009; Ellis and Chaudhuri, 2011), but the method used was 
unsuitable for use in this chapter. Calculating mean pore diameter and effective porosity 
(analogous to resistance) using the method outlined in these works lead to wildly differing 
results when compared to SEM imagery of the fibre surfaces shown in Section 5.3.1 and 
calculations of resistance through Darcy’s law on Table 5.4. Others have modelled the 
behaviour of fluid flow through PLGA hollow fibre bioreactors for a number of 
experimentally determined or assumed permeation values of the similar magnitude (2E-16 m2) 
as those calculated in Section 5.3.3, (Shipley et al., 2010).  
Wen and Tresco (2006) performed liquid permeation on PLGA hollow fibres with added pore-
forming agents, but characterised fibres in terms of their molecular weight cut off, and not 
their general permeability to water alone. No other works featuring the addition of different 
quantities of NaCl porogen to PLGA hollow fibres were found. Using PEG as a pore former 
for PLGA scaffolds as described by (Krok and Pamula, 2012) yielded non-porous scaffolds 




when replicated for this work. Permeability of PEG/PLGA scaffolds was not measured, so no 
comparison could be drawn with the porous fibres described in this chapter. 
5.5 CONCLUSONS 
The results in this chapter indicate that addition of ~9 µm sized NaCl crystals as a porogen to 
PLGA/NMP solutions yields scaffolds with surface pores of ~ 5 µm that are permeable to both 
gas and liquid. This was the first time this method of producing NaCl had been implemented 
to provide porosity to the surfaces of PLGA hollow fibres manufactured via immersion 
precipitation. Control experiments with no NaCl were non porous. From the experiments 
outlined in this chapter it has been concluded:  
i) Pores formed on the bottom surface of PLGA flat sheets and on both the inner 
and outer walls of PLGA hollow fibres as a direct result of NaCl addition. 
 
ii) Pore densities on the bottom surface of PLGA flat sheets and the inner wall of 
hollow fibre membranes were statistically similar between 10% and 20% NaCl, 
as well as between 40% and 60% NaCl, indicating a critical NaCl concentration 
that is thermodynamically and/or kinetically favourable for pore formation.  
 
iii) Pore sizes were generally different from one another on each surface at different 
NaCl contents, leading to a greater total area pore coverage on scaffolds with 40% 
NaCl compared to 60% NaCl. 
 
iv) Fibres with 20% and 60% NaCl displayed significantly greater degrees of 
permeability and flux of water compared to 10% and 40% NaCl fibres.  
 
v) The non-proportional relationship between NaCl content and fibre permeability 
indicates a limitation in permeation potential within the fibre structure that is not 
solely dependent on NaCl content. 
All other factors being equal, increasing NaCl content should yield greater surface porosities 
on membranes once human error is eliminated in setting up the hollow fibre spinning rig. An 
automated spinning system would eliminate some of these issues. Liquid permeation data 
would be improved if several different pressures could be applied to the fibre. Replacing some 
components in the liquid permeation rig may improve the scope of data that can be acquired. 
Further care should also be taken when preparing hollow fibres for SEM imagery, as some 
were compressed when cut and mounted. 




The next step in this work should be the application of permeable PLGA hollow fibres. 
Biodegradable and porous PLGA hollow fibres can allow for novel applications as cell 
delivery devices. The batches of porous fibres manufactured in this chapter may not be 
consistently porous with increasing NaCl, however that does not discount the fact that four 
batches of fibres with different permeabilities were manufactured.   
Section 2.3.3 outlined the limitations with current methods of engineered cell delivery, and 
suggested that the encapsulation of cells within the lumen of hollow fibres could be a novel 
development to try and improve the initial rates of cell delivery into a wound site in the heart. 
The porous PLGA hollow fibres characterised in this chapter will be investigated for their 
ability to sustain a population of cells within the hollow fibre lumen. This is a vital first step 
to determine the feasibility of this novel approach to cell delivery. That work is outlined in  













































6. CHAPTER SIX: CELL GROWTH WITHIN THE 
LUMEN OF A HOLLOW FIBRE 
6.1 INTRODUCTION 
The hollow fibre bioreactor is typically used to grow a population of cells on its external 
surface, facilitated by the perfusion of growth media permeating through the lumen of the 
hollow fibres to provide a low shear growth environment with minimal regions of stagnation 
that allow the removal of spent materials and cell by-products. It is their increased surface area 
to volume ratio, and continuous operation that make hollow fibre bioreactors a useful tool for 
cell growth.  
If grown into high enough quantities, cell populations can be transported via a delivery device 
into a patient for use as a cell therapy to regenerate damaged tissue. Such treatments are on 
the forefront of medical science, with stem cell therapy available to assist in the treatment of 
(but not limited to) heart disease, diabetes and a multitude of neurodegenerative conditions. 
In all cases, a suitable method for cell implantation must be utilised which enables efficient 
cell transport to the target area, and effective interaction between the implanted cells and the 
host tissue.  
Several different delivery methods are available, each with their advantages and disadvantages 
explained in detail in Section 2.3.3. In brief, delivery vectors are typically split into two 
categories – traditional and engineered. Traditional delivery involves direct cell administration 
to the target area either via a syringe, intravenously through the blood stream, or released 
through a catheter passed through the circulatory system; however each carry the risk of cell 
leakage from the site of injection, dilution of the cell dose, or complexity of administration 
respectively.  
Engineered delivery involves cell attachment on or suspension within an implantable 
biodegradable scaffold, with aim to improve upon the poor rates of cell retention around 
treatment sites found in traditional delivery methods. Such methods include, cellular sheets, 
hydrogels, or micro-fibrous threads; however each have their drawbacks. In cellular sheets, 
attached cells are detected in significant quantities in other organs and have poor rates of 
migration into the damaged tissue itself. Injectable hydrogels offer much promise with many 
tailorable properties and improved long term retention, however can suffer from immediate 
expulsion from the injection site if gelation is not achieved quickly – limiting the initial dose. 
Cells loaded onto the surfaces of tubular threads allow cell migration throughout the scaffold, 




however cells on its surface can be stripped off due to shear forces while being sewn into the 
wound site.  
This work proposes that porous hollow fibres can offer an advantageous geometry that allows 
the encapsulation of cell therapies while offering improved initial retention rates of cells after 
delivery into the infarct site of a human heart. During the research and development of 
scaffolds for this application it is important to identify early how a device made in the lab can 
be made into a product, and also useful to recognise issues involved in product handling or 
feasibility of use. The first step in this process is to see if a population of cells can be 
successfully encapsulated within the lumen of a hollow fibre and sustained.  
When treating patients suffering from an on-going heart condition the time to acquire the 
required concentration of cells must be short, the logistics of achieving that concentration must 
be relatively straightforward, and the implantation procedure to be as simple as possible for a 
surgeon.  This can be illustrated by describing how certain scaffolds would fit into this process, 
and discussing their advantages and drawbacks.  
If a flat sheet patch were desired then MSCs could be grown on the scaffold directly at close 
to 100% cell attachment efficiency, and then implanted into the patient; however this static 
environment would require manual media changes, provide a static growth environment which 
is disadvantageous for effective differentiation into cardiomyocytes if desired, and the low 
surface area to volume ratio of a flat sheet bioreactor system may require a larger scaffold to 
be implanted, increasing the complexity of the implantation procedure. Micro-fibrous threads 
contained in a bioreactor for external cell seeding would be similar to flat sheets as cells would 
grow in a static, non-continuous operation. Threads can be pre-attached to a needle and 
function as a surgical suture, offering a very simple method for implantation (Guyette et al., 
2013), but also lower cell implantation rates as cells are removed due to shearing as the suture 
is sown into the wound site. Cell growth within microbeads is achievable in both static and 
continuous flow regimes, however are typically inoculated into the wound site in a similar 
fashion to traditional delivery methods, leading to similar problems such as leakage and/or 
low cell dose concentrations.  Hollow fibres allow for simple cell seeding, cultivation, 
differentiation and removal in a continuous flow environment, with cells seeded on the 
external surface to achieve these benefits. However this leads to the same issues found on all 
other externally seeded scaffolds where cells can detach as a result of handling and 
implantation.  
In this chapter a potential solution is investigated. MG63 cells will be seeded within the lumen 
of the hollow fibre with media perfused through the extra capillary space permeating through 
the hollow fibre wall and feeding the cells on the inside. This would offer the same advantages 




associated with a continuous flow bioreactor but would protect the cells during future 
transportation and implantation, increasing the number successfully reaching the wound site.  
Cell number and viability, as well as D-glucose and L-lactate concentrations in the media were 
determined over a 6-day time course with two different ECS flow rates considered. PLGA 
hollow fibres with 60% NaCl by weight were used for in these experiments. Porosity and 
liquid permeation data for this specific hollow fibre is outlined in Section 5.3  Construction of 
the bioreactor and the method of cell seeding is explained in Section 3.3.6. 
6.2 CELL GROWTH THEORY 
6.2.1 Depletion of D-glucose 
For a cell to function and reproduce new cell material (biomass), a variety of nutrients 
(substrates) must be consumed. These substrates are provided by the cell growth media, which 
contains sources of carbon, nitrogen, minerals, vitamins and energy. In the growth media used 
in this work, D-glucose is the main source of carbon and energy, with amino acids (primarily 
L-alanyl-glutamine) providing a source of nitrogen (Invitrogen, 2015).  
MG63 cells are fuelled by aerobic respiration, a process which consumes substrates and 
oxygen to generate adenosine triphosphate (ATP), a store of chemical energy used to fuel 
metabolic pathways within the cell. Glucose is converted onto pyruvate with the assistance of 
an oxidised nicotinamide adenine dinucleotide (NADH) enzyme found within the cell and 
already available ATP in a process called Glycolysis. Pyruvate is oxidised using pyruvate 
dehydrogenase enzymes into acetyl coenzyme A (acetyl-CoA) in the presence of oxygen. 
Acetyl-CoA then enters the citric acid cycle (also known as the TCA or Krebs cycle), a series 
of enzyme driven reactions which yields a net increase of ATP as well as carbon dioxide and 
water as waste by-products (Bailey, 2016). In order to assist cell respiration, sodium pyruvate 
was supplemented into the cell media, as well as additional amino acids. This series of 
equations can be simplified to Equation 6.1 (Doran, 1995): 
𝑪𝟔𝑯𝟏𝟐𝑶𝟔(𝒂𝒒) + 𝟔𝑶𝟐(𝒈) → 𝟔𝑪𝑶𝟐(𝒈) + 𝟔𝑯𝟐𝑶(𝒍) + 𝒉𝒆𝒂𝒕 
Equation 6.1 – Simple aerobic respiration equation. 
For each mole of oxygen consumed, the heat of reaction is approximately -460 kJ/mol, 
therefore for each mole of glucose consumed -2,760 kJ/mol of energy is produced (Cooney et 
al., 1969). While this equation expresses how cells aerobically respire, it does not take into 
consideration additional cell biomass produced. Methods for establishing an equivalent 
stoichiometric equation describing this ‘reaction’ can be obtained by assuming the biomass as 
a physical quantity of C, H, O and N atoms and performing simultaneous ‘goal seeking’ 




equations. As an adequate atomic representation of MG63 cells could not be found this method 
was not utilised to model ideal theoretical cell growth. This method is fully explained by Roels 
(1980). 
6.2.2 Production of L-lactic acid 
If dissolved oxygen in media is consumed at a greater rate than it can be replaced from the 
atmosphere in an incubator, then anaerobic respiration will take place. In limited oxygen 
environments glycolysis cannot take place aerobically because NADH cannot be oxidised 
(RSC, 2011). Under such conditions NADH is oxidised by pyruvate, forming lactic acid 
(which disassociates to lactate) as a by-product, which accumulates. A simplified expression 
for the conversion of glucose to lactic acid is shown in Equation 6.2.   
𝑪𝟔𝑯𝟏𝟐𝑶𝟔(𝒂𝒒) → 𝟐 𝑪𝟑𝑯𝟔𝑶𝟑(𝒂𝒒) 
Equation 6.2 – Simplified equation for anaerobic respiration. 
Upon reintroduction of aerobic conditions lactate can then be oxidised back into pyruvate and 
glycolysis can continue as before; however if aerobic conditions do not resume the 
accumulation of lactic acid will lead to a decrease in pH, and the high concentrations of 
hydrogen ions will begin to negatively affect metabolic reactions and cell enzyme behaviour 
(Doran, 1995). Production of CO2 during aerobic respiration and its concentration within the 
media also contributes to lower pH.  
Lactic acid is one of the degradation products of PLGA, and its concentration from this source 
must be properly attributed in order to obtain accurate concentrations of lactic acid originating 
from cell metabolism. In this study this was achieved by performing suitable control 
experiments with no cells inoculated to determine the degree of PLGA degradation in the 
bioreactor.  
6.2.3 Oxygen Dependency 
Oxygen (O2) is required as part of aerobic respiration for cells to function and proliferate. A 
constant atmospheric environment consisting of approximately 75% N2, 20% O2 and 5% CO2 
at 37°C is provided to the cell bioreactors by an incubator. As discussed in Section 2.2.3, the 
dissolved oxygen content of blood provided to human heart tissue is 20.4% (AnaesthesiaUK, 
2005), making these incubator conditions appropriate for this experiment. The concentration 
of oxygen dissolved in the media is dependent on pressure, temperature and salinity, and can 
be calculated using Henry’s law. Henry’s law states that the amount of dissolved gas in liquid 
is proportional to its partial pressure. Henry’s constant (kH) for O2 at standard temperature and 
pressure (ϴ = 298 K, 1 atm) is 0.0013 mol/atm.L (Sander, 1999). The partial pressure of O2 




in the incubator is 0.20 atm and its molar mass is 32 g/mol. Therefore the amount of O2 in 
water at these conditions can be calculated in Equation 6.3: 
𝐶𝑂2 = 𝑘𝐻 . 𝑝𝑂2 
𝐶𝑂2 = 0.0013 [
𝑚𝑜𝑙
𝑎𝑡𝑚. 𝐿
] × 0.20[𝑎𝑡𝑚] × 32 [
𝑔
𝑚𝑜𝑙




𝑪𝑶𝟐 = 𝟖. 𝟑𝟐 𝒎𝒈/𝑳 
Equation 6.3 – Calculation of dissolved O2 in cell media using Henry’s Law. 
Salinity of the solution leads to a reduced dissolved oxygen concentration (Johnson, 2010). 
The cell media used for the experiments in this thesis is formulated with 6,400 mg/L NaCl as 
well as smaller concentrations of other salts, therefore Henry’s constant must be modified to 




) = 𝑘𝑠𝑒 . 𝐶𝑁𝑎𝐶𝑙    
Equation 6.4 – Henry’s Law with consideration for salinity. 
The Sechenov constant (kse), is derived empirically and relates how Henry’s constant changes 
with NaCl concentration. Jamnongwong et al. (2010) studied oxygen uptake in solutions of 
water at 25°C supplemented with NaCl at 6000 mg/L, and from that data a Sechenov constant 
of -2.278E-05 (-) can be determined at these conditions. Applying this value to Equation 6.4, 
an approximation for Henry’s constant of the media with similar salinity at standard 












log(𝐶𝑂2 𝑚𝑒𝑑𝑖𝑎) − log(8.32) = −0.1367 
log(𝐶𝑂2 𝑚𝑒𝑑𝑖𝑎) = 0.9201 − 0.1367 
𝑪𝑶𝟐 𝒎𝒆𝒅𝒊𝒂 = 10
0.7834 = 𝟔. 𝟎𝟕 𝒎𝒈/𝑳 
Equation 6.5 – Calculation of dissolved O2 in cell media using Henry’s Law with consideration for salinity. 
Oxygen is more readily soluble in liquids of a higher temperature (Sander, 1999). A measure 
of dissolved oxygen content at standard temperature and pressure can be modified to account 
for the elevated temperature in the incubator (310 K) as long as a value for the ratio of the heat 




of solution of oxygen (ΔHsol) to the gas constant (RG) is known. This value is 1500 K (Sander, 
1999). This is shown in Equation 6.6: 
𝐶𝑂2 = 𝐶𝑂2




















𝟑𝟏𝟎𝑲 = 𝟔. 𝟎𝟕 [
𝒎𝒈
𝑳
] 𝒆𝟎.𝟏𝟗𝟓𝟖 = 𝟕. 𝟑𝟕 𝒎𝒈/𝑳 
Equation 6.6 – Calculation of dissolved O2 in cell media using Henry’s Law with consideration for salinity 
and temperature. 
From these calculations the theoretical concentration of 7.37 mg/L O2 is available in the media 
during bioreactor operations in an incubator. As the media is continuously replenished with 
oxygen from the incubator, it is assumed that dissolved oxygen is not rate limiting to cell 
growth.  Dissolved oxygen concentration of the recirculating media reservoir will be measured 
after each time point, and used to monitor the overall health of the experiment, ensuring that 
no infections occur. Media infection would cause the dissolved oxygen within the bulk media 
to drop. In-line dissolved oxygen readings within the ECS and the lumen are not available.  
6.2.4 Permeation of Media into Hollow Fibre Lumen 
For cell proliferation experiments within hollow fibres it is assumed that the permeation of 
media from the ECS into the hollow fibre lumen occurs at the same flux as that calculated for 
permeation of water from within the lumen out to the ECS as investigated in Chapter 5. As 
pressure readings could not be taken during the cell proliferation experiments it was assumed 
that the pressure differential that drove permeation outwards was the same as that which would 
be required to cause permeation inwards. It was also assumed that the differing external pore 
coverage on the inner (0.68%) and outer (0.17%) surfaces of the hollow fibre were 
independent of this pressure differential; as the flow rate of media through a surface with a 
lower pore coverage would be same as that through a surface with a higher pore coverage at 
the same pressure difference. As shown in Table 5.5, hollow fibres with 60% salt content 
allowed a liquid flux (J) of 6.63 m3m-2h-1bar-1 (± 77.2%), or 0.0097 m3m-2h-1 (±65.3%), 
through a surface area (A) of 2.91 cm2 at an internal flow rate of 1 mL/min. The rate of 
permeation under these conditions can be calculated, as shown in Equation 6.7: 
𝑄𝑝𝑒𝑟𝑚 = 𝐽 × 𝐴 = 0.0097 [
𝑚3
𝑚2ℎ




Equation 6.7 – Rate of permeation through fibres at ECS flow rate of 1 mL/min. 




This is a permeation fraction of 4.7% ±3.1%. By comparing the D-glucose requirements of 
cells growing on flat sheet PLGA, an equivalent flow of media through the ECS of a hollow 
fibre bioreactor can be calculated to provide a similar quantity of D-glucose to cells seeded 
within the lumen of the hollow fibre.  
From cell growth experiments on flat sheet PLGA the average mass consumption (G) of 
D-glucose between Day3 and Day 6 was 0.70 mg/day. As the cell growth media had an initial 
D-glucose concentration (C) of 4.5 mg/mL, the volume of media required to provide the cells 


















Equation 6.8 – Flow rate of media permeation required for 0.70 mg/day D-glucose consumption.  
As the required media permeation rate for sufficient D-glucose supply is now known, and the 
expected permeation fraction through the hollow fibre has been calculated, the ECS flow rate 
required to facilitate the required permeation can now be calculated, as shown in Equation 6.9: 
















Equation 6.9 – Calculation of ECS flow rate required for desired permeation. 
For permeation of 0.11 µL/min, a minimum ECS flow rate of 2.29 µL/min is required to allow 
sufficient permeation of D-glucose into the lumen to sustain the cells. For the experiments in 
this Chapter ECS flow rates of 10 µL/min and 50 µL/min were set to provide permeation of 
0.47 µL/min and 2.35 µL/min respectively. These values are larger than the calculated 
minimum ECS flow of 2.29 µL/min for permeation of 0.11 µL/min. This is to ensure that 
D-glucose concentration does not become a rate limiting factor for cell growth.   
6.2.5 Cell Rolling/Shear 
It is assumed that the vast majority of cells seeded within the lumen of the hollow fibre will 
successfully settle onto the internal surface. The only exception would be from cells lost 
during the seeding process or those that leak out of the end of the bioreactor during the initial 
stages of operation when media permeation is initiated. A cell’s connection to a surface is 
governed by many factors including surface roughness, cell surface ligand concentration and 
surface charge. For this experiment it was assumed that the internal flow rate of permeating 
media would be insufficient to detach cells.  




6.2.6 Bioreactor Configuration 
The construction of the bioreactor with associated ancillary equipment and support structure 
is outlined in detail in Section 3.3.6. After cell seeding in the hollow fibre lumen the lumen 
inlet of the bioreactor is closed and a continuous flow rate of media at either 10 µL/min or 
50 µL/min is perfused through the ECS for the duration of cell growth. Both the ECS and 
lumen outlets were recycled back to the media reservoir.  Four bioreactors were operated in 
parallel, and each were removed and analysed on days 1, 3 and 6, with one bioreactor as a 
spare. A schematic of this configuration is shown in Figure 6.1. 





Figure 6.1 – Schematic of the hollow fibre bioreactor system for internal cell growth.





Control experiments for MG63 growth were performed on tissue culture plastic and on flat 
sheet porous PLGA in order to determine if the hollow fibre bioreactor configuration offered 
improved cell numbers over traditional growth methodologies. Individual wells or bioreactors 
were used to represent 1, 3 or 6 days growth. Viable cell count was characterised by 
trypsinisation of the scaffold and trypan blue staining, and total cell count quantified by 
performing picogreen assay. Concentration of D-glucose and L-lactic acid were obtained by 
performing their respective assays, taking into account a media change on Day 3 for static 
experiments. Dissolved oxygen and pH measurements were taken on the media reservoirs of 
hollow fibre bioreactor experiments on days 0, 1, 3 and 6 and used to determine if the media 
was infected and abort the experiment. These measurements could not be conducted on tissue 
culture plastic or PLGA flat sheet samples because of insufficient media volumes. The media 
within the lumen itself could not be analysed in-situ because in-line dissolved oxygen sensors 
were unavailable. Full details of these analytical methods are described in Section 3.4.1.      
6.3.1 Cell Growth on Tissue Culture Plastic 
Flat-bottom cell culture flasks with area 75 cm2 were seeded at a density of 34,407 cells/cm2 
on Day 0, and mixed with 20 ml media. This provided a specific volume of 3.75 cm2/mL cell 
media. Three individual flasks were seeded per experiment and each were counted for cells, 
checked for viability, and analysed for D-glucose and L-lactic acid concentrations on Days 1, 
3 and 6. The experiment was replicated four times, with counts and assays performed in 
triplicate for each day of the time course. A control flask with no cells seeded was also run 
alongside each experiment, which was replicated five times. 
Manual cell counting was performed after trypsinisation of the flask surface. Picogreen assay 
was performed at each step of the time course, however samples were not diluted enough 
which led to DNA fluorescence over the upper limit recommended by the manufacturer for 
reliable results. Cell media was not changed for the duration of the experiment. Initial 
D-glucose concentration of the media was measured as 4.50 ± 0.26 mg/mL, and initial 
L-lactic acid concentration was assumed to be zero, as it was not listed in the media 
formulation documentation (Invitrogen, 2015).  





Figure 6.2 – Cell growth on tissue culture plastic. Changes in viable cell density (including viability), 
D-glucose and L-lactic Acid concentrations over time. X error = ± 1 hour, Y error = SD (N=4, n=3). 
 
 
Table 6.1 – Average values of viable cell density, cell viability, D-glucose and L-lactic acid concentrations 











Av. SD Av. SD Av. SD Av. SD 
0 34,407 8,046 93.7% 2.7% 4.50 0.26 0.00 0.00 
1 26,746 5,851 97.6% 1.5% 3.90 0.15 0.48 0.47 
3 130,773 26,709 98.1% 1.1% 3.60 0.26 1.05 0.74 



































































Time (days) Viable Cell Density
D-glucose Concentration
L-lactic Acid Concentration




The data displayed in Figure 6.2 and Table 6.1 shows an increase in viable cell density over 
the time course. A slight drop in cell number occurs between Day 0 and Day 1 but this was 
within one standard deviation of the cell count on Day 0. After Day 1 cell number shows 
significant increases (P<0.05) by Day 3 doubling every 0.873 days, and by Day 6 doubling 
every 2.081 days.  
After seeding, cell viability remained consistent between Day 1 and Day 3, but dropped 
significantly (P<0.05) by Day 6. Reduction in viability and growth rate after Day 3 was likely 
due to cell over-confluence on the plastic surface, the depletion of D-glucose and increase of 
L-lactic acid present in the flask. This is confirmed by the decrease in media pH from 7.8 ± 0.2 
to 6.9 ± 0.1. Dissolved oxygen concentration remained constant at 7.9 ±0.1 mg/L over the 
time course. D-glucose was in high enough concentration until Day 3 to allow for a higher 
growth rate, but as it was consumed it became growth limiting.  
6.3.2 Cell Growth on PLGA Flat Sheet 
PLGA flat sheet scaffolds were attached to a custom 24 well plate as described in 
Section 3.3.4. Scaffolds were seeded with 100,000 ± 16,600 viable cells on Day 0 within a 
media inoculant of 21.5 µL and wells filled with 1 mL media. Available attachment area 
within each well was 1.88 cm2, providing a cell surface density of 53,191 ± 8,841 cells/cm2, 
and a cell media specific volume of 1.88 cm2/mL. Nine wells were seeded per scaffold, 
allowing for attached cells to be counted on Days 1, 3 and 6 in triplicate. An additional three 
wells that were not inoculated with cells acted as a control to detect any cell growth due to 
infection for each day of the time course. This experiment was replicated four times. 
On the desired day the 1 mL media was removed from the well and retained to detect for 
reductions in D-glucose and increases in L-lactic acid concentrations. L-lactic acid assays 
were performed on wells without cells to attribute L-lactic acid resulting from breakdown of 
the PLGA scaffold. Scaffold surfaces were trypsinised and the cells were manually counted 
and checked for their viability. Wells which were used for cell growth to Day 6 had their 
media changed on Day 3, with calculated concentrations of D-glucose and L-lactic acid on 
Day 6 adjusted to reflect this. Picogreen assay for DNA quantification was not undertaken 
over the time course as it was not possible to remove a sample of the scaffold from the custom 
well plate for the freezing process. 





Figure 6.3 – Cell growth on PLGA flat sheets. Changes in viable cell density (including viability), 
D-glucose and L-lactic Acid concentrations over time. X error = ± 1 hour, Y error = SD (N=4, n=3). 
 
 
Table 6.2 – Average values of viable cell density, cell viability, D-glucose and L-lactic acid concentrations 











Av. SD Av. SD Av. SD Av. SD 
0 53,191 8,841 94.7% 1.9% 4.50 0.26 0.00 0.00 
1 30,634 4,997 88.1% 5.3% 4.24 0.24 0.18 0.03 
3 129,285 21,419 93.2% 4.3% 4.21 0.24 0.47 0.05 
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The data shown in Figure 6.3 and Table 6.2 show an increase in viable cell density over the 
six-day time course experiment. The number of cells significantly increase between Day 1, 3 
and 6 (p<0.05), however only 58% of cells of the original inoculant remained after one day, 
far outside the standard deviation range of Day 0. This consistent trend with a small standard 
deviation could be attributed to insufficient mixing of inoculant solution prior to seeding, or 
due to insufficient washing of the membrane surface after sterilisation with 70% ethanol, 
leading to death of some cells.  
Cell viability significantly changed between each day (P<0.05): decreasing between Day 0 
and Day 1, increasing between Day 1 and Day 3, before decreasing again between Day 3 and 
Day 6. This corresponds to the concentrations of D-glucose and L-lactic acid within each well. 
D-glucose concentration remains consistent from Day 1 through to Day 3 as viable cell density 
quadruples, doubling every 0.963 days. A significant drop (P>0.05) in D-glucose 
concentration between Day 3 and Day 6 corresponds to a reduction in the rate of cell growth, 
now doubling every 1.874 days, with growth rate decelerating due to the limiting 
concentration of D-glucose despite a media change on Day 3. L-lactic acid concentration 
consistently increases over the 6 days as viable cell density increases. During this experiment 
an average of 0.090 mg/mL L-lactic acid per day is produced from PLGA breakdown.  
6.3.3 Cell Growth within Hollow Fibre Lumen 
The lumen of the hollow fibre was seeded with cells, mounted into a tubular glass housing, 
and connected to a circuit of tubing with a continuous flow of media passing through. The full 
seeding and assembly process is described in Section 3.3.6. The usable length of hollow fibre 
was 10 cm and had an internal diameter of 0.925 mm, with a corresponding internal surface 
area of 2.91 cm2 and lumen volume of 67.2 µL. The internal volume of the glass bioreactor 
was 0.69 mL. 100,000 cells were seeded into the hollow fibre lumen in an inoculant of 
67.2 µL, providing an internal surface cell density of 34,407 cells/cm2. Three bioreactors were 
seeded per experiment, each representing either 1, 3 or 6 days of growth. Experiments were 
replicated four times (N=4, n=1). 20 mL of media was circulated through each bioreactor 
through the extra capillary space between the outer hollow fibre surface and the glass housing 
at either 10 µL/min or 50 µL/min. 
 Control Experiments 
Initial control experiments were undertaken to account for any differences that arose between 
the flat sheet and hollow fibre configurations; the first of which featured media perfusion 
through an empty bioreactor. This would provide a measure for any cells present in the system 
from insufficient sterilisation or accidental infection over the six day time course. One time 
course experiment was done for each of the two flow rates chosen (N=1, n=1).  



















Av. SD Av. SD Av. SD Av. SD 
0 0 21.4% 0 21.4% 4.50 0.26 0.000 0.000 
1 69 20.0% 16 20.0% 4.56 0.30 0.064 0.011 
3 176 32.5% 42 32.5% 4.75 0.33 0.072 0.000 
6 181 23.6% 43 23.6% 4.38 0.30 0.092 0.022 
Picogreen assay on the 20 mL cell media showed a very small DNA absorbance reading, 
indicating some form of DNA is present in the system throughout the time course, although 
none could be seen during manual counting. Using a ratio of the bioreactor volume and the 
total volume of media in the system, an equivalent cell density that could potentially be 
attached to a hollow fibre and affect results of seeded experiments was shown to be no more 
than 43 cells/cm2. This population did not affect the D-glucose concentration in the system, as 
the average reading of each day is within the standard deviation of the Day 0 D-glucose 
reading. 
A second control experiment was performed with unseeded hollow fibres to determine the 
quantity of L-lactic acid over six days due to break down of PLGA. One time course 
experiment was done for each of the two flow rates chosen (N=1, n=1), and an average is 
shown in Table 6.4. 















Av. Error Av. Error Av. Error Av. Error 
0 0 0 0 0 4.50 0.26 0.000 0.000 
1 218 188 52 848 4.20 0.14 0.116 0.031 
3 180 117 43 524 4.21 0.23 0.132 0.041 
6 292 290 69 928 4.25 0.05 0.064 0.003 
This experiment showed a slightly larger cell concentration in the media than the previous 
control experiment, indicating a small population of cells remained within the hollow fibre 
after overnight ethanol sterilisation.  D-glucose concentration decreased between Day 0 and 
Day 1, and was maintained through to Day 6. L-lactic acid concentration is larger than, or 
equal to, that found in the media only control, indicating that some degree of breakdown of 
PLGA occurs in this configuration. This is equivalent to an average of 0.056 mg/mL and 




0.080 mg/mL L-lactic acid per day at 10 µL/min and 50 µL/min respectively, less than the 
0.090 mg/mL per day on flat sheet PLGA. This remains consistent after normalising for 
available external scaffold surface area. 
 Seeded Bioreactors 
The data shown in Table 6.3 and Table 6.4 was used to normalise the seeded hollow fibre 
experiments so that rates of cell attachment, D-glucose depletion and L-lactic acid formation 
could be exclusively attributed to cell growth. All three bioreactors in the time course were 
pumped with 20 mL media at either 10 or 50 µL/min. Each time course for both flow rates 
were replicated four to eight times, half were trypsinised and counted manually to characterise 
viable cell count, and half underwent picogreen assay to quantify total cell count. The four 
bioreactors that were trypsinised were also tested for D-glucose and L-lactic acid 
concentrations. 
 
Figure 6.4 - Cell growth within PLGA hollow fibres at 10 µl/min. Changes in cell density (including 
viability), from manual counting and picogreen assay, D-glucose and L-lactic Acid concentrations over 








































































Table 6.5 – Average values of cell density, cell viability, D-glucose and L-lactic acid concentrations during 
cell growth within PLGA hollow fibres at 10 ml/min external flow rate. 
Day 














Av. SD Av. SD Av. SD Av. SD Av. SD 
0 34,407 0 34,364 0 94.7% 0.0% 4.50 0.26 0.000 0.000 
1 869 581 44,171 49,358 2.0% 1.3% 4.22 0.16 0.050 0.042 
3 782 687 43,209 20,737 1.8% 1.0% 4.24 0.20 0.028 0.027 
6 320 270 48,235 60,141 0.7% 1.5% 4.18 0.13 0.124 0.123 
Time course data for bioreactors fed with 10 µL/min media is shown in Figure 6.4 and Table 
6.5. After seeding on Day 0 the average viable cell density by Day 1 dropped to 2.0% of that 
seeded, dropping further to 1.8% by Day 3 and 0.7% by Day 6. The total number of cells 
(viable and non-viable) remained constant between Day 1 and Day 6, but the percentage of 
viable cells decreased from 94.7% on Day 0 to 2.0% on Day 1. D-glucose concentration 
decreases between Day 0 and Day 1, indicating that some degree of cell respiration occurred 
within the initial 24 hours, however the concentration of D-glucose does not change after 
Day 1 due to the sudden reduction in cell viability. L-lactic acid concentration increases from 
zero on Day 0 to 0.05 mg/mL on Day 1, indicating that anaerobic respiration occurred quickly 
after seeding. This indicates that insufficient dissolved oxygen was reaching the cells in the 
lumen at an ECS flow rate of 10 µL/min. 






Figure 6.5 – Cell growth within PLGA hollow fibres at 50 µl/min. Changes in cell density (including 
viability), from manual counting and picogreen assay, D-glucose and L-lactic Acid concentrations over 
time. X error = ± 1 hour, Y error = SD (N=2, n=1). 
 
Table 6.6 – Average values of cell density, cell viability, D-glucose and L-lactic acid concentrations during 
cell growth within PLGA hollow fibres at 50 µl/min external flow rate. 
Day 














Av. SD Av. SD Av. SD Av. SD Av. SD 
0 34,407 0 34,364 0 93.2% 0.0% 4.50 0.26 0.000 0.000 
1 1,529 1,953 22,906 18,863 6.7% 8.5% 4.33 0.19 0.033 0.041 
3 2,098 3,051 35,733 3,609 5.9% 8.5% 4.16 0.22 0.031 0.040 
6 1,307 265 4,275 517 30.5% 6.2% 4.08 0.06 0.197 0.071 
Time course data for bioreactors fed with 50 µL/min media is shown in Figure 6.5 and Table 
6.6. Once again, the number of viable cells rapidly decreases between Day 0 and Day 1, 
however the number of viable cells at Day 1 is 6.7% of the seeded quantity, triple that which 
survived at 10 µL/min. Total number of cells remains constant (accounting for error) between 
Day 0 and Day 3, with a drop between Day 3 and Day 6. D-glucose consumption occurs at a 
faster rate between Day 0 and Day 1, as does L-lactic acid production indicating again that the 





































































24 hours. The remaining viable cells up to Day 6 explain the continuing decline in D-glucose 
consumption, however the increase in L-lactic acid concentration at Day 6 is likely evidence 
of a small infection in those bioreactors. As a different bioreactor is used for each part of the 
time course, this would not affect the results of previous days.    
6.4 DISCUSSION 
6.4.1 Proliferation on Flat Surfaces 
Cell seeding on static flat sheet PLGA scaffolds has shown to produce comparable viable cell 
densities over six days to those seeded on tissue culture plastic, as can be seen in the data 
shown in Figure 6.2 and Figure 6.3. Despite the larger initial seeding density used on PLGA 
scaffold (53,191 ± 8,841 cells/cm2) compared to tissue culture plastic 
(34,407 ± 8,046 cells/cm2), the Day 1 viable density of cells was 30,634 ± 4,997 cells/cm2 and 
26,746 ± 5,851 cells/cm2 respectively. Aside from the initial seeding density, comparing both 
surfaces on each day show no significant differences between the two, implying that growth 
on PLGA flat sheets provides comparable cell densities to those grown on tissue culture plastic 
over six days.  In other studies where MG63 cells were seeded on PLGA with tissue culture 
plastic as a control, cells on PLGA had a shorter cell doubling time (Pamula et al., 2009). This 
has also been noted in studies of cell growth on polysulphone (Stankova et al., 2014), however 
tissue culture growth has been shown to be better than on poly(esterurethane) (Podporska-
Carroll et al., 2014). 
Table 6.1 and Table 6.2 indicate that both PLGA and tissue culture plastic showed shorter cell 
doubling times between Days 1 and 3 (0.963 and 0.873 respectively) than between Days 3 and 
6 (1.874 and 1.388 respectively). This can be attributed to the increasing confluence of the 
cell monolayer on the surface, and likely formation of additional cell layers hindering transport 
of oxygen and media nutrients to the original monolayer, leading to increasing apoptotic 
signalling from any dying cells underneath.  
This is confirmed by the depletion of D-glucose and production of L-lactic acid in both 
systems, however these concentrations change at a faster rate in the tissue culture flask 
compared to the PLGA flat sheet. Both surfaces had the same initial concentration of 
D-glucose in media available, but both had different volumes of media in each system. A 
sample of PLGA flat sheet within the custom well plate had a seeding area of 1.88 cm2 and 
1 mL media available, providing a specific area of 1.88 cm2/mL; whereas the tissue culture 
plastic within a T75 flask had a seeding area of 75 cm2 and was provided with 20 mL media, 
for a specific area of 3.75 cm2/mL; with both being changed on Day 3 with an equal amount 
of media as previous. Tissue culture plastic had a relatively greater volume of media available 
throughout the time course, and therefore a larger quantity of dissolved oxygen. The growth 




in the tissue culture flask resulted in larger D-glucose consumption and L-lactic acid 
production despite having similar cell densities over from Day 1 and Day 6 to cell growth on 
PLGA. Cells grown on the PLGA scaffold were exposed to less L-lactic acid than on tissue 
culture plastic even when accounting for the extra lactic acid formed from PLGA breakdown. 
This can be attributed to the increased specific volume of the media in the tissue culture flask 
allowing a greater quantity of L-lactic acid to reside in the media relative to the media in the 
well of a PLGA flat sheet.  
Studies comparing the data in Figure 6.2 with other studies of MG63 cell growth on tissue 
culture plastic are collected in Table 6.7. To allow as near a comparison as possible the data 
was constrained to cell growth between days 1 and 3 for most studies. Cell doubling time was 
rarely directly stated in these studies, and on many occasions had to be inferred from 
absorption data changes between day 1 and day 3 from a variety of cell quantification methods. 
For the majority of studies listed an initial rate of cell attachment was not stated, with many 
opting for a Day 1 value as the first check on cell viability. Day 1 cell values were typically 
non comparable with initial seeding values in these studies because the corresponding 
absorption test was not performed on an initial cell sample, so were not an accurate reflection 































34,470 78% (24h) 0.873 Day 1 - 3 Manual count 
Zhou et al. 
(2016) 
3,125 Unknown 2.000 Day 1 - 3 WST-8 Assay 
(Skindersoe et 
al., 2015) 
21,053 Unknown 1.220 Day 0 - 3 MTS Assay 
Podporska-
Carroll et al. 
(2014) 
26,316 Unknown 1.041 Day 1 - 3 
Picogreen Assay 
 
Stankova et al. 
(2014) 
2,830 43% (24h) 1.200 Day 1 - 3 Cell counter 
Wang et al. 
(2011a) 
10,526 80% (6 h) 2.424 Day 1 - 3 WST-1 Assay 
Zhao et al. 
(2009) 
Unknown Unknown 1.300 Day 1 - 3 MTT Assay 
Amaral et al. 
(2008) 
10,000 Unknown 2.391 Day 1 - 3 MTT Assay 
Pamula et al. 
(2009) 
100,000 45% (24h) 4.314 Day 1 – 3 Cell counter 
Zhao et al. 
(2006) 
9,600 Unknown 1.002 Day 0 - 5 Cell counter 
The cell doubling time in this work is shorter than that published in (or inferred from) other 
works; which can be attributed to the larger initial cell seeding density. This would allow 
greater initial cell contact and signalling that would accelerate the formation of a cell 
monolayer. Cell attachment after 24 hours was greater than the other comparable works of 
Stankova et al. (2014) and Pamula et al. (2009) with 43% and 45% efficiency respectively.  
A comparison of the data displayed in Figure 6.3 for MG63 growth on flat sheet PLGA with 
that found in literature is displayed in Table 6.8. As so few other studies of seeding MG63 
cells on PLGA could be found, comparison is also drawn with MG63 cells grown on other flat 
sheet polymeric scaffolds. The same limitations on data comparison that were discussed 









Table 6.8 – Growth of MG63 cells on flat sheet PLGA and other polymers in various studies. 
Source 














This work PLGA (75:25) flat sheet, with 
added NaCl for salt leaching. 
Dissolved in NMP solvent (20:80 
wt%) and phase inverted in water 
non-solvent. 
34,470 58% (24h) 0.963 1 – 3  Manual 
Count 
Vandrovcova 
et al. (2011) 
PLGA (85:15) flat sheet, 
dissolved in methylene chloride 
solvent (10:90 wt%) and left to 
evaporate in air 
17,000 100% (24h) 1.181 1 – 3  Cell 
counter 
Pamula et al. 
(2009) 
PLGA (85:15), flat sheet, with 
added NaCl for salt leaching. 
Dissolved in methylene chloride 
(10% w/v) and left to evaporate 
in air 
100,000 32% (24h) 3.542 1 – 7 Cell 
counter 
Liu et al. 
(2009) 
Poly(L-lactic acid) dissolved in 
an undisclosed solvent and phase 
inverted in an undisclosed non-
solvent 
6,494 Unknown 2.319 1 – 3 LDH 
Assay 
Cecen et al. 
(2015) 
3D Collagen scaffold coated in 
poly-L-lactic acid. Polymer 
dissolved in chloroform (4:96 
wt%), and phase inverted in 
ethanol. 
Unknown Unknown 1.165 1 – 3 MTT 
Assay 
Podporska-
Carroll et al. 
(2014) 
Poly(ester urethane) flat sheets, 
With added NaCl for salt 
leaching. Dissolved in a solution 
of N,N-dimethylformamide–N 
and N-dimethylacetamide and 
phase inverted in water 




Polysulphone dissolved in 
dichloromethane (0.1 g/mL), 
poured into mould to evaporate in 
air 
2,830 35% (24h) 1.042 1 – 3  Cell 
counter 
Salerno et al. 
(2012) 
Poly(ε-caprolactone) plates (1-
2mm thick) melted and 
compression moulded.  






methacrylate) sheet. Unknown 
method of manufacture 
5,405 7% (1h) 
16% (3h) 




20% Poly(etherimide) flat sheet 
with porous bottom surface. 
Dissolved in NMP solvent (20:80 
wt%), and phase inverted in a 
solution of 30% NMP and 70% 
methylene chloride. Soaked in 
Acetone, then water  
26,316 Unknown 1.409 1 – 4 MTT 
Assay 
Lee et al. 
(2004) 
Commercial Polycarbonate sheet 
with 5um pores and 7.2% pore 
surface coverage. Unknown 
method of manufacture. 
Unknown Unknown 1.793 2 – 4 Manual 
count 




Cell doubling time of MG63 cells grown on porous PLGA flat sheets with 60% NaCl by 
weight is shorter in this work when compared to other PLGA studies. Vandrovcova et al. 
(2011) produced PLGA flat sheets of 85:15 lactide to glycide ratio dissolved in methylene 
chloride by 10% weight and left to dry in air, and cultured MG63 cells had a cell doubling 
time of 1.181 days. Pamula et al. (2009) prepared PLGA scaffolds the same way, but added 
NaCl particles that yielded pore sizes in the range of 200 – 600 µm, two orders of magnitude 
larger than those formed in PLGA flat sheets described in this thesis. The PLGA sheets of 
various had similar to worse cell doubling times between day 1 and day 7, all of which were 
longer than the cell doubling time of cells grown on porous PLGA sheets in this work of 
0.963 days, however by day 15 cell numbers were twice as large as that found on the non-
porous PLGA, owing to the larger internal surface area now available for cell proliferation. 
Studies on PLA as well as other polymeric flat sheets all show a greater cell doubling time in 
comparison to the porous PLGA used in this study. Lee et al. (2004) utilised a commercially 
available polycarbonate sheet manufactured with 5 µm diameter pores and surface pore 
coverage of 7.2%, and had a cell doubling time twice that of the PLGA in this work with an 
average pore size of 5.0 ± 3.8 µm and coverage of 1.44% ± 0.20%. This higher pore coverage 
would lead to a reduced available surface area for cells to spread across and grow, which 
would explain the higher cell doubling time if the available surface area were filled sooner.   
6.4.2 Proliferation within Hollow Fibres 
The graphs displayed in Figure 6.4 and Figure 6.5 illustrate that cell growth within hollow 
fibres is not achievable under the tested conditions. Within 24 hours viable cell density 
decreased to 2.0% and 6.7% at 10 µL/min and 50 µL/min respectively. While this does 
indicate that, at least over this time frame, the greater ECS flow rate provided a slightly better 
cell survival rate, overall permeation of media from the ECS to the lumen was insufficient.  
ECS flow rates were set assuming that the permeation of D-glucose was the rate limiting factor 
in cell respiration. It was originally assumed that sufficient dissolved oxygen would permeate 
through with the D-glucose in the media, as well as diffuse to the lumen from the ECS. It is 
clear that this assumption was in error, and that the rate of diffusion for dissolved oxygen in 
this system combined with permeating dissolved oxygen was insufficient. It is likely that this 
led to anaerobic conditions in the lumen and subsequent acidification of the media in the 
lumen, making the cells non-viable. In this section the diffusion of dissolved oxygen and L-
lactic acid to and from the lumen will be quantified, and a mass balance of these species will 
be performed to quantify their deficit and accumulation in the lumen respectively. From this 
a new minimum ECS flow rate will be calculated to provide sufficient dissolved oxygen 
permeation to the lumen. 




 Dissolved Oxygen Mass Balance  
Given that the rate of liquid permeation at an ECS flow rate of 50 µL/min is 2.35 µL/min (Q), 
and the concentration (C) of dissolved oxygen in the media is 7.37 mg/L, the mass flow rate 
(G) of dissolved oxygen at that ECS flow rate can be calculated in Equation 6.10: 
𝐺𝑂2 = 𝑄𝑂2 × 𝐶𝑂2 = 50 [
µL
min
] × 7.37 [
𝑚𝑔
𝐿




Equation 6.10 – Mass flow rate of dissolved oxygen permeating into the lumen.  
At 50 µL/min a mass flow rate of 0.03 mg/day dissolved oxygen permeates into the lumen. 
To further quantify the movement of oxygen in this system, diffusion of oxygen from the ECS 
to the lumen must be considered.  
The rate of diffusion of dissolved oxygen from the ECS into the lumen, as well as the rate of 
diffusion of lactate from the lumen to the ECS can be characterised using a simplified 1D 
Fick’s law model for diffusion flux (J) with knowledge of the diffusivity (D) of both species 
in a hollow fibre system. This is visualised in Figure 6.6. 
 
Figure 6.6 – Cross section of hollow fibre bioreactor indicating oxygen and lactate diffusivities at each 
point. 
The values for oxygen diffusivity in the ECS of a hollow fibre were system were obtained 
from Ye et al. (2006). Diffusivity of oxygen in the bulk ECS media is 3E-09 m2/s. Ye et al. 
(2006) also suggested that the hollow fibre itself hindered diffusion by a factor of 10, and that 
bone cells hindered diffusion by a factor of 5, providing diffusivity values of is 3E-10 m2/s 
and 6E-10 m2/s respectively. Holm et al. (1981) suggests that the diffusivity of lactate in the 
ECS would be 1.4E-09 m2/s, and Eggleton et al. (1928) determined that the diffusivity of 
lactate through muscle cells is 6E-09 m2/s. No value for diffusivity of lactate through the 
hollow fibre has been determined, however Shipley and Waters (2012) assumed a similar 




factor of 10 hindrance as used for oxygen diffusion through the hollow fibre. All stated values 
for oxygen and lactate diffusivity have been used by Shipley et al. (2011) to model fluid and 
mass transport of these species within a hollow fibre bioreactor system. The modelling in this 
section is greatly simplified by utilising a 1D Fick’s law model for diffusion flux, along with 
the values of diffusivity stated, and knowledge of the dimensions of the hollow fibre system.  
An idealised mass flow rate of dissolved oxygen through the hollow fibre by diffusion is 
calculated in Equation 6.11, assuming that the media in the ECS has a dissolved oxygen 
concentration of 7.37 mg/L, and the dissolved oxygen in the lumen is completely exhausted 
at 0 mg/L. While it is likely that dissolved oxygen in the lumen is greater than zero, assuming 
zero provides the greatest possible concentration gradient, which results in the greatest 
possible diffusion flux of oxygen, which is an important limitation to quantify. The fibre is 
0.138 mm thick (x) with a surface area (A) of 2.91 cm2. The diffusivity of oxygen through the 
































Equation 6.11 – Fick’s law for maximum diffusion flux of dissolved oxygen through the hollow fibre wall. 
This indicates that from diffusion alone, at a maximum possible concentration gradient a 
maximum of 0.40 mg/day oxygen permeates through the hollow fibre. This is much greater 
than the 0.03 mg/day that has been calculated to permeate into the lumen at an ECS flow of 
50 µL/min. To complete the oxygen balance and to determine the oxygen deficit in this 
system, the consumption rate of oxygen by the cells needs to be calculated.  
First the known mass consumption of D-glucose (0.70 mg/day) is converted into a molar 















Equation 6.12 – Calculation of molar daily consumption of D-glucose. 




Referring to the stoichiometric reaction for aerobic cell respiration shown in Equation 6.1, 
1 mole of D-glucose reacts with 6 moles of oxygen to produce the energy required to facilitate 
cell function. Knowing this, the molar daily consumption of oxygen can be calculated, along 
with the mass daily consumption, as shown in Equation 6.13.  
𝑁𝑂2 = 6 × 𝑁𝑔𝑙𝑢𝑐𝑜𝑠𝑒 = 6 × 0.0039 [
𝑚𝑀𝑜𝑙
𝑑𝑎𝑦




𝐺𝑂2 = 𝑁𝑂2 ×𝑚𝑤𝑂2 = 0.0232 [
𝑚𝑀𝑜𝑙
𝑑𝑎𝑦
] × 32.00 [
𝑔
𝑀𝑜𝑙




Equation 6.13 – Calculation of mass daily consumption of dissolved oxygen. 
Note that Equation 6.1 does not account for the requirements for production of additional 
biomass, only respiration of cells; however as empirical measurement of dissolved oxygen 
consumption could not be undertaken with flat sheet PLGA growth samples, Equation 6.1 has 
been used as a substitute. The mass balance of oxygen in the lumen over the initial 24 hours 
has now been completed, and is summarised in Table 6.9. 
Table 6.9 – Mass balance on dissolved O2 in the lumen 
dO2 Consumption Rate 0.74 mg/day 
dO2 Diffusion Rate In 0.40 mg/day 
dO2 Permeation Rate In 0.03 mg/day 
dO2 Deficit 0.31 mg/day 
Time until dO2 Exhausted 0.57 days 
Between Day 0 and Day 1 there is a deficit of 0.31 mg/day dissolved oxygen. From this a new 
value for ECS flow rate can be calculated in order to provide enough oxygen to balance with 
the consumption rate of 0.74 mg/day. Given the concentration of dissolved oxygen in the 
media is 7.37 mg/L, the equivalent volume of cell media consumed over time by the cells in 


















Equation 6.14 – Calculation of volume media consumption of dissolved oxygen. 
From the liquid permeation experiments outlined in Chapter 5, the 60% NaCl PLGA hollow 
fibres selected for this experiment provide a permeation of 4.70% of the feed rate. Given this 
ratio, and the requirement for a minimum media permeation flow of 69.96 µL/min, the 
equivalent ECS flow rate to achieve that degree of permeation can be calculated, as shown in 
Equation 6.15: 










] = 1487.05 [
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Equation 6.15 – Calculation of ECS flow rate for sufficient dissolved oxygen permeation. 
For sufficient permeation to ensure that dissolved oxygen is not the rate limiting factor in cell 
growth, an ECS flow rate of 1.49 mL/min is required to ensure a permeation of 69.96 µL/min. 
This is much greater than the original minimum ECS flow rate when D-glucose was assumed 
to be rate limiting (2.29 µL/min) as well as the actual selected flow rates (10 µL/min and 
50 µL/min). This is because the concentration of dissolved oxygen in the media (7.37 mg/L) 
is much smaller than the concentration of D-glucose (4,500 mg/L), as well as factoring in the 
much smaller molecular weight of molecular oxygen (32.00 g/mol) compared to D-glucose 
(180.16 g/mol) and how that affects molar requirements for cells.  
 L-lactic acid Mass Balance  
So far it has been established that there is a dissolved oxygen deficiency in the bioreactors 
tested, however the impact of the low oxygen environment and cell death over 24 hours has 
not been directly linked. In order to do this the production of L-lactic acid from anaerobic 
respiration needs to be characterised, and how the pH within the lumen changes.  
Assuming that the cells respire aerobically for so long as there is available dissolved oxygen, 
then respire anaerobically when the dissolved oxygen is exhausted, aerobic respiration occurs 
for the first 0.57 days, then anaerobic respiration for the remaining 0.43 days. As shown in 
Equation 6.2 in Section 6.2.2, anaerobic respiration produces 2 mol of lactic acid from 1 mol 
of D-glucose. Assuming that the rate of D-glucose consumption is the same during aerobic 
and anaerobic conditions (0.0039 mMol/day), the molar and mass rate of L-lactic acid 
production can be calculated as shown in Equation 6.16. 




𝐺𝐿𝐴 = 𝑁𝐿𝐴 ×𝑚𝑤𝐿𝐴 = 0.0033 [
𝑚𝑀𝑜𝑙
𝑑𝑎𝑦
] × 90.08 [
𝑔
𝑀𝑜𝑙




Equation 6.16 – Calculation of mass daily L-lactic acid production,  
The MG63 cells in the lumen produce 0.30 mg/day L-lactic acid between Day 0 and Day 1. 
This rate of production contained in such a small volume will likely decrease the pH, making 
conditions much too acidic for cell growth to continue. The maximum concentration of L-
lactic acid in the lumen is calculated in Equation 6.17. 
 











Equation 6.17 – Calculation of concentration of L-lactic acid in the lumen. 
However, L-lactic acid can diffuse away from a higher concentration in the lumen, to a region 
of lower concentration in the circulating media flowing in the ECS. Using the simplified 1D 
Fick’s law model again, a mass flow rate of L-lactic acid leaving the lumen through the hollow 
fibre can be calculated. This assumes an L-lactic acid concentration of 4.43 mg/L within the 
lumen, and zero in the ECS, again to characterise the maximum possible rate of diffusion. The 
fibre is 0.138 mm thick with a surface area of 2.91 cm2, and the diffusivity of L-lactic acid 
(DLA) through the hollow fibre is 1.4E-10 m2/s (Shipley and Waters, 2012). This calculation 































Equation 6.18 – Fick’s law for maximum diffusion flux of L-lactic acid through the hollow fibre wall. 
From this data we can determine the accumulation of L-lactic acid within the lumen over the 
initial day. This is summarised in Table 6.10. 
Table 6.10 – Mass balance on L-lactic acid in the lumen 
L-lactic Acid Production Rate 0.30 mg/day 
L-lactic Acid Diffusion Rate 0.11 mg/day 
L-lactic Acid Accumulation 0.19 mg/day 
Now that the mass of L-lactic acid accumulating within the lumen over the first day has been 
calculated, the pH change of the media within the lumen can be determined. To do this a value 
for dissolved H+ ions in the media solution must be calculated. This can be done through 
knowledge of the equilibrium reaction for L-lactic acid disassociation. L-lactic acid 
disassociates into a lactate ion and hydrogen ion, as shown in Equation 6.19. 
 𝑪𝟑𝑯𝟔𝑶𝟑 ↔ 𝑪𝟑𝑯𝟓𝑶𝟑
− +𝑯+ 
Equation 6.19 – Disassociation of L-lactic acid. 
 










Equation 6.20 – Equilibrium constant of L-lactic acid disassociation.  
This expression can be simplified by using relative molar rates of change for this reaction. 
This is summarised in a RICE chart, shown in Table 6.11. 
Table 6.11 – A RICE chart to assist in calculating [H+]. 
Reaction [C3H6O3] [C3H6O3-] [H+] 
Initial Concentration Ca 0 0 
Change -X +X + X 
Equilibrium Ca - X X X 
The reaction components can be replaced in Equation 6.20 with the relative changes ‘X’. This 
expression can then be reorganised into a quadratic equation allowing the concentration of H+ 
in the lumen to be calculated. In this system, Ca is 0.03 mol/L, and the disassociation constant 





[𝑋]2 + 𝐾𝑎[𝑋] − 𝐾𝑎𝐶𝑎 = 0 
[𝑋] = [𝐻+] 
[𝐻]2 + 𝐾𝑎[𝐻] − 𝐾𝑎𝐶𝑎 = 0 
[𝐻]2 + 1.38 × 10−4[𝐻] − 4.21 × 10−6 = 0 
Equation 6.21 – A quadratic equation to calculate the concentration of H+ in the lumen. 
Solving Equation 6.21 yields a H+ concentration of 1.98E-03 mol/L. This is converted into a 
value of pH in Equation 6.22: 
𝑝𝐻 =  − log10[𝐻
+] = − log10[1.98 × 10
−3] = 2.7 
Equation 6.22 – Equation to calculate pH from the concentration of hydrogen ions. 
Between Day 0 and Day 1, assuming that all dissolved oxygen has been depleted and that 
anaerobic respiration then occurs, the pH of the media within the lumen will decrease from 
7.8 to 2.7. Given that the viability of MG63 cells decreases from 100% to 75% over 24 hours 
when pH is decreased from 7.4 to 6.4 (Lee et al., 2011), it is highly likely that the majority of 
the cells in this system became non-viable well before the pH would ever reach 2.7 in the 




lumen. However, given that cell viability did decrease so drastically between Day 0 and Day 
1, and that insufficient oxygen was permeating through to the cells in the lumen, it is likely 
that the production of L-lactic acid and the subsequent decrease in pH was the cause of cell 
death.  
 Improvements to the System 
Increasing the ECS flow rate to a minimum of 1.49 mL/min should provide the 100,000 cells 
in the lumen with sufficient permeating dissolved oxygen and D-glucose in order to 
aerobically respire and proliferate. This would reduce the concentration of L-lactic acid in the 
lumen, and ensure that cells will not die due to acidification of the media. Given that oxygen 
is provided to the recirculating media continuously in the incubator by way of an oxygen 
permeable vent, the consumption of dissolved oxygen in the lumen will only be limited by the 
rate of media permeation, so no increase in the volume of media itself is necessary. 
The increased rate of permeation will put the attached cells within the lumen under additional 
shear forces. Cell rolling and eventual expulsion from the lumen may occur if the adhesive 
forces between the cells and the membrane are not strong enough. This would be undesirable 
as it would adversely affect the ability of the hollow fibre to act as a device for cell delivery. 
Shear within the lumen would need to be calculated, and the cells subjected to tests to 
determine their attachment strength on PLGA. If shear forces through the lumen were a factor, 
the membrane itself could be altered to increase its porosity and encourage higher rates of 
dissolved oxygen and L-lactic acid exchange through the lumen by diffusion.   
Using a smaller cell inoculant may also be beneficial in characterising the system in its current 
state. 100,000 cells were seeded in this system, and the values for D-glucose and dissolved 
oxygen consumption and L-lactic acid production were calculated based upon the demands of 
100,000 cells. A future iteration of this experiment could reduce the number of seeded cells 
to 10,000 whilst increasing the rate of sampling to every 12 hours over 3 days. Assuming the 
demands of 10% of the seeded cell population was equivalent to 10% of the original dissolved 
oxygen demand, then dissolved oxygen consumption would be 0.07 mg/day, compared to the 
0.40 mg/day that diffused in.  
In conclusion, shear experiments to allow the calculation of a force balance between lumen 
flow rate and cell attachment strength should be conducted to determine the maximum value 
of ECS flow rate that can be applied. If this leads to cell removal then fibres of increased 
porosity should be manufactured and seeded with a lower number of cells to characterise the 
diffusion potential in the system and how this affects the seeded cell population. 




6.5  CONCLUSIONS 
The results outlined in this chapter suggest that the selected hollow fibre bioreactor 
configuration was insufficient to sustain a population of MG63 cells. While the experiment 
was ultimately unsuccessful, this was the first time MG63 cells were inoculated into the lumen 
of a hollow fibre to characterise its ability to grow cells, making this research a novel 
endeavour. This initial challenge needs to be overcome before hollow fibres can be further 
investigated for use as a medical device for delivery cell therapies. From the experiments 
outlined in this chapter it has been concluded that: 
i) Flat sheets of 60% NaCl porous PLGA sustained a greater number of cells than 
tissue culture plastic over a 6 day time course. 
 
ii) Cell doubling time of MG63 cells on porous flat sheet PLGA was shorter than 
found on other porous PLGA flat sheets, non-porous PLGA flat sheets, and on 
flat sheet scaffolds made from other polymers. 
 
iii) Dissolved oxygen availability is the limiting factor that prevented cell survival 
after 24 hours within hollow fibres. Diffusion of dissolved oxygen into the lumen 
was unable to compensate for the poor rate of media permeation. Subsequent 
investigations into the oxygen demands of this system have shown that an ECS 
flow rate of 1.49 mL/min would be required for sufficient permeation of dissolved 
oxygen to sustain 100,000 MG63 cells. 
 
iv) Accumulation of L-lactic acid, and its subsequent disassociation, led to an 
increased media acidity within the lumen (pH 2.7), which led to cell death within 
24 hours.  
While the aim of this chapter, to sustain a population of cells within a hollow fibre lumen, was 
not achieved, the limitations of this system were identified and the means to mitigate them 
were explored. Future work would seek to implement a greater ECS flow rate for increased 
permeation of dissolved oxygen, or modify the permeability of the hollow fibre itself to allow 
for a greater rate of dissolved oxygen diffusion into the lumen.  
The limitations of traditional and engineered cell delivery mechanisms still hinder the 
effectiveness of clinical cell therapies, and the proposed solution outlined in this work cannot 
yet be discounted at this stage until further experiments are carried out.  
 






























7. CHAPTER SEVEN: CONCUSIONS AND 
FUTURE WORK 
7.1 CONCLUSIONS 
The literature review in Chapter 2 uncovered limitations in the current methods used to grow 
and deliver cell therapies to treat infarct tissue in the human heart. This thesis has investigated 
these limitations and has outlined solutions that could lead to accelerated and/or improved 
clinical outcomes for patients. 
Traditionally administered cell therapies for improving cardiac function after a heart attack 
require a minimum of 50 million cells. Mesenchymal stem cells (MSCs) show the most 
promise, with those extracted from the adipose tissue surrounding the heart more likely to 
differentiate into cardiomyocytes. However extraction rates from this source are 
approximately 812,800 ± 318,400 cells, thus requiring expansion in order to be clinically 
useful. Hollow fibre bioreactors (HFB) were found to be the best technology for this 
expansion, with cells growing on the external surface of hollow fibres. Rates of cell seeding 
within HFB are around 20%, with the remaining cells failing to attach leading to accumulation 
in the bottom of the bioreactor housing. With this MSC extraction rate and cell seeding 
efficiency, it would take approximately 12.6 ± 5.2 days to grow 50 million cells in a HFB. 
Chapter 4 sought to improve upon this rate of cell attachment in order to reduce the required 
amount of time necessary to grow cells for traditionally administered cell therapies. This was 
achieved by using a novel dynamic seeding method.  
Theoretical rates of cell attachment based of gravity settling onto static individual fibres 
indicated a maximum cell attachment of 24% ± 4%, assuming all cells that fell onto the fibre 
would attach. Experiments indicated that 18% ± 16% of cells attached. Both values for cell 
attachment are close to 20%, confirming the limitation with seeding HFBs as described in 
literature.  
A series of experiments were carried out to determine of the act of motion would allow seeded 
MG63 cells more opportunities to attach to the external surface of the hollow fibre. Bioreactors 
were attached to a rotating drum and spun at 2, 6 or 8 RPM while orientated at different angles 
to determine if cell attachment would improve. A model utilising modified particle settling 
equations for use in a rotating environment indicated that 59% ± 22% cell attachment could 
be achieved in horizontally orientated bioreactors rotating at 6 RPM. Experiments under those 
conditions showed 39% ± 12% cell attachment, a value within the margin of error shown in 
the data from the theoretical model. This almost doubles the rate of cell attachment on hollow 




fibres, and if applied to MSCs would allow the growth of 50 million cells in 11.2 ± 4.7 days, 
1.4 days quicker than with previous rates of cell attachment of 20%. 
Other experiments where bioreactors were positioned horizontally on the rotating drum (2 
RPM and 8 RPM) also showed improved attachment (31% ± 7% and 22% ± 6%) over the 
static control, however bioreactors rotated at a constant rotational velocity at other orientations 
(diagonal and vertical) showed worse attachment (15% ± 11% and 16% ± 1%). The work in 
Chapter 4 has shown that using a novel dynamic method for seeding cells onto hollow fibres 
has led to improved rates of cell attachment, which reduces the amount of time necessary to 
produce a clinically applicable dose of MSCs.  
Chapter 5 sought to manufacture porous hollow fibres for use in a HFB. Previous attempts at 
hollow fibre manufacture using wet-spinning phase inversion produced fibres with a thick 
non-porous skin layer. For use in HFBs, the fibres needed to be porous in order to allow 
nutrients, waste and gases to permeate through the fibre and enable cell growth. To that end, 
PLGA polymer was dissolved in NMP solvent and augmented with 10%, 20%, 40% and 60% 
sodium chloride (by weight % of PLGA). Hollow fibres and flat sheet scaffolds were 
manufactured and imaged to quantify surface porosity, and experiments conducted to 
determine how NaCl content affected the permeability of fibres.  
Imaging of scaffolds revealed that addition of manufactured NaCl particles provided the 
internal and external surfaces of hollow fibres with pores. Addition of 10% and 20% NaCl 
yielded statistically similar pore densities of 120 ± 5 and 115 ± 17 pores/mm2 and addition of 
40% and 60% NaCl, yielding statistically similar pore densities of 260 ± 83 and 268 ± 51 
pores/mm2 on the inner hollow fibre surface. This indicates that the addition of larger 
quantities of NaCl will increase the surface pore density, however the non-linear relationship 
between NaCl content and subsequent surface porosity might indicate a critical NaCl 
concentration between 20% and 40% beyond which conditions are better suited for surface 
pore formation.  
Similarly, liquid permeability of these fibres did not increase linearly with NaCl content, 
demonstrating that surface porosity was not the limiting factor for liquid permeation. This 
indicated that the internal tortuous network of pores within hollow fibres produced as a result 
of the wet-spinning phase inversion manufacturing process was rate limiting. The fibre with 
the greatest liquid permeability was the 60% fibres with 1.91E-15 m2 (± 50.5%), and this 
batch of fibre was used for future experiments for cell growth in HFBs.  
The literature review also summarised the current limitations with traditionally administered 
cell therapies, particularly the low rates of cell retention in the wound site that facilitated the 




need for such high cell doses in the first place. Of an ‘initial dose’ of 50 million cells, only a 
1 million cell ‘functional dose’ would be retained (2%), but despite this studies have shown 
improvements in heart function after traditionally administered treatment. It was proposed that 
if a similar or larger sized functional cell dose can be administered and retained at the wound 
site, the required expansion step to make this functional dose would be much shorter than that 
required to grow the typical 50 million cells for traditionally administered cell therapies, while 
requiring much fewer cells.  
Current engineered delivery methods do utilise fewer cells, and include administering cell 
patches, injecting cell loaded hydrogels, or suturing cell loaded threads into a wound site; 
however each have their own drawbacks that limit their therapeutic potential, and still suffer 
from a loss of cells during implantation like traditionally administered methods. A novel 
device allowing the encapsulation of cells in the lumen of a porous hollow fibre was proposed 
as a method to protect the cells during implantation, and to allow transport of nutrients, waste 
and oxygen in vivo after implantation. Chapter 6 undertook preliminary experiments to 
determine if a population of cells seeded within the lumen of a hollow fibre could grow or be 
sustained ex vivo. The hollow fibres manufactured and characterised in Chapter 5 were used 
in this work.  
MG63 cells were seeded within the lumen of 60% NaCl PLGA hollow fibres within a glass 
bioreactor housing. This HFB was attached to a system which pumped media through the 
extracapillary space of the HFB, allowing permeation and diffusion of glucose and dissolved 
oxygen through the fibre and into the lumen. ECS flow rates were set at 10 and 50 µL/min to 
ensure that glucose did not become rate limiting, and it was assumed that the incubator in 
which the system was placed would ensure that dissolved oxygen did not become rate limiting. 
The experiments conducted in Chapter 6 showed that at the calculated required flow rates of 
10 and 50 µL/min in the extracapillary space were insufficient to sustain a population of MG63 
cells within the lumen of a hollow fibre. Subsequent modelling of the system revealed that 
limited permeation of dissolved oxygen caused the MG63 cells to anaerobically respire, which 
produced lactic acid that accumulated in the lumen, leading to the death of cells from the 
increased acidic conditions (pH 2.7). Suggested improvements to the system include 
increasing the ECS flow rate to a minimum of 1.49 mL/min to enable sufficient permeation 
of dissolved oxygen to sustain 100,000 MG63 cells, or manufacture a fibre with greater 
permeability to facilitate additional dissolved oxygen transfer by diffusion.  
While this particular ex vivo experiment did not successfully sustain cells over 6 days, the 
limitations of this system were identified and the means to mitigate them in future works 




was investigated. Work on cell encapsulation within hollow fibres should continue to be 
explored, as this novel route for cell delivery cannot yet be dismissed.  
7.2 FUTURE WORK 
The work contained within this thesis stands on its own merits, however there is scope to 
achieve additional improvements in external cell attachment on hollow fibres, and to further 
investigate encapsulated cell growth within a hollow fibre for eventual use as a cell delivery 
device. This section will discuss further avenues to the research outlined in this work. 
Cell Attachment on Hollow Fibre External Surfaces (Chapter 4) 
Cell attachment was improved from 18% ± 16% to 39% ± 12%, which would reduce the time 
to grow 50 million MSCs from 12.6 ± 5.2 days to 11.2 ± 4.7 days, however if cell attachment 
were further improved this would further reduce the growth time. If all inoculated cells 
attached in the HFB, it would only take 9.1 ± 4.0 days. This this shows that MSC growth time 
could be reduced by an additional 2.1 days. While it is unlikely that 100% attachment could 
be achieved, this study has shown that there is scope to investigate dynamic seeding as a viable 
alternative to standard static seeding, and to that end further dynamic regimes should be 
trialled to seek further improvements. 
One particular regime that should be investigated further is cell seeding using the periodic 
mixing offered by the MACSmix rotator drive. While in Chapter 4 it showed the near worst 
rate of cell attachment (10% ± 4%), cells were only allowed 4 minutes to attach between each 
minute of rotation.  Studies on flat sheets has shown rates of attachment increase from 20% ± 
11% after 5 minutes to 84% ± 31% after 3 hours, therefore a longer waiting time in between 
periods of rotation might offer improved cell attachment in the first instance, while offering 
additional opportunities for cells that miss the hollow fibre to attach after rotation.  
The theoretical model for dynamic attachment could also be improved. In this work it was 
assumed that a moving linear cell front resulting from centrifugal force allowing cells to make 
contact with the hollow fibre(s) at the centre of a bioreactor. Other models for cell movement 
could be more appropriate, for example modelling attachment as a result of random cell/fibre 









Sodium Chloride Particles Used for Manufacture of Porous PLGA Scaffolds (Chapter 5) 
While every effort was made to maintain constant fibre spinning conditions between different 
quantities, hollow fibres with different NaCl concentrations formed hollow fibres of differing 
internal and external diameters. Wet-spinning is an intricate manufacturing method, requiring 
a specific polymer flow rate and internal water bore flow rate. Spinning was successful within 
a range of these flow rates, however not necessarily at the same flow rates between spinning 
batches. While salt content can affect viscosity of polymer solutions, which in turn affects the 
required flow rate of polymer, no trend between salt content, spinning flow rates, or resultant 
fibre dimensions was observed.  
It was also extremely difficult to successfully wet-spin hollow fibres. Given the high failure 
rate of the equipment, only a single batch of each NaCl/PLGA/NMP fibre mixture could be 
produced. Therefore, abnormalities displayed in the data could be caused by batch to batch 
variation and not necessarily by variations from NaCl content alone. Alternative methods for 
hollow fibre production, such as melt-spinning, should be investigated to determine if it would 
provide more consistent fibre production.    
As the fibres were to be used to encapsulate cells, with cell media passively permeating 
through, additional liquid permeation experiments using cell growth media would be useful 
to characterise any fouling may affect the permeability of the fibres and how this would impact 
the encapsulated cells. If fouling effects were observed, then fibres with a higher molecular 
weight cut off would be required, or the bioreactor configuration would require alteration to 
treat fouled membranes by back flushing.  
Study of liquid permeation at an applied back pressure was attempted but the available 
equipment did not allow for fine enough variations in pressure to provide a consistent 
permeate stream from the hollow fibre walls. If the apparatus could be reconstructed to allow 
for this permeation could be controlled, allowing a greater degree of operational flexibility 
when the fibre is used in the bioreactor.   
The results in Chapter 5 showed statistically similar pore densities in certain fibre surfaces 
between 10% - 20% and 40% - 60% NaCl content. Characterisation of NaCl content between 
20% - 40% should be investigated to determine the nature of this sudden increase in pore 
density. 
Increasing NaCl content does not correlate with increased gas or liquid permeability of hollow 
fibres. As surface porosity is not the rate limiting step to permeation as first postulated, studies 
on how NaCl content affects the internal porous network should be carried out to see if the 
addition of porogen improves the interconnectivity of the macrovoids within the hollow fibre 
structure.  




Cell Growth within the Lumen of a Hollow Fibre (Chapter 6) 
The encapsulated population of 100,000 MG63 cells became non-viable 24 hours after 
seeding. It was determined that insufficient dissolved oxygen was permeating from the 
extracapillary space at the set flow rates of 10 and 50 µL/min, resulting in aerobic respiration 
of cells, and formation of lactic acid which acidified the media within the lumen. To ensure 
sufficient dissolved oxygen permeation for aerobic respiration of cells, the ECS flow rate 
should be increased to a minimum of 1.49 mL/min.  
However, care should be taken at this ECS flow rate, as the subsequent flow rate of permeated 
media within the lumen could lead to increased shear stresses that could damage the cells or 
remove them from the internal lumen wall. Studies should be conducted to quantify the shear 
forces within the lumen, and to determine the strength of the bonds between the cells and the 
hollow fibre surface in order to provide a maximum flow rate the cells can resist. If shear is 
too great at an ECS flow rate of 1.49 mL/min then the porosity of the hollow fibre should be 
increased by adding more NaCl particles during fibre manufacture in order to further facilitate 
dissolved oxygen transfer by diffusion.  
If subsequent experiments are successful in sustaining a population of 100,000 cells, further 
work should aim to sustain larger cell populations of MSCs up to the functional dose offered 
by traditional methods of 1 million cells, and then beyond. From here studies should further 
detail how a successful medical device can be manufactured, with particular focus on the 
practicalities of removing the hollow fibre from the bioreactor housing without the loss of 
cells, the logistics of retaining those cells as the fibre is transported, and ensuring a suitable 
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A. APPENDIX A: DETAILED HOLLOW FIRBE 
SPINNING PROCEEDURE 
Spinning hollow fibres is a multi-step process, but can all be done in the space of one day 
depending on how much you need to spin and how lucky you are. Please use look at the 
attached schematic when setting up. Prior to spinning, make sure that the RO water tank is 
completely full. If not, please follow the SOP for filling it. Put on PPE NOW! (Lab coat, 
goggles, gloves) 
Filling the Spinning Rig 
 Check that all outlet tubing is free from tears and is tightly constricted with clamps.  
 Find the large blue and white buckets in 4.02 
 Go down to the plant room on level 1 (through the Mays hydrogen lab) and retrieve 
the red trolley. Take it upstairs in the lift. 
 Place the buckets on the trolley and take through to 4.05. Ideally with someone to help 
with doors. You can wedge open 4.02, but not 4.05. 
 Fill both buckets while they are on the trolley. Be very careful when moving the 
trolley at heavy load.  
 Wheel the trolley into 4.02 and back into the space between the rig and the work 
surfaces. 
 Use your foot to push the hydraulic lever and raise the trolley to its maximum height. 
 Gently tip the first bucket to fill up the rig. Rest the bucket against the lip of the metal 
trough and use it to assist in pouring. Repeat with the second bucket. 
 Release the hydraulics by turning the handle on the trolley. Use it to control the decent 
of the trolley.  
 Repeat until the whole rig is filled. It should take 6-8 buckets to fill. Half way through 
filling the metal walls of the rig will bounce outwards and make a sound. Do not be 
alarmed! 
 Leave a bucket of water beside the rig as a source of RO water for later. 









Assembling the spinneret 
The spinneret is made from three parts, the top part (with the inlet at the top and the needle sat 
at the bottom), the chamber part (with the polymer inlet in its side), and the extra bit that 
screws into the bottom of the chamber part. There is no reason for these two parts to be 
separated, so screw the extra part onto the chamber part before starting. All components and 
equipment should be in the top drawer nearest the spinning rig on the centre island. 
Testing the Needle for Water Leaks 
 Check that the needle part of the spinneret is clean, free from any residual white 
polymer chunks, and is dry.  
 Select the needle. Check the needle is clear by forcing a narrow metal thread down 
the bore of the needle.  
 The top part of the spinneret has a moving part for no real reason. It is a threaded 
section that can freely move up and down, and can actually be removed if enough 
force is applied. Move it to the very top of the top part and wrap a double layer of 
PTFE tape around the exposed smooth cylindrical section directly beneath it. 
 Gently twist and force this part back down over the PTFE, twisting with the direction 
of the tape (as you should do always) until it has reached the very bottom. 
 Wrap a couple of layers of PTFE tape around the threads of this same part.  
 Fill up a large container with RO water and place the inlet tube to the peristaltic pump 
inside; taping he tube to the container if necessary (it tends to flick out). 
 The pump should be set to the correct tube setting by default. Check the two digit 
number at the end of the serial number on the tubing and check it matches with the 
number that is lit up on the pump itself. This means that the flow rates displayed 
should be accurate. 
 Screw the pump outlet tubing onto the top of the needle part of the spinneret.  
 Initiate the pump, causing liquid to enter the tubing at the desired flow rate. Turn off 
the pump when water is around 10 cm away from reaching the top part of the spinneret 
(this is called priming the pump). 
 Wrap the base of the needle with a few wraps of PTFE tape.  
 Gently force the PTFE end of the needle into the outlet of the needle part. Use a wide 
pair of tweezers if you wish. Make sure you twist with the movement of the thread. 
 When you are confident the needle is tight, place the chamber part of the spinneret 
over the top part, ensuring the needle has found the hole in the bottom of the chamber 
part, and tighten. 




 The needle needs to poke out of the bottom of the spinneret by 1-2 mm. If it is barely 
showing from the bottom of the spinneret then re-seat the needle in the top part and 
check again. 
 Unscrew the chamber part of the spinneret, hold the top part needle side down, and 
initiate a flow rate of around 12 ml/min from the pump. 
 Check the connection between the needle and the top part of the spinneret for leaks. 
A very obvious drop will appear to form if a leak is present. Allow water to flow for 
2 minutes.  
 When you are sure there are no leaks, reverse the flow of the pump to remove all 
liquid from inside the needle and the first 10 cm of the tubing that is entering the top 
part of the spinneret.  
 Screw the chamber part back onto the top part and rest the spinneret on its side. This 
is to protect the needle. Don’t leave the needle in the top part of the spinneret if you 
are just going to leave it and do something else. The spinneret WILL put weight on 
the needle and potentially bend it. 
Setting up the Pressure Vessel 
 Locate the pressure vessel (PV), two valves, the gas inlet line, the PV-spinneret 
connection line and the two connectors used to attach the valves to those lines. 
 Check that they are all clean; with no solidified polymer lumps stuck in the tubes or 
lining any threads etc, and also dry. 
 The valves will be labelled; one will be to control the PV inlet and the other for the 
PV outlet. The valves have arrows showing the direction of flow through them. 
 The first objective is to test the equipment attached to the bottom of the PV for leaks 
before polymer is poured in. 
 Wrap PTFE around the thread of the bottom of the PV outlet valve, screw in the 
connector, and then repeat with the top of the PV outlet valve and screw into the 
bottom of the PV, tightening with spanners.  
 Screw the outlet tubing into the bottom of the valve connector. No need for PTFE.  
 Do the same with the equipment to be placed at the top of the PV, but do not 
excessively tighten as this will soon be removed. 
 Fix the PV into the arms above the spinning rig.  
 Attach the gas line from the wall to the PV inlet.  
 Ensure that the PV inlet valve, PV outlet valve and the Wall valve are all closed 
 Go to the gas canister in the storage cupboard.  




 There are two pressure gauges; P1 (on the left) shows the pressure exiting the gas 
canister in bar gauge, and P2 (on the right) shows the pressure of gas (the quantity) 
in the gas canister itself. 
 Open the tank outlet valve by one turn with the allen key already attached. 
 Turn the regulator valve clockwise to pressurise the copper line between the gas 
canister and the wall valve. Turn until a pressure of 2 bar gauge. 
 Return back to the PV and open the Wall valve and the PV inlet valve. Everywhere 
between the gas canister up to and including the PV will be at 2 bar gauge, as 
confirmed by P3 on the gas line. 
 Use a dilute mixture of soap and water in a squirty bottle and spray the joints 
between the PV outlet valve and the PV. If you see bubble expand in a certain joint, 
that joint must be tightened.  
 Either way, the PV must now be depressurised. Close the Wall valve and slowly 
open the PV outlet valve to remove pressurised air between these two points. P3 
should read zero. Tighten the joints if leaks were found. 
 Close the PV outlet valve; remove the gas line from the PV inlet valve, then remove 
the PV inlet valve from the PV. 
 Pour the polymer into the top of the PV, being careful to not hit the threads. If you 
do, give them a wipe. The polymer will eat away at the PTFE otherwise. 
 Wrap new PTFE around the PV inlet valve and reattach to the top of the PV. 
 Reattach the gas line and tighten everything one more time with spanners. 
 Close the PV inlet valve and open the wall valve to pressurise everything up to the 
PV inlet valve. Check that joint for leaks 
 Fully open the PV inlet valve and test the joint between it and the PV for leaks.  
 If leaks are found, close the wall valve and carefully loosen the joint between the gas 
line and the PV inlet valve. A small hiss will mean that pressure is being released. 
The pressure being read in P3 will decrease to zero.  











 If you are at this point all this should be true: 
o Polymer is in the PV. 
o Needle is attached to spinneret and is leak free. 
o Pressure from the gas tank is set to 2 bar gauge. 
o The spinning rig is full of RO water. 
o PV outlet valve is closed, all other valves are open. 
o The motor is plugged in. 
o A bucket of RO water has been placed below the bucket to collect fibres. 
o The water pump is primed and has access to enough water to pump 
continuously. 
 Attach the spinneret to the arm above the water. Raise the arm to its highest point. 
 Attach the polymer inlet line to the spinneret.  It is short and inflexible; do not drop it 
into the water. If you do, dry it off and pull out the subsequent solid bit of polymer 
from the end. 
 Turn the peristaltic pump on initiate water flow through the spinneret at 12 ml/min. 
 The flow will be a continuous stream that will fall straight downwards into the water 
bath. If it is angled wipe the outlet with a paper towel. If it persists the spinneret may 
not be fully cleaned internally or the needle not centred. Dismantle the spinneret and 
check. 
 Reduce the flow to the lowest you can get it while maintaining a constant flow from 
the spinneret that doesn’t ‘widen’ the stream or cause drops of water to form (7-9 
ml/min). 
 Open the PV outlet valve halfway and watch as the polymer flows through the tubing. 
There will be a delay before polymer leaves the spinneret as the chamber fills with 
polymer. 
 The polymer will start to coagulate as it flows out of the spinneret and contacts the 
flowing water. Use a pair of tweezers to guide a string of polymer into the water. This 
may take a little while. If the polymer is not forming as desired, try changing the water 
flow rate or increasing the gas pressure (to increase the polymer flow rate). 
 Once you are happy with the extruded polymer, loosen the arm holding the spinneret 
and lower the spinneret into the water bath by about 5 mm so that the needle is below 
the water.  
 Allow the fibre to fall to the bottom of the tank and use the hooking arm attached to 
the spinning rig to take the fibre upwards, over the central roller and into the second 




bath. Allow a degree of slack in the fibre ‘string’ when doing this and do not pull the 
fibre taught. 
 Place the roller side of the hooking arm into the deepest part of the rig and ensure that 
the fibre is trapped underneath it. This will guide the polymer downwards and prevent 
it from spiralling as it leaves the spinneret.  
 Guide the fibre through the second bath and underneath the second roller. 
 Switch on the pickup motor on the lowest speed setting. Hook the fibre underneath 
and then over the roller and guide it down into the fibre collection bucket.  
 Check the condition of the polymer as it comes out. If the lumen is too large reduce 
the water flow rate. If you want the outer diameter of the polymer to be larger increase 
the polymer flow rate. Modifying these values can only do so much. A lot of it is 
dependent on the properties of the polymer itself. 
 The flow rate of fibre leaving the spinneret must be equal to that of the speed of the 
pickup motor to avoid the fibre spiralling (motor too slow) or being stretched and held 
taught (motor too fast). Continuously check to make sure that neither of things are 
happening. 
 Check that the fibre is correctly being aimed into the collection bucket and is being 
picked up by the motor correctly. Sometimes the fibres can get knotted on the pickup 
rotor.  
 If the fibre on the motor keeps on ‘slipping’ try to find something to wrap around it 
that will provide grip to the fibre (paper towels maybe). Make sure that whatever is 
wrapped around the motor maintains the smooth cylindrical surface of the roller on 
the motor. If there are sharp edges then the fibre could bend at sharp angles instead of 
maintaining a good shape. 
 Keep checking all of these things until enough fibre is obtained or the polymer has 
run out. When all polymer is used up a very obvious bubbling sound can be heard 











Shut Down Procedure 
This can vary depending on whether or not the spinning process has been ended early with 
polymer still in the PV. Polymer can remain in the PV for another spinning session as long as 
the PV inlet and outlet valves are closed.  
No Polymer to Recover 
 Close PV outlet valve. 
 Switch off water flow pump. 
 Allow all fibre to be taken through the water bath and deposited in the collection 
bucket. 
 Close wall valve. 
 Detach water line from the spinneret. 
 Detach the polymer inlet line from the spinneret. 
 Hold a glass flask under the line and slightly open the PV outlet valve to depressurise 
the PV and the gas line up to the wall valve. Watch P3 decrease to zero. The glass 
flask is to collect any residual polymer as it is shot out of the PV. 
 Unscrew the gas line from the PV inlet valve and remove the PV with valves from the 
support arms. Place to one side. 
 Go back to the gas canister and turn the regulator valve anti-clockwise to shut it. P1 
will still display the pressure set during the spinning process because the copper line 
between the regulator valve and the wall valve is still pressurised. Close the tank outlet 
valve with the allen key attached. 
 Slightly open the wall valve whilst holding onto the gas line tightly. A hissing will be 
heard as the pressurised air rushes out of the gas line. The line is depressurised when 
no air is flowing. Check that P3 and P1 now read zero bar gauge 
Polymer to Recover 
 Close PV outlet valve. 
 Switch off water flow pump. 
 Allow all fibre to be taken through the water bath and deposited in the collection 
bucket. 
 Close PV inlet valve. 
 Detach water line from the spinneret. 
 Detach the polymer inlet line from the spinneret. 




 Hold a glass flask under the line and slightly open the PV outlet valve to depressurise 
the PV and the gas line up to the wall valve. Watch P3 decrease to zero. The glass 
flask is to collect any residual polymer as it is shot out of the PV. 
 Close the regulator valve on the gas canister. P1 and P3 will still display the pressure 
set during the spinning process because the copper line between the regulator valve 
and the PV inlet valve is still pressurised. 
 Gently loosen the connection between the gas line and the PV inlet valve until a hiss 
of air escaping can be heard. P3 and P1 will fall to zero as the line is depressurised. 
Tighten the connection when done 
 Go back to the gas canister and open the regulator valve to a pressure of 0.5 bar gauge. 
This lower pressure is required to ease the remaining polymer from the PV into the 
glass container. 
 Open the PV inlet valve fully and open the PV outlet valve slightly, with the glass 
container under the line exiting the PV. 
 The polymer should flow at a moderate flow rate. Close off the PV outlet valve as 
soon as you can see that no more polymer is leaving the PV into the outlet line. Try 
and retrieve as much polymer from the line as possible, however if you don’t shut it 
off in time air will be forced into the glass container, leading to air bubbles forming 
in the polymer.  
 Place a lid on the glass container, label it, and place it to one side. 
 Close the regulator valve and the tank outlet valve and open the PV outlet valve to 
depressurise the whole system. Check that P1 and P3 read zero bar gauge.  
Washing up 
When washing up do not leave things in to soak for prolonged periods of time (overnight). 
This will cause the polymer to expand more and make it very difficult to remove. 
 Prepare a wash bowl with water in it and place it in the sink 
 Remove the valves and connectors from the pressure vessel. Submerge all but the PV 
inlet valve and that connector in the wash bowl (the PV inlet valve has not been 
exposed to polymer). 
 Remove the spinneret from the holding arm, dismantle and be ready to catch any 
excess polymer still in the spinneret.  
 Remove the needle with tweezers at its base and place to one side. 
 Run the main spinneret components under a gentle water flow to coagulate the 
polymer and remove with tweezers. Repeat another time and place in the wash bowl 




 Very gently wash the needle, removing all PTFE tape. Remove coagulated polymer 
with a paper towel in a gloved hand. Clean the bore of the needle with a thin metal 
thread and leave out on paper towels to dry. 
 Remove any coagulated polymer from the submerged spinneret using tweezers, 
making sure to also remove all PTFE tape, and checking in all the crevices and 
inlet/outlet ports. Pay special attention to cleaning the threads. Use a large metal 
needle to clean the polymer outlet hole at the bottom of the spinneret. Leave out on 
paper towels to dry 
 Clean the PV outlet valve connector in the same way. 
 The coagulated polymer on the inside of the polymer inlet tubing can be easily 
removed by flowing compressed air from the hood through it. Submerge again and 
repeat. 
 It will be hard to remove coagulated polymer from the PV outlet valve. Open the valve 
fully and alternate between scraping away the polymer and applying a compressed air 
flow. Fully close the valve then scrape the valve needle. Hold the valve internals into 
the light for a better look. 
 Remove the PV from the wash bowl and wash the internals with water from the tap at 
a high flow rate, being sure to hit the inner walls with the jet stream. If the skin has 
peeled off as a result you will see a blockage in the pressure vessel. Use tweezers to 
remove or apply a compressed air flow to shoot it out. Repeat and leave to dry. 
 When all components have dried, place back in the drawer.  
Draining Water Rig 
 Place a bucket under the second trough and loosen the clamp to drain it. Only half fill 
the bucket because it will have to be drained in the sink and it can get very heavy.  
 Put the long tube that exits the bottom of the first trough into the sink. Ensure it is 
fully secured before loosening the two clamps along its length. This flow will stop at 
about 75% empty. 
 Move the tubing into a bucket and drain and empty into the sink. The tank will now 
be about 95% empty. Be prepared to stop flow to empty the bucket a few times. 
 Move the tubing into a short sided wash bowl to get the final bit of water out.  
 Empty the water tank on the pump inlet and drain all water from the pump tubing. 
 Mop up any spillages and clear any work surfaces 
 
 





Figure A.1 - Schematic of Spinning Rig




B. APPENDIX B: DETAILED PROCEEDURE 
FOR ANALYSIS OF SEM IMAGES USNG 
IMAGE J SOFTWARE  
SEM images of porous scaffolds were analysed using ImageJ software (version 1.48). ImageJ 
allowed modification of raw SEM photos into binary black and white images to differentiate 
pores on the surface, which ImageJ sized and counted.  A macro was written to facilitate this 
process due to the large number of images to be analysed. An example of SEM image 
modification of Figure B.1 is outlined in this section 
  
Figure B.1 – SEM image of a flat sheet PLGA scaffold 
Firstly the scale bar on the raw SEM image was used as a reference to attribute SI length units 
to the image instead of pixels, the default ImageJ unit. A line of known pixel length was placed 
over the scale bar length, and assigned the same length. Figure B.2 shows a yellow line of 150 
pixel length being made equivalent to 50 µm, the same length shown on the SEM image.  





Figure B.2 – Menu for setting a comparable scale 
 
Next, the image was cropped to remove the overlaid text at the bottom (Figure B.3).  
  
 
Figure B.3 – Cropped SEM image 




A bandpass filter was applied to the cropped image, as shown in Figure B.4. 
 
Figure B.4 – Menu to apply a bandpass filter 
Large structures, such as pores or any other points of contrast, were filtered down to 40 
pixels. This smoothed out the obvious variations in the brightness of the image, i.e. 
increased the prominence of the larger dark pores compared to the lighter surface 
surrounding them. Smaller structures were filtered up to 5 pixels, increasing the prominence 
of the lighter surface surrounding the smaller pores. This acted as a shading correction to 
increase the degree of contrast between pore areas and non-pore areas, resulting in Figure 
B.5.  
 
Figure B.5 – Image with a bandpass filter applied 




The colour threshold of this image was modified in order to obtain a binary image for particle 
analysis (Figure B.6). 
 
Figure B.6 – Menu to modify image colour threshold 
Altering threshold settings allowed grayscale images to be modified to highlight areas of 
interest from the background. In the first instance an ‘Over/Under’ display mode was selected 
and the sliders changed until the entirety of pores were highlighted in blue (Figure B.7). This 
is then applied to the image. 
 
Figure B.7 – Menu showing colour threshold sliders 




Display mode is changed to black and white, and applied again without changing the sliders, 
producing Figure B.8. 
 
Figure B.8 – Binary image showing surface pores in black 
From this the black ‘particles’ can be analysed for their geometric properties (Figure B.9). The 
outlines of the particles are selected, as well as the desired ranges of particle size and 
circularity.  
 
Figure B.9 – Menu to outline the pores and select desired parameters 
 
 




A final image is output (Figure B.10) with each pore allocated a number. 
 
Figure B.10 – Image of pores circled and numbered 
A set of data for each particle is also output. The desired properties that are tabulated can be 
selected from a large list of geometric attributes (Figure B.11). 
 








The macro code of this procedure for this particular image is included in Figure B.12.  
run("Set Scale...", "distance=0 known=0 pixel=1 unit=pixel"); 
//setTool("line"); 
makeLine(553, 846, 702, 846); 
run("Set Scale...", "distance=149.33 known=50 pixel=1 
unit=um"); 
//setTool("rectangle"); 
makeRectangle(0, 0, 1278, 833); 
run("Crop"); 
saveAs("Tiff", "\\\\myfiles\\sma25\\dos\\PhD\\Thesis\\5. 
Results Chapter 2 - PLGA Porosity\\Image J\\Image Export\\1. 
Cropped.tif"); 
run("Bandpass Filter...", "filter_large=40 filter_small=5 
suppress=None tolerance=5 autoscale saturate"); 
saveAs("Tiff", "\\\\myfiles\\sma25\\dos\\PhD\\Thesis\\5. 










run("Convert to Mask"); 
saveAs("Tiff", "\\\\myfiles\\sma25\\dos\\PhD\\Thesis\\5. 
Results Chapter 2 - PLGA Porosity\\Image J\\Image Export\\3. 
Threhsold.tif"); 
run("Analyze Particles...", "size=5-Infinity circularity=0.50-
1.00 show=Outlines display exclude clear summarize"); 
saveAs("Tiff", "\\\\myfiles\\sma25\\dos\\PhD\\Thesis\\5. 
Results Chapter 2 - PLGA Porosity\\Image J\\Image Export\\4. 
Pores.tif"); 
saveAs("Results", "\\\\myfiles\\sma25\\dos\\PhD\\Thesis\\5. 





Figure B.12 – Macro code to obtain surface porosity data from an SEM image 
C.  




C.APPENDIX C: CALCULATION OF CELL 
SETTLING CONTACT AREA FOR MULTI FIBRE 
MODULES  
 
Figure C.1 – Cross section of a multi HFB module displaying the predicted cell contact area  
The volume of the green shaded region in Figure C.1 can be calculated from shape geometry 
using trigonometry. While the cells are settling in three dimensions, taking the cross section 
of the HFB will yield an area that is proportional to the overall volume of that section. The 
areas in question are labelled in Figure C.2 below: 
 
Figure C.2 – Single HFB module geometry labelled in segments 




Area A is the cross sectional area of the inner wall of the HFB, with a diameter of 7.50 ± 0.05 
mm. Area  B is the cross sectional area of the hollow fibre with an outer diameter of 5.00 ± 
0.05 mm. Areas C and D are chords of equal area that touch the outermost points of Area B 
while moving vertically downwards. Areas E and F remain, with Area E being the region of 
interest directly above the hollow fibre. This area is calculated in Equation C.1, with rOF 
representing the outer fibre radius, and rIB representing the inner bioreactor wall radius.   
𝐴𝑟𝑒𝑎 𝐴 =  𝜋𝑟𝐼𝐵
2 =  𝜋3.752 = 14.06𝜋 
𝐴𝑟𝑒𝑎 𝐵 =  𝜋𝑟𝑂𝐹
















− sin 𝜃) 
𝐴𝑟𝑒𝑎 𝐸 = Area 𝐴 − Area 𝐵 − Area 𝐶 − Area 𝐷 − Area 𝐹 
𝐴𝑟𝑒𝑎 𝐹 = 𝐴𝑟𝑒𝑎 𝐸 ∴ 
𝑨𝒓𝒆𝒂 𝑬 =








Equation C.1 – Calculation of Area E to determine theoretical cell attachment 
The angle (θ) in Equation C.1 is the central angle of the chord (c) within the circle. Area D is 
a circle segment that can be calculated using the internal radius of the bioreactor (rIB) and the 
central angle of the segment. With reference to Figure C.3, this angle can be calculated as 
shown in Equation C.2: 
 
Figure C.3 – A representation of the variables required to calculate segment area in a single HFB module 
















) = 48.2° 
𝜽 = 𝟗𝟔. 𝟒° ± 𝟎. 𝟕° 
Equation C.2 – Calculation of the segment angle of a chord 
By inserting the known dimensional values of the HFB system, the segment Area E can be 
calculated, and by multiplying the segment area by the hollow fibre length (Lhf,) the volume 
of the segment can be found, as shown in Equation C.3: 
𝐴𝑟𝑒𝑎 𝐸 =




180 − sin(96.4 ± 0.7))
2
= 7.43 ± 0.22 𝑚𝑚2 
𝑉𝑜𝑙𝑢𝑚𝑒 𝐸 = 𝐴𝑟𝑒𝑎 𝐸 × 𝐿ℎ𝑓 
𝑉𝑜𝑙𝑢𝑚𝑒 𝐸 = 7.43 ± 0.22 [𝑚𝑚2] × 120 ± 0.05 [𝑚𝑚] 
𝑽𝒐𝒍𝒖𝒎𝒆 𝑬 = 𝟖𝟗𝟏 ± 𝟐𝟕 [𝒎𝒎𝟑] 
Equation C.3 – Calculation of available ECS volume for cells to naturally settle onto the hollow fibre 
Volume E can then be taken as a percentage of the total available volume in the ECS:  
  𝐶𝑒𝑙𝑙 𝑆𝑝𝑎𝑐𝑒 = (𝐴𝑟𝑒𝑎 𝐴 − 𝐴𝑟𝑒𝑎 𝐵)  ×  𝐿 
𝐶𝑒𝑙𝑙 𝑆𝑝𝑎𝑐𝑒 = (14.06𝜋 − 6.25𝜋)[𝑚𝑚2] × 120 ± 0.05[𝑚𝑚]
= 2944 ± 1 [𝑚𝑚3] 
𝑉𝑜𝑙𝑢𝑚𝑒 𝐸 =
891 ± 27[𝑚𝑚3]
2944 ± 1 [𝑚𝑚3]
× 100% 
𝑽𝒐𝒍𝒖𝒎𝒆 𝑬 = 𝟑𝟎% ± 𝟏% 
Equation C.4 – Calculation of available ECS percentage for cells to naturally settle onto the hollow fibre 
Assuming that: the hollow fibre is completely straight and resides in the very centre of the 
bioreactor, the cells in the media are well mixed throughout the entire cell space and do not 
interact with one another, and that cells settle due to the force of gravity directly downwards, 
this model indicates that a maximum 30% ± 1% of cells will have a chance to attach to the 
hollow fibre in this module. However this does not take into account the fact that cell 
attachment on the hollow fibre will become more difficult the steeper the gradient of the 




available surface is. This means that cells that make fibre contact close to the chords shown 
in Figure C.2 will be unlikely to attach. Therefore maximum cell attachment is likely to be 
smaller than 30% ± 1%. 
D.APPENDIX D: SUPPLEMENTARY DATA 
TABLES 





Single Fibre Bioreactor 6h Extrapolation 
2 RPM 6 RPM 8 RPM 
Value Error Value Error Value Error 
Static 
Phase 
Cell contact from initial settling 
on hollow fibre 23.9% 4.4% 
23.9% 4.4% 
23.9% 4.4% 
Time before initiating rotation 
(min) 5 - 
5 - 
5 - 
Cell attachment after this time 
on flat sheets 
19.6% 11.2% 19.6% 11.2% 19.6% 11.2% 
Cell attachment on hollow 
fibre 
4.7% 2.7% 4.7% 2.7% 4.7% 2.7% 
Dynamic 
Phase 
Unattached cells on bottom of 
bioreactor 
95.3% 2.7% 95.3% 2.7% 95.3% 2.7% 
Total rotation time (hours) 6 - 6 - 6 - 
Projected fibre surface area 
relative to bioreactor 
50.0% - 50.0% - 50.0% - 
Time cells in contact with fibre 
due to centrifugal action (hours) 03:07 - 
05:32 - 
05:45 - 
Cell attachment after this time 
on flat sheets 83.9% 
34.5% 83.9% 34.5% 
83.9% 34.5% 
Cell attachment on hollow 
fibre 
40.0% 16.5% 40.0% 16.5% 40.0% 16.5% 
Total 
Cell Attachment From Initial 
Settling 4.7% 2.7% 
4.7% 2.7% 
4.7% 2.7% 
Cell Attachment From 
Centrifugal Action 40.0% 16.5% 
40.0% 16.5% 
40.0% 16.5% 
Total Theoretical Dynamic 
Cell Attachment 
44.7% 16.7% 44.7% 16.7% 44.7% 16.7% 








Figure E.1 – SEM image of the outer surface of PLGA hollow fibre spun with dioxane as the non-solvent 
 




F.APPENDIX F: PERMEATION SENSITIVITY 
ANALYSIS 
Minimum Fibre Thickness 




0% 10% 20% 40% 60% 
Value Error Value Error Value Error Value Error Value Error 
Outer 
Diameter 
1350 1.9% 1250 5.7% 937.5 5.7% 1050 2.4% 987.5 1.8% 
Inner 
Diameter 
1140 2.2% 912.5 5.8% 737.5 2.4% 900 2.8% 712.5 2.5% 
Thickness 105 16.8% 169 26.2% 100 28.0% 75 23.6% 138 9.1% 
Gas Permeation 
 
Figure F.1 – Permeation of nitrogen through PLGA hollow fibres with different NaCl content. 
X error = 0.01 bar, Y error = SD (n=3). 
 
Figure F.2– Resistance of PLGA hollow fibres with different NaCl percentage to nitrogen permeation. 
X error = 0.01 bar, Y error = SD (n=3). 






Figure F.3 – Reynolds no. of nitrogen permeating through PLGA hollow fibre walls with different NaCl 





Table F.2 – Average gas permeability, resistance and flux of fibres with different NaCl content between 
0.03 – 0.42 barg  
NaCl 
Permeability (m2) Resistance (m-1) Flux (m3m-2h-1bar-1) 
Average Error Average Error Average Error 
0% 0 N/A ∞ N/A 0 N/A 
10% 2.37E-17 42.1% 2.20E+12 21.8% 14.6 19.7% 
20% 6.39E-16 22.1% 1.21E+11 15.0% 163.7 24.8% 
40% 3.49E-16 32.2% 1.53E+11 19.4% 127.2 21.5% 













Figure F.4 – Permeation of ddH2O through PLGA hollow fibres with different NaCl content. 




Figure F.5 – Resistance of PLGA hollow fibres with different NaCl percentage to ddH2O permeation. 
X error = SD (n=54), Y error = SD (n=54). 
 





Figure F.6 – Reynolds number of nitrogen permeating through PLGA hollow fibres with different NaCl 




Table F.3 – Average liquid permeability, resistance and flux of fibres with different NaCl content between 
0.001 – 0.004 bar  
NaCl 
Permeability (m2) Resistance (m-1) Flux (m3m-2h-1bar-1) 
Average Error Average Error Average Error 
0% 0 N/A ∞ N/A 0 N/A 
10% 4.33E-16 22.8% 4.10E+11 22.7% 1.21 33.7% 
20% 1.59E-15 17.1% 6.52E+10 21.1% 7.23 25.9% 
40% 3.45E-16 48.7% 2.88E+11 64.8% 2.00 60.1% 











Maximum Fibre Thickness 




0% 10% 20% 40% 60% 
Value Error Value Error Value Error Value Error Value Error 
 Outer 
Diameter 
1350 1.9% 1612.5 5.7% 1187.5 5.7% 1220 2.4% 1212.5 1.8% 
 Inner 
Diameter 
1140 2.2% 912.5 5.8% 737.5 2.4% 900 2.8% 712.5 2.5% 
Thickness 105 16.8% 350 26.2% 225 28.0% 160 23.6% 250 9.1% 
Gas Permeation 
 
Figure F.7 – Permeation of nitrogen through PLGA hollow fibres with different NaCl content. 
X error = 0.01 bar, Y error = SD (n=3). 
 
Figure F.8 – Resistance of PLGA hollow fibres with different NaCl percentage to nitrogen permeation. 
X error = 0.01 bar, Y error = SD (n=3). 






Figure F.9 – Reynolds no. of nitrogen permeating through PLGA hollow fibre walls with different NaCl 





Table F.5 – Average gas permeability, resistance and flux of fibres with different NaCl content between 
0.03 – 0.42 barg  
NaCl 
Permeability (m2) Resistance (m-1) Flux (m3m-2h-1bar-1) 
Average Error Average Error Average Error 
0% 0 N/A ∞ N/A 0 N/A 
10% 1.30E-16 42.1% 2.82E+12 21.8% 14.6 19.7% 
20% 1.64E-15 22.1% 1.41E+11 15.0% 163.7 24.8% 
40% 1.01E-15 32.2% 1.69E+11 19.4% 127.2 21.5% 














Figure F.10 – Permeation of ddH2O through PLGA hollow fibres with different NaCl content. 
X error = SD (n=54), Y error = SD (n=54). 
 
 
Figure F.11 – Resistance of PLGA hollow fibres with different NaCl percentage to ddH2O permeation. 































Figure F.12 – Reynolds number of nitrogen permeating through PLGA hollow fibres with different NaCl 
percentage. X error = SD (n=54), Y error = SD (n=54). 
 
 
Table F.6 – Average liquid permeability, resistance and flux of fibres with different NaCl content between 
0.001 – 0.004 bar  
NaCl 
Permeability (m2) Resistance (m-1) Flux (m3m-2h-1bar-1) 
Average Error Average Error Average Error 
0% 0 N/A ∞ N/A 0 N/A 
10% 7.83E-16 22.8% 4.70E+11 22.7% 1.21 33.7% 
20% 3.16E-15 17.1% 7.38E+10 21.1% 7.23 25.9% 
40% 6.82E-16 48.7% 3.12E+11 64.8% 2.00 60.1% 














G.APPENDIX G: PERMEATION LITERATURE 
COMPARISON 
This section takes a value of flux through a hollow fibre found in Diban et al (2013), and 
uses it to determine an equivalent value for permeability using the dimensions of hollow 
fibres made in this thesis.  
From Diban et al, 2013: 
Parameter  Units Value SD % error 
 Permeation flux m
3/m2.h.bar 3.7 1.2 32.4% 
 Inner diameter m 3.86E-04 3.40E-05 8.8% 
 Outer diameter m 4.95E-04 3.50E-05 7.1% 
 Thickness m 5.50E-5 3.00E-06 5.5% 





 From My Work      
 Salt  Value SD 
% 
error 
  10%  ΔP (barg) 0.0032 0.0006 17.6% 
  20%  ΔP (barg) 0.0012 0.0002 13.7% 
  40%  ΔP (barg) 0.0026 0.0006 24.9% 
  60%  ΔP (barg) 0.0015 0.0006 41.3% 
       
      
       
       
      
       
       
       
       
       
      
       
       


























Flux (m3/m2.s) Flow Rate (m3/s) Permeability (m2) Resistance (m-1) 
Value Error Value Error Value Error Value Error Value Error 
324 10% 3.7 32.4% 3.33E-06 36.9% 2.82E-10 37.9% 4.19E-16 43.3% 1.31E+11 43.6% 
115 20% 3.7 32.4% 1.18E-06 35.2% 1.01E-10 36.3% 4.19E-16 40.4% 1.31E+11 40.8% 
255 40% 3.7 32.4% 2.62E-06 40.9% 2.23E-10 41.8% 4.19E-16 49.9% 1.31E+11 50.2% 
146 60% 3.7 32.4% 1.50E-06 52.5% 1.27E-10 53.3% 4.19E-16 68.3% 1.31E+11 68.6% 
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